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Raman and infrared (IR) spectroscopies provide detailed information about biological 
constituents such as lipids, proteins, carbohydrates and DNA/RNA, etc. Based on this, 
these techniques can be used to differentiate cells and tissues, as well as employed as a 
diagnostic tool for detecting post-exposure biochemical alterations in toxicity 
assessment due to the induced changes of chemical composition and structure 
reflected by their spectral properties. Over the past few decades, Raman and IR 
spectroscopies with the development of more sophisticated instruments can provide 
high-resolution spectral data from heterogeneous biological samples, which consisting 
of large amount of biochemical information, is complex. Therefore, computational 
analysis is employed to process and analyse the data for obtaining meaningful 
information and getting deeper insight into the wavenumbers-related biochemical 
alterations. Carbon-based nanoparticles (CNPs) are most widely used novel 
nanomaterials. With their widespread application, concerns emerge on their potential 
risk to the health of organism and human, and investigation on their possible toxicity 
is urgently required. This thesis is contributing to the toxicity assessment of CNPs by 
using spectroscopic techniques coupled with computational analysis.  Findings from 
our projects indicated that this approach has the capability of detecting the CNPs-
induced biochemical alterations both in vitro and in vivo, which implies that 
techniques involved in IR and Raman spectroscopy can provide a rapid and highly 
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With the rapid development, nanotechnology is no longer mysterious for the public 
and is no longer the privilege on scientist’s bench; it is more common that the 
nanomaterials present in the commercial or industrial products. They are now 
increasingly found in plastic wares, clothing, cosmetics, electrical appliances, and 
even food products (Becheri et al. 2008; Serpone et al. 2007). Their applications also 
extend into the biomedical field and healthcare, particularly in medical imaging and 
diagnosis, pharmaceuticals, drug delivery, and clinical therapy (Bakry et al. 2007; 
Bianco et al. 2005; Gooding 2005; Katz and Willner 2004; Liu et al. 2009). Due to the 
increasing production of synthetic nanoparticles, the potential release of nanoparticles 
in the environment is supposed to dramatically increase, as well as occupational and 
public exposure to nanoparticles in the coming years. However, many researchers 
have commented that in actuality, there is still much more to be understood about 
nanomaterials, especially that knowledge regarding to the health risks and hazards is 
still limited. 
Traditional Toxicology addresses adverse poisoning effects of chemicals to humans, 
animals and the environment, and it is often associated with the concept of dose and 
dose response. In conventional toxicology, concentration and timeare the two key 
parameters. For single chemicals, it is easy to measure these factors; or for certain 
chemicals of established dose response, threshold levels can be determined whether 
safe or dangerous. However, nanotoxicology as a new branch in toxicology has only 
recently emerged years after the development of nanotechnology. While the properties 
of bulk materials or chemicals have already been largely understood, new 
propertiesare being discovered with the nanomaterials introduced at nanoscale. Their 
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physicochemical properties changes when bulk materials are made into nanomaterials 
(Nel et al. 2006). Additionally, interaction mechanisms between nanoparticles and 
living systems are not yet fully understood. The complexity comes with the particles' 
ability to bind and interact with biological matter and change their surface 
characteristics, depending on the environment they are in. For example, nanoparticles 
of the same material can show different behaviour intracellularly due to their slight 
difference in shape, size and surface charging or coating. The complexity increases 
when moving from in-vitro to in-vivo models. Furthermore, conventional bioassays 
show limitations involving nanotoxicity assessment and new paradigms are required 
to be introduced (Monteiro-Riviere et al. 2009), because there are many more 
variables to be considered in nanotoxoclogy, including    the material, size, shape, 
surface, charge, coating, dispersion, agglomeration, aggregation, and concentration 
(Savolainen et al. 2010). In order to better understand nanotoxicology, reliable and 
reproducible screening protocols are required to test basic materials as well as 
consumer products made from them (Meng et al. 2009). 
Biospectroscopy is a powerful technique widely applied in biological research, 
providing  us with information about the structure, functional groups and environment 
of the biomolecules in  the biological samples (Martin et al. 2010). Moreover, 
spectroscopic methods are optimised with the rapid development of the 
instrumentation, and coupled with spectral data-analysis techniques it provides a 
sensitive and costless method as alternative for conventional bioassays in the 
toxicological research (Ellis and Goodacre 2006; Trevisan et al. 2010). 
In this thesis, biospectroscopic techniques have been used to explore the toxic effects 
in cells and fishes induced by carbon-based nanoparticles.  
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2. Carbon-based nanoparticles 
Carbon-based nanoparticles (CNPs) are man-made materials mainly consisting of 
carbon with a tiny size scale of 100 nm or even less. Among CNPs, Fullerene, single-
walled carbon nanotubes (SWCNTs) and multi-walled carbon nanotubes (MWCNTs) 
are the most widely used and well developed three types of the CNPs in terms of 
research investigations and current applications consumer products. Fullerene is 
known as the carbon molecules arranged into a spherical shape resembling a geodesic 
dome (McHedlov-Petrossyan 2013). And it is commonly identified as molecules of 
CN, N is the number of carbon atoms in the fullerene, such as C60, C70 and C84, all 
well-known. By far, the fullerenes C60 are the most studied and widely used 
compound, and especially they are employed to serve as platforms for producing 
advanced materials. The fullerenes exhibit enormous electron affinity (e.g., the high 
electron-acceptor ability and polarizability), and they are used in versatile applications 
(e.g., electronics, optics, fuel cells, etc.) (Jensen et al. 1996). Single-walled carbon 
nanotubes (SWNTs) are one-layered graphitic cylinders with diameters of a few 
nanometers, whereas multi-walled carbon nanotubes (MWNTs) have between two and 
more concentric cylinders with outer diameters commonly between 30 and 50 nm. 
They are consisting of extensive sp
2
 carbon atoms arranged in fused benzene rings. 
Their extraordinary structures give them exceptional material properties, which 
contribute to the applications in composite materials, sensors, hydrogen-storage fuel 
cells, and various environmental utilizations (Mauter and Elimelech 2008). Thus, it is 
expected that there will be a high production of these CNPs in the following years 




2.1 The release of Carbon-based nanoparticles into environment 
Incorporating CNPs into products means that these nanomaterials will ultimately be 
released into the environment. Carbon nanoparticles enter the environment through 
various routes. It is determined that potential release of nanoparticles to the 
environment possibly occurs during the production of CNPs and the manufacturing of 
CNPs-incorporated products (Bello et al. 2009). Direct release is possible from 
accident causes or spill from equipment during manufacture. It also could lead to 
indirect release via exhaust emission and wastewater discharge. Normal mechanical 
use of the carbon-based consumer products has a lifetime of years. During use and 
disposal, CNPs nanocomposites will be exposed to a wide range of harsh 
environmental conditions, and it is likely to cause the release of CNPs from the 
composites. For example, during use of a CNTs composite framed tennis racket, some 
CNTs may be released whenever the racket frame is scratched by abrasion on the 
court, or after disposal in a landfill or by incineration. In a landfill, the matrix may 
undergo hydrolytic degradation and, to a lesser extent, photodegradation, release to 
the environment (Petersen et al. 2011b). Furthermore, fire or ultraviolet UV radiation 
exposure during the long-term also can accelerate the release of the CNPs from the 
products (Wohlleben et al. 2011). However, there is a knowledge gap regarding the 
fate and transport of any CNPs within engineered systems, including wastewater 
treatment facilities. Nanoparticles synthesized from silver, copper, fullerenes, and 
titanium, cerium, and silicon oxides have already been detected in the sludge at the 
site of wastewater treatment plants (Benn and Westerhoff 2008; Ganesh et al. 2010; 
Kiser et al. 2010). Unfortunately, the removal of the CNPs in wastewater treatment 
plants is not clearly understood. In addition, it is similar to many other pollutants that 
some of the CNPs release occurs from non-point source (e.g., using cosmetics or 
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sunscreen containing nanoparticles; textiles with nanomaterials), which is difficult to 
control. 
Generally, the possible release routes includes discharge during material production, 
incorporation of CNPs into products, the lifecycle of CNPs containing products, as 
well as disposal processes at sewage treatment plants (STP), wastewater incineration 
plants (WIP), landfills  and recycling (Gottschalk and Nowack 2011) (Figure 1). Thus, 
it is possible that humans would be exposed to nanoparticles via inhalation, ingestion 
and dermal absorption in occupational, environmental and consumer settings 
(Johnston et al. 2013). All these potential release pathways pose a serious concern 












2.2 Toxicity of Carbon-based nanoparticles 
Although they are consisting of only one element, the carbon nanoparticle types are 
complex, and they are varying in size, shape, surface charge, production method and 
physicochemical property. These factors may affect their potential toxicity both in 
vitro and in vivo (Figure 2). 
Among these CNPs, C60 is considered  to be the least toxic CNP (Jia et al. 2005). 
Toxic test on the alveolar macrophage, after six hours of exposure to C60, no 
significant toxicity was observed. However, C60 was found to aggregate along the 
plasma membrane. Furthermore, it is evidenced that C60 is likely to pass into the cells 
and accumulates in lysosomes, cytoplasm, and even presents at the nuclear membrane 
and insides the nucleus. Further studies showed that C60 exerts genotoxicity in 
bacteria and leads to DNA damage (Matsuda et al. 2011). However in a previous 
study, it is reported that C60 did not show genotoxicity either in vitro or in vivo 
(Shinohara et al. 2009). Additionally, it showed that in aquatic environment C60 could 
induce oxidative stress in the fish brain and result in lipid peroxidation (Oberdörster 
2004a). 
In contrast to the complicated toxic results for C60, SWCNTs have consistent reports 
on its toxic effects both in vitro and in vivo. In the toxic assessment, SWCNTs ranked 
as the most toxic one among the three types CNPs (Jia et al. 2005). When cells were 
exposed to SWCNTs, toxic effects were found both dose-dependent and time-
dependent (Nel et al. 2009). It is also determined that SWCNTs are able to induce 
oxidative stress in biological systems (Ren and Zhong 2010). In aquatic environment, 
it is reported that the SWCNTs are a respiratory toxicant in fish, involving gill 
irritation and brain injury by SWCNTs (Smith et al. 2007). Studies on MWCNTs have 
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yielded results similar to those of SWCNTs. Studies indicated that CNTs have the 
ability to induce pulmonary toxicity (Kayat et al. 2011), and test on mice showed that 
CNTs could induce inflammation (Crouzier et al. 2010). However, for MWCNTs, the 
one with larger size (especially in length) seems to be more toxic (Lowry et al. 2012). 
 





2.3 Mechanism of nanotoxicity 
The mechanisms underlying the toxicity of nanoparticles have been studied 
intensively, and the generation of reactive oxygen species (ROS) is considered to be a 
predominant mechanism in nanotoxicity, which may lead to subsequent formation of 
oxidative stress (OS) in cells or tissues (Gonzalez et al. 2008) (Figure 3). During the 
metabolism inside the cells, a small amount of the oxygen escaping from the process 
of the ATP synthesis, where a sequence of coupled proton and electron transfer 
reactions involved in, has not been reduced completely and further cause the 
production of the superoxide anion radicals or forming other oxygen-containing 
radicals. Consequently, ROS, biologically including superoxide anion radicals, 
hydroxyl radicals, singlet oxygen, and hydrogen peroxide (H2O2), are then produced 
as the by-products of the cellular oxidative metabolism, and this usually occurs in the 
mitochondria (Halliwell 1991; Turrens 2003).  In some cases, overproduction of ROS 
occurs in cells and induces oxidative stress, resulting in cells failing to maintain 
normal physiological redox-regulated functions (Simon et al. 2000). The dysfunction 
in cells will then cause oxidative modification of proteins to generate protein radicals, 
lipid peroxidation, DNA-strand breaks, and even modification to nucleic acids 
(Bagchi et al. 1995; Cabiscol et al. 2010; Griveau et al. 1995). Furthermore, it will 
impact on the modulation of gene expression through activation of redox-sensitive 
transcription factors, and modulation of inflammatory responses through signal 
transduction, finally leading to cell death and genotoxic effects (Shi et al. 2004; Xia et 
al. 2006). The level of ROS generated by nanoparticles is dependent on the 
physicochemical property of the nanoparticles, including that their small size, large 
surface area and high reactivity. 
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Additionally, the direct interaction between nanoparticles and cells at this nano-bio 
interface is regarded as a physical mechanism (non-oxidative stress effects) in the 
nanotoxicity resulting from the size and surface property of the nanoparticles 
(Elsaesser and Howard 2012). It could lead to membrane disruption, and disturb the 
transport processed on membrane, and even pass the nanoparticle itself into the cell 
and interfere directly with cell function (Shvedova et al. 2012). These effects would 
finally lead to a number of follow-up biological responses in the cell. These cellular 
responses can occur before or after internalisation of particles. 
 




2.4 Interaction of nanoparticles with environmental contamination 
Due to their high adsorption capacity, nanoparticles can be utilized for biomedical 
applications (Bakry et al. 2007; Bianco et al. 2005) or environmental remediation 
(Mauter and Elimelech 2008). However, when nanoparticles are released to 
environment, this inherent property can represent a double-edged sword. Especially in 
aquatic environments, NPs will interact with other components, including not only 
dissolved organic matter, but also hydrophobic organic contaminants and inorganic 
ions, including heavy metals (Aiken et al. 2011; Nowack and Bucheli 2007; Zhang et 
al. 2009). The interaction of nanoparticles with toxic compounds can amplify or as 
well as alleviate the toxicity of both the nanoparticles or/and the compounds, which is 
still largely unknown. Investigations on such binary effects of nanoparticles with other 
compounds were started from the “Trojan horse” effect first postulated by Limbach et 
al, which reported that nanoparticles could facilitate the cellular intake of the absorbed 
toxic molecules (Limbach et al. 2007). However, when this concept is extended to the 
environmental context, the biological effects of the mixtures are difficult to predict. It 
is more challenging to deal with mixture of nanoparticles with other chemical 
compounds rather than that mixtures of common pollution compounds, as the 
interaction of contaminates with nanoparticles is dependent on the characteristics of 
nanoparticles, including the size, composition, morphology, structure, and the status 
of agglomeration/aggregation (Christian et al. 2008). 
Carbon-based nanoparticles have been widely applied in many areas, and they exhibit 
a strong affinity for organic contaminants due to their excellent absorption capacity. 
Adsorption of hydrophobic organic compounds (HOCs) by CNPs may impact on their 
toxicity and affect the fate, transformation, and transport of HOCs in the environment 
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(Yang et al. 2006). Investigations on the absorption of chemical compounds showed 
that it is a complicated process (Pan and Xing 2008), which would turn to be more 
complex in real environmental conditions. Although there are already quite a lot of 
studies being carried out on the toxicity of CNPs, few studies investigated their 
interactive effects with other pollutions or biological organism. The reports on such 
interactive toxicity are sometimes quite controversial. A few investigations 
determined that CNPs could enhance the toxicity of pollution with co-exposure. 
Investigation on the exposure of phenanthrene with the presence of SWCNTs showed 
that the SWCNTs acting as a contaminants carrier could enhance the bioavailability of 
phenanthrene (Su et al. 2013). Other studies also highlighted the same fact underlying 
on C60 (Baun et al. 2008; Lehto et al. 2014). It was determined by in vitro evidence 
that co-exposure of arsenium and C60 could facilitate the uptake of arsenium in 
zebrafish hepatocytes (Azevedo Costa et al. 2012). Another similar study showed that 
C60 could enhance the toxicity in when interacted with B[a]P (Ferreira et al. 2014). 
However, it is not always the case. It was found that when the 17α-ethinylestradiol 
(EE2) was delivered to cultured cells together with carboxyl-functionalized SWCNTs, 
the bioactivity of adsorbed EE2 on cf-SWCNTs was significantly inhibited (Song et al. 
2014). C60 was also found of the capability to reduce the bioavailability of EE2 in 
zebrafish during co-exposure (Park et al. 2011; Park et al. 2010).  Additionally, it was 
reported that MWCNTs could reduce the bioavailability and the toxicity of the biocide 
triclocarban in cells (Simon et al. 2014). In general, the toxicity data reported is quite 
complicated and further work is required to explore the mechanism underlying this 
issue. Moreover, most of the investigations were conducted at a quite high dose of 
CNPs, which requires further studies should be carried out at a realistic environmental 
level, or closer to that level. 
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3. Nanotoxicity assessment: challenges and methods 
Despite the fact that there are already quite a lot of investigations carried out on 
nanotoxicity, the knowledge of the health and safety aspects on nanotechnology still 
lag far behind its development. This is possibly due to that there are still many 
experimental challenges in the toxic assessment of nanoparticles. Recently, most 
methods used are from conventional toxic assessment, which is initially designed for 
chemical toxicity. However, the unique physicochemical properties of nanoparticles 
may interfere with the classical toxicity assays. Their high adsorption capacities, 
different optical properties, and increased catalytic activities can influence the results 
of many in vitro toxicity assays, leading to the misinterpretation of results (Dhawan 
and Sharma 2010). Thus, much more extensive characterization is initially required to 
be carried out on the nanoparticles (such as size, shape, solubility, agglomeration, 
elemental purity, surface area, etc.) than other chemical compounds (Bouwmeester et 
al. 2011; Powers et al. 2007). Incomplete characterization and incorrect preparation of 
nanoparticle dispersion for experiments will hinder attempts to find a correlation 
between various biological effects and particle properties. Moreover, it also requires a 
standard methodology and guideline for different research groups, making it possible 
to compare the toxicity assessment. 
3.1 Limitations in recent toxicity tests for nanotoxicology 
Currently, in vitro assays are commonly applied to screen adverse biological effects 
prior to in vivo testing, allowing for a simpler, faster and more cost efficient 
assessment of defined toxicity endpoints. A number of classical in vitro toxicity 
assays have been utilized to determine cytotoxicity of nanoparticles in cultured cells. 
These relatively simple assays use colorimetric or fluorescent dyes as markers to 
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determine cell viability assessing membrane integrity (e.g., neutral red, calcein AM) 
or cell metabolism (e.g., MTT, alamar Blue). Although these assays have been found 
to provide accurate toxic data for classic pure chemical cytotoxicity studies, they it 
displayed less reliable when assessing nanoparticles. For example, the colorimetric 
MTT assay is a widely used cell viability assay based on the reduction of the yellow 
tetrazolium dye 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltet-razolium bromide (MTT) 
to a purple water insoluble formazan in cells bearing intact mitochondria. When it was 
applied in the experiment to assess the impact of SWCNTs on the cell viability, false 
negative results were reported (Casey et al. 2007b). This is because nanoparticles 
present in the reaction mixture may influence the reaction by increasing the light 
absorption due to their optical property (Wörle-Knirsch et al. 2006). Additionally, the 
same problem appears in other colorimetric methods, including lactate dehydrogenase 
(LDH) assays for cell necrosis (Holder et al. 2012), detection of intact lysosomes via 
neutral red uptaking (Casey et al. 2007a; Monteiro-Riviere and Inman 2006), and 
caspase-3 activity assays for cell apoptosis (Kroll et al. 2009). Furthermore, it is also 
evidenced that NPs could exert influence on the substrates or enzymes in 
immunological experiments (Kroll et al. 2012; Kroll et al. 2009). Absorption of 
cytokines by carbon nanoparticles was observed (Monteiro-Riviere and Inman 2006). 
Generally, it is concluded that the obstacles in these bioassays results from the unique 
properties of nanoparticles including their high adsorption capacity, optical property, 
and potential catalytic activity (Kroll et al. 2009). 
It is generally accepted that in vitro toxicity test on nanoparticles have been the first 
choice for most researchers due to its advantages of faster, convenient, cost less, and 
devoid of ethical issues by contrast to in vivo tests. However, the cell type for in vitro 
testing system is dependent on the route of exposure condition and the investigation 
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aim, but the cell type can influence the results greatly, because different cell type 
would possibly increase or reduce the cellar response as the measurable endpoint of 
the experiments.  It is also a trouble that using cultured cells for in vitro tests have lost 
all the information about the complexity of cell-matrix interactions, the diversity of 
cell types, and hormonal effects present in vivo. Especially, it is impossible to explore 
the long term chronic toxicity without in vivo experiments.  It is also reported that 
toxicity monitoring by in vitro screening studies cannot reflect the actual effects of 
nanoparticles observed by in vivo experiments (Sayes et al. 2007; Warheit et al. 2009). 
While an in vitro system can be used to detect the potential pass across the cell 
membrane of nanoparticles, it cannot explain the realistic pharmacokinetics or 
toxicokinetics of nanoparticles inside the body (Clift et al. 2011). Additionally, it is 
difficult to use in vitro system for identifying some endpoints such as histological 
alterations and the impact on the immune system (Nel et al. 2012). However it is 
certainly important for both in vitro and in vivo tests that the exposure dose of 
nanoparticles used for experiments is derived from the actual scenario, and the 
nanoparticles are well dispersed while dispersant is biocompatible (Hurt et al. 2006). 
3.2 Characterization of Nanoparticles 
In order to measure toxicological endpoints, it requires an initial characterization of 
the test substance prior to any toxicity screening. For nanotoxicology, it is also 
imperative to carry out characterization for nanoparticles before conducting 
experiments. However, distinguished from the common chemical toxicants, 
nanoparticles demand a comprehensive characterization on their physicochemical 
propertied, including size distribution, shape, surface area, crystallinity, purity, 
agglomeration state, surface charge, solubility, etc. (Table 1). But it is difficult to 
 18 
 
conduct a complete characterization of nanoparticles, because in most toxicology 
laboratories the facilities are not fully comprehensive. Therefore, sometimes it is the 
availability of facilities that determines the type of characterization performed rather 
than the design or the aim of the experiments. 
Among all parameters, size is the most important considered for characterization, 
which plays a critical role in nanotoxicity. Light microscopies are favoured techniques 
in the biological science, but they are difficult to adapt for nanotoxicity studies as the 
size scale of nanostructure lies below optical resolution limits. Thus, the most 
commonly used techniques includes scanning electron microscopy (SEM), 
transmission electron microscopy (TEM), dynamic light scattering (DLS) and atomic 
force microscopy (AFM). Electron microscopy is a simple technique that can directly 
measure the size and morphology of the particle, as well as the size distribution. 
However this technique has some disadvantages that it is quite time-consuming and 
requires specific sample preparation. Moreover, the measurement is carried in a 
vacuum condition with dry samples, which may alter the property of the samples. 
Thus it is not able to analyse the samples in dispersion. By contrast, the AFM is a 
cost-efficient technique that can perform the characterization in air or in liquid 
dispersions. It can provide information on many physical properties, such as size, 
morphology and surface state. Technique of DLS is straightforward to measure 
hydrodynamic diameter under the conditions closer to the exposure situation. But it 
usually gives a larger size than the other techniques, due to the solvent layer outside 
the particles is calculated including. 
In many toxicity investigations of nanoparticles, there is a primary limitation that it 
lacks quantification of the nanoparticles concentrations in the test media. It is 
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suggested that it requires a quantification measurement at the beginning and the end of 
experiments when a specific dose is adopted. Recently, the quantification 
measurements of nanoparticles in the aqueous phase have been conducted most 
commonly in experiments with C60 fullerenes. This is because C60 can be simply 
measured under ultraviolet-visible (UV/vis) spectroscopy following toluene extraction 
(Hungerbuehler et al. 1993; Tervonen et al. 2010). However, the concentrations of 
CNTs in aqueous phase are limited to nominal concentrations; fractions of CNTs 
appear commonly in the dispersion. Nevertheless, other techniques such as 
spectrofluorometric determination, thermal optical transmittance, and radioactivity 
measurements for radioactively labelled nanoparticles, are available for quantification 
measurements (Petersen and Henry 2012). 
In general, other parameters of the nanoparticles also require characterisation to 
correlate to the toxicity, and many methods still need optimization and development, 
especially for new types of nanoparticles in aqueous dispersion, while extensive 





Table 1  Characterisation techniques for nanoparticles 
 










1) Analyse sample under high 
vacuum 
2) Samples require drying; not 
capable of aqueous samples 
3) It is time-consuming 
4) It requires a sufficient 
amount of nanoparticles for 
size distribution analysis 
5) SEM usually possesses a 
lower resolution than TEM 
Dynamic light scattering Size ( 
Size distribution 
agglomeration 
1) The measured size is larger 
than the real size 
2) It is not compatible for 
carbon nanotubes 







1) It is no necessary to conduct 
analysis in vacuum 
2) It is cost-effective 






1) It can identify the purity of 
nanopartciles 
2) It can determine the 
chemical composition, 







1) It is highly sensitive 





3.3 Dispersion of nanoparticles for toxicity tests 
It is one of the key facts in toxic assessment of the carbon nanoparticles (CNPs) both 
in vitro and in vivo of how to disperse CNPs in toxic test, because the aggregation or 
agglomeration of CNPs in culture media or vehicles complicates the interpretation of 
the toxicity test results. It has been shown that unstable and agglomerated 
nanoparticles dispersions used in toxicity tests could result in inaccurate data for 
nanotoxicity and even cause misleading conclusions (Jiang et al. 2009). It was also 
found that the hydrodynamic size of the nanoparticles is often larger than the primary 
size when dispersed in liquids. Thus, it is important to understand the behaviours of 
nanoparticles under different solution conditions prior to the toxicity assessments, and 
this will highly facilitate these investigations. 
The weak or strong forces among the molecules or atoms, respectively, including van 
der Waals forces, electrostatic forces, and sintered bonds, tend to give a rise to the 
agglomerate and aggregate for nanomaterials (Porter et al. 2008; Sager et al. 2007). 
Especially, the van der Waals interaction energy of tube-tube contact that bundles 
CNTs is relatively high, which makes CNT dispersion one of the most important 
challenges for the widespread industrial application of CNTs (Girifalco and Hodak 
2002; Girifalco et al. 2000; Madni et al. 2010). Agglomeration is defined as the 
collection of weakly bound particles or aggregates or mixture of both, which is found 
to result in external surface areas is nearly equal to the sum of the surface areas of the 
individual components. However, aggregation is defined as the collection of strongly 
bonded or fused particles, which causes that the external surface areas possibly shrink 
in comparison to the sum of calculated surface areas of the individual components. 
This indicates that aggregates are held by strong forces, such as covalent bonds. 
Therefore, agglomerations are more loosely bound particles, which may be because of 
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the high ionic strength shielding the nanoparticles charge repulsion, while 
aggregations represent highly tight bound or fused particles, and it alters the size, 
surface area and the physicochemical property of the nanoparticles (Jiang et al. 2009; 
Keller et al. 2010). 
The nanomaterials are dramatically different form their bulk ones in terms of the 
physicochemical property. Agglomerations appear to have a high impact on the 
biological effects of nanoparticles by contrast to the well-dispersed ones. It was found 
that dispersed SWCNTs could significantly inhibit the proliferation of BEAS-2B cells, 
while non-dispersed SWCNTs had no effect on the cells (Wang et al. 2010).  Thus 
how to disperse nanoparticles is also one of the most important determinants in the 
toxic test for CNPs (Bihari et al. 2008; Buford et al. 2007; Foucaud et al. 2007; 
Vippola et al. 2009; Warheit 2006). What is more important? The dispersant used for 
CNPs itself should have no adverse effects on the test system. For example, the 
dispersant should not exert toxic effect on the cell lines, microorganisms and animals 
used in the test, or the effects are eliminated to minimum extend if there’s no better 
choice. However, it is a tough job to find a good dispersant for the CNPs toxic tests 
meeting the requirements of biocompatibility, dispensability and dispersion stability. 
Fullerenes C60 were the first artificial nanomaterial and gained much attention. 
Aqueous C60 can be generated by using water or other vehicle solvent. Previously, 
tetrahydrofuran (THF) has been used to prepare aqueous C60 as a vehicle solvent in 
toxicology studies (Deguchi et al. 2001; Lovern and Klaper 2006; Oberdörster 2004b). 
However THF can change the surface charge of C60 particles, and THF can still be 
retained in C60 aggregates (Brant et al. 2005). This could possibly lead to false 
positive results in the toxic test of C60, because of that the actual toxicity result from 
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the presence of THF or its degradation products were neglected. This speculation was 
later determined by investigation conducted on larval zebrafish that a THF 
degradation product (γ-butyrolactone) played a key role in the toxic effects rather than 
that induced by C60 (Henry et al. 2007). 
Despite the solvent, CNPs can also be suspended using a range of natural and 
synthetic polymers and surfactants such as natural organic matter (NOM), sodium 
dodecyl sulphate (SDS), polyvinylpyrrolidone (PVP), and polyethyleneimine (PEI). 
The role that these surface coatings have in CNP toxicity is not yet well understood, 
but limited numbers of studies have investigated this topic using Daphnia magna 
(Edgington et al. 2010; Petersen et al. 2011a). Researchers also turned their eyes to 
other dispersant for CNPs, such as distilled water, dimethylsulfoxide (DMSO), a 1,2-
dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) solution, bovine serum albumin 
(BSA) and Tween 80, and it suggested that appropriate dispersants were proposed 
according to the type of CNT (Kim et al. 2011). In addition, it is important to test the 
dispensability, dispersion stability, and biocompatibility of the selected dispersant 




Table 2 Possible obstacles in the dispersion method for nanoparticles 
 
Dispersion approach  Disadvantages 
Using solvent or 
chemical dispersants 
1) The possible toxicity of the solvent or dispersants; 
2) The residue solvent or dispersants in nanoparticles, e.g., 
tetrahydrofuran in fullerene C60; 
3) A solvent control is required; 
4) Solvent or dispersant may change the characteristics of 
the nanoparticles, such as shape, surface chemistry. 
Ultra-sonication 1) It may break the carbon nanotubes into small pieces by 
high energy, or it can damage the surface of 
nanoparticles; 
2) Long time sonication may generate lots of heart and 
increase the temperature 
3) Only using sonication may not maintain the dispersion 
of nanoparticles for a long period. 
Stirring 1) It often takes very long time; 
2) It may break the nanotubes or alter the surface of the 
nanoparticles; 
3) Only using stirring may not maintain the dispersion of 






Spectroscopy is a powerful technique, which is traditionally used by chemists and 
physicists to identify the unknown molecular entities. With the spectroscopic 
instruments updated, spectroscopy shows its ability to characterise biochemical 
components in complex bio-samples and it has been introduced to many biological 
research laboratories, where biospectroscopy starts. Conventional bio-assays are 
usually time-consuming and labour-intensive; especially it requires expertise training 
on the sample preparation and test conduction. Additionally, some agents used in 
these bio-assays are expensive. In contrast with these traditional techniques, 
biospectroscopy provides a rapid, label-free analytical route for biological research. 
Particularly, it can save time and labour, and only requires a minimum amount of 
training for experiment conduction. Mainly there are two spectroscopic approaches 










4.1 Infrared spectroscopy  
Biomolecules are characterised by IR spectroscopy due to the IR absorption of the 
vibration movements (e.g., bending, stretching, wagging or scissoring) in their 
chemical bonds. IR absorption occurs at a specific wavenumber corresponding to the 
specific energy of the vibrational movement. Thus, peaks in the IR spectra particularly 
present identical chemical bond in the samples. For biospectroscopy, the mid-infrared 
(MIR) spectroscopy (4000-400 cm
-1
 in wavenumbers) is commonly used.  In contrast 
to the near-infrared (NIR), MIR contains fundamental vibrational transitions rather 
than overtones. This means MIR can provide inherently higher signal intensities given 
the increased absorption cross-section. Furthermore, within MIR, the range of 1800-
900 cm
-1
 is regarded as the biochemical fingerprint region for bio-samples, because 
this region can generate identifiable peaks at specific absorption frequencies, such as 
Amide I (~1650 cm
-1
), Amide II (~1550 cm
-1





), glycogen (~1030 cm
-1
), lipids (~1750 cm
-1
), asymmetric phosphate 
stretching vibrations (νasPO2; ~1225 cm
-1
), symmetric phosphate stretching vibrations 
(νsPO2; ~1225 cm
-1
) and protein phosphorylation (~970 cm
-1
)(Kelly et al. 2011). 
Fourier-transform infrared (FTIR) spectrometer is widely applied in biological studies. 
The most used IR spectroscopic methods are transmission, transflection and 
attenuated total reflection (ATR) (Figure 5).  On transmission mode, infrared beam is 
directly passed. Transflection is another method, where IR beam is reflected off by an 
IR-reflective surface [such as that found on low-emissivity (Low-E) slides], travels 
back through the sample to the detector. In these two modes, the beam is travelling 
through the absorbing sample, thus it requires short pathlengths in the samples. This 
means the thickness of the samples is quite critical; too thick will cause too long 
 28 
 
pathlength of IR beam in sample, which would result in all the IR radiation being 
absorbed by the sample and none reaching the detector. Utilizing the same principle, 
but based on a different pathway, ATR-FTIR spectroscopy directing the infrared light 
at an interface between an infrared transparent material with a high refractive index 
called the internal reflection element (IRE, e.g., a prism made of ZnSe, diamond, 
silicon or germanium) and a sample on the surface of the IRE. Because in this 
situation the angle of incidence of the IR beam is greater than the critical angle, total 
internal reflection occurs consequently. At the reflecting surface, a standing wave of 
radiation (i.e., an evanescent wave) is established, and this evanescent wave interacts 
with the sample, attenuating the infrared beam of light exiting the IRE back to 
detector. The depth of penetration for the evanescent wave in a sample is dependent 
on the angle of incidence and the refractive indices of both the IRE and the sample. It 
is typically in the range of 0.5-2 µm (Kazarian and Chan 2013). However, since the 
evanescent wave reaches deeper site in the sample than the depth of penetration, it 
should be noted that absorbance information is obtained from the sample beyond this 











The combination of FTIR with optical microscopy has been frequently used for 
imaging. Due to the property of the IR spectroscopy, FTIR microscopy is a useful 
non-destructive and label-free molecular imaging tool, providing chemical specificity 
of mid-infrared spectroscopy with spatial specificity (Bhargava 2012). In this 
approach, an absorption spectrum is regarded as a molecular fingerprint of sample at 
every pixel, and biochemical information can be extracted from each spectrum that 
can be correlated with known biochemical structure. Conventional IR microscope is 
coupled to interferometers equipped with globar sources, and image maps are obtained 
by raster scanning with single-point detectors. This means the conventional IR 
microscope has the drawback that the acquisition time for a high-resolution 
microspectroscopic map is highly time-consuming. Thus, a synchrotron beam is 
employed to replace the thermal IR source, in order to improve the signal-to-noise 
ratio (SNR) and spatial resolution (Miller and Dumas 2006; Nasse et al. 2011). 
Furthermore, a focal plane array (FPA) multichannel detector is used instead of the 
single element detector to accelerate data acquisition through parallel detection in 
benchtop instruments (Baker et al. 2014). It is now determined that the coupling of 
synchrotron light with a wide-field FPA detector can highly increase the SNR of 










4.2 Raman spectroscopy 
Raman is a scattering technique, measuring the interaction when the photon from a 
monochromatic light source (i.e., laser) encounters the chemical bond in molecules 
(Figure 6). Following the light photons are absorbed and released back, the vibrational 
energy of the molecules are also caused to increase and decrease subsequently. In this 
situation, sometimes the molecules do not return back to its previous energy state, 
there will be a frequency shift occurring in the released photon in order to maintain 
the energy balance. This phenomenon of shift is inelastic scattering or so-called 
Raman scattering (Kneipp et al. 1999). However, this does not occur efficiently; the 
incidence is less than 1% of the total photons absorbed by the molecules. The back-
ward light is then filtered that only the Raman scattering reaches the detector and 
generate a spectrum. 
For chemical analysis, IR spectroscopy is currently the most used vibrational 
spectroscopy technique, mainly because it is higher intrinsic sensitive and much 
cheaper for instrument when compared with the Raman spectroscopy. However, in 
biological systems, IR spectroscopy has a severe disadvantage that there is a strong 
absorbance of the ever-present water (Ellis and Goodacre 2006).  Although NIR with 
less sensitivity is not limited by water to the same e, the bands in NIR region are 
mostly overtones and combination bands, which are too broad to serve as convenient 
identifiers of complex systems (Wang and Mizaikoff 2008). Such a situation leaves 
Raman spectroscopy as the most suitable vibrational spectroscopy of biological 
systems. 
The major advantage distinguished from IR spectroscopy is that Raman spectroscopy 
is rather oblivious to aqueous environments (Krafft et al. 2009). The Raman cross-
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section of water is very small. Furthermore, progress has been made in Raman 
instrumentation, including higher sensitive detectors, more efficient rejection filters, 
and improved collection system. This step forward has bridged up much of gaps in the 
sensitivity and cost between IR and Raman spectroscopy.  Nevertheless, by the nature 
of how Raman spectroscopy works, the basic disadvantage of normal Raman 
spectroscopy is its inherent weak intensity and corresponding low sensitivity. This is 
still an obstacle for the routine use of Raman. This disadvantage is especially distinct 
in biological systems, because here many of the target biocompounds are present at 
low concentrations. Additionally, due to its unselective nature to the various 
molecules present in the biological samples, Raman often generates highly congested 
spectra, that are usually very difficult to analyze. Besides, normal Raman often 
encounters a strong fluorescence background, giving rise to deteriorate the quality of 
the spectra, and bring down the signal-to-noise ratio (SNT). 
4.3 Surface-enhanced Raman spectroscopy 
When using the normal Raman, one often encounters a strong fluorescence 
background (intrinsic or impurity-originating) that deteriorates the quality of the 
spectra, and adversely affects the signal-to-noise (S/N) ratio. Surface-enhanced 
Raman spectroscopy (SERS) (Figure 7), by its nature of enhancing the Raman cross-
sections, can provides intense spectra and help us overcome these disadvantages of 
normal Raman. It provides us a rapid and highly sensitive tool to detect chemical 
structure information for the application in biological research. SERS significantly 
improves the S/N ratio by the ability of SERS-active substrates to quench fluorescence. 
The field of SERS has started since it was first time recognized that Raman spectra of 
sub monolayer coverage of molecules could be acquired on electrochemically roughed 
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coinage metal surfaces (Albrecht and Creighton 1977; Jeanmaire and Van Duyne 
1977). Although research struggle was paid, the mechanism underlying the highly 
enhanced spectra by SERS is not completely understood yet. In general the 
enhancement factors for SERS, as compared to normal Raman scattering, are mainly 
attributed to two mechanisms: an electromagnetic enhancement mechanism and a 
chemical  enhancement (charge-transfer)) mechanism (Campion and Kambhampati 
1998; Moskovits 1985). Plasmon, so called as the collective excitation of the electron 
gas of a conductor, its energy on a smooth surface is bound to the surface. Thus, on a 
suitably roughened surface, the plasmon with a perpendicular component is created. 
When exciting radiation (laser beam) interacts with the surface, the plasmon energy 
causes the Raman process to occur in the analyte molecule. Then the energy is 
transferred back into the plasmon, and also into the scattered radiation, which is 
shifted in frequency by the energy transferred to the nuclei in the Raman process, is 
detected by the spectrometer.  Generally, the electromagnetic field of the radiation at 
the surface can be greatly enhanced under conditions of surface plasmon excitation, 
and both the incident laser field and the scattered Raman field are amplified via their 
interaction with the surface, and these constitute the electromagnetic SERS 
mechanism (Campion and Kambhampati 1998). Charge-transfer (chemical) 
enhancement, regarded as a second enhancement mechanism, operates independently 
from the electromagnetic mechanism. In this situation, the molecule is bound to the 
metal surface to form a charge transfer complex.  When the exciting radiation interacts 
with the metal, form an electron–hole arises and energy is transferred to the analyte 
through the new metal to the bonds of the molecule.  While the Raman process occurs 
on the analyte, and the energy is then transferred back into the metal for scattering, 
and an enhanced signal will be detected. For highly optimized surfaces, the total 
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SERS enhancement factor may approach ~ 10
10–1011 (Sharma et al. 2012). This makes 
SERS an ultrasensitive detection tool; even the single molecule level can be detected 
(Camden et al. 2008; Kneipp et al. 1997). It is generally acknowledged that the 
electromagnetic effect make a much greater contribution to the enhancement by 
contrast to the charge-transfer effect. Additionally, electromagnetic enhancement is 
regarded as a nonselective amplifier for Raman scattering by all molecules adsorbed 
on a particular surface (Hering et al. 2008). However,  as the dominant contributor to 
most SERS processes is the electromagnetic enhancement mechanism, the maximum 
SERS enhancing region decreases dramatically rapidly with distance (r
-10
 for spheres), 
and the largest enhancement can be found only in a few nanometre closest to the Au 
nanoparticle surface (Stiles et al. 2008). 
The success of SERS is highly reliant on the interaction between the analyte molecule 
and the surface of plasmonic substrates. Usually, gold (Au), silver (Ag), or copper (Cu) 
are used as the classic SERS substrates. Due to their stable physicochemical property, 
Au and Ag are most often used SERS substrates. Since surface plasmons have to be 
excited by the incident laser beam, the excitation wavelength for a SERS experiment 
must be adapted to the plasmon wavelength of the respective metal and also to the 
nanostructure of the metal surface, which also has an effect on the plasmon resonance 
wavelength (Campion and Kambhampati 1998). Thus, SERS excitation lines cover 
mainly the visible spectral region and the near infrared (NIR) wavelength range (Stiles 
et al. 2008). With the development of SERS, novel SERS substrates have been 
introduced, including Au and Ag nanoparticles with various shapes and even with 
coating to form the shell-isolated nanoparticle (Li et al. 2010), such as Au-Ag core-
shell particle (Cao et al. 2001),  SiO2 coating Au nanoparticle colloids (Lu et al. 2002), 
2D Ag nanoparticle arrays (Cho et al. 2012), and nano-Au film (Wang et al. 2009). 
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Beyond Au and Ag, other metals including the alkali metals (Li, Na, K, Rb, and Cs), 
Al, Ga, In, Pt, Rh, and metal alloys have been explored in the applications for 
plasmonic substrates for SERS (Sharma et al. 2012). And applications of novel 
nanomaterials such as graphene (Huang et al. 2010; Ren et al. 2011; Zhang et al. 2011) 
and quantum dots (Kulakovich et al. 2002; Quagliano 2004) have recently been 
reported as well. 
 
 










5. Spectroscopic Data analysis 
The using spectroscopic techniques in biological research can generate tremendous 
amount of data. And the advancement of the spectroscopic instrumentation has even 
led to an explosive growth in stored or transient data. All these data provide us 
massive information on the biochemical constituents in the biological samples such as 
DNA/RNA, proteins, carbohydrates and lipids. Owing to the heterogeneous nature of 
bio-molecules, the spectroscopic data derived from biological samples are complex 
and diverse. This means that tiny differences in these data may contain critical 
information. Thus, it is difficult to interpret the information in the spectra by a simple 
data-analysis method. To overcome these intricacies and gain a deeper insight into the 
data, it is urgent to introduce new and automated methods for the spectral data 
analysis (Figure 8). 
5.1 Pre-processing for spectra 
Spectral data pre-processing is an important step in workflow of the spectral data 
analysis (Figure 8). And it has been regarded as an indispensable part involving 
specific processing procedures performed on the raw spectral data. It is recognised 
that the a proper pre-processing data is the basis for a better performing of the 
quantitative and classification models on data when compared with that solely using 
the raw data (Heraud et al. 2006; Liu et al. 2003). Generally, a proper data pre-
processing could help improve the robustness and accuracy of subsequent quantitative 
and classification analysis; format the data to be better understood by researchers and 
computer; detect and remove the outliers and trends; and cut out the irrelevant or 
redundant information by feature selection (Lasch 2012). 
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5.1.1 Pre-processing in IR spectra 
For the repeatability and reproducibility of the spectra, quality test is performed on the 
dataset firstly, which can be also considered as outliers test. The outliers are the 
“wrong” measurements that are unsuitable for data analysis, which may be resulted 
from instrument saturation (too high absorption because of excessive sample 
thickness), instrument malfunction, atmospheric changes, gas contamination, 
excessive scattering or dispersion phenomena, and excessive noise (Trevisan et al. 
2012). The quality test can help us check for the absorption bands of atmospheric 
water vapour, samples thickness, and the spectral signal-to-noise ratio (SNR). The 
water vapour disturbance in the spectra now can be successfully compensated by the 
software (e.g., OPUS) (Naumann 2008). According to the quality test, the outliers 
could be then removed. 
5.1.1.1 Normalisation 
The use of normalization allows an effective comparison in classification analysis of 
the IR spectra derived from heterogeneous sets of samples. Normalisation can be 
applied to minimize the impacts of varying optical pathlength on the spectra, to 
compensate for the intensity variations of the IR source, or to correct for the different 
sample thickness or concentrations. 
During the IR spectra acquisition, spectral baseline could be distorted due to the 
scattering problems or IR absorption by the supporting substrates in transmission and 
transflection FTIR, or the change of instrumental factors. In each situation, a baseline 
correction is required to make the spectral parameter more accurately (Mazet et al. 
2005). There are numerous methods suggested for the baseline correction, while most 
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of them are mainly based on the distinct principles and algorithms, and aim to 
minimize unwanted spectral offsets, broad baseline distortions, and positive or 
negative slopes.  For example, rubberband baseline correction can be used to achieve 
baseline correction; it can stretch the spectra down such a minimal area of the spectral 
region to fit a convex polygonal line and then subtract spectra from the original 
spectrum. Differentiation is also used as a means for both bassline correction and to 
resolve overlapped bands, which frequently occurs in IR spectra. First-order 
differentiation is most frequently used single pre-processing step, while the second-
order one is applied together with vector normalisation. However, the differentiation 
at each order can enhance the spectral noise by one order of magnitude(Trevisan et al. 
2012). For de-noising, Savizky-Golay (S-G) smoothing and Wavelet de-noising 
(WDN) can be used. WDN utilizes non-linear filtering implemented through multi-
scale decomposition and thresholding (Trevisan et al. 2012). WDN method is 
considered as a better alternative, especially for the spectra that contain sharp peaks 
(i.e., Raman spectroscopy). 
In some cases, differences in the sample thickness or concentration can be the main 
cause of the spectral variation among samples (Shin and Markey 2006). To minimize 
these adverse impacts, the spectra need to be scaled to match a specific criterion. Most 
occasionally, if there is such a peak consistently presenting in all spectra in the dataset, 
normalisation to a particular peak can be applied. For examples, spectra can be 
normalised to amide I peak (~ 1650 cm
-1
) or amide II peak (~ 1550 cm
-1
). When there 
is no apparently consistent peak across the spectra, vector normalisation is often 




5.1.2 Pre-processing in Raman spectra 
Generally, most of the pre-processing methods employed on the IR spectra can be 
shared using the Raman spectral data. Many studies suggest that there are no principle 
differences on the applicability of quality test, baseline correction, and normalisation 
methods between the Raman and IR spectra. However, for exceptions, it is not 
necessary to take the correction water vapour and resonant Mei scattering into account 
during the pre-processing on Raman spectra. But it is more important to notice that a 
lower SNR often occurs in Raman spectra of biological samples. For this fact, it is 
particular important to introduce de-noising methods in the Raman spectra pre-
processing. Due to the nature of the Raman instrument, a sharp and intense cosmic ray 
artefact would occur in the spectra by random, and the fluorescence back frequently 
turn up in the spectra in the same wavelength region with the Raman signal. Thus, the 
pre-processing in Raman spectra focus on the methodologies to the disadvantages of 
cosmic ray and strong florescence background (Lasch 2012). 
Cosmic ray could be generated when the high-energy cosmic particles hit the charged-
coupled devices (CCD), which is used as the sensitive integrating detector in Raman 
spectrometers. This cosmic ray may then superimpose on the Raman signals. A few 
methods have been carried out to eliminate the occurrence of the cosmic ray (Li and 
Dai 2011; Zhang and Ben-Amotz 2002; Zhao 2003). As the cosmic ray are usually 
sharp and intense peaks superimposed in the raw spectra. Thus, following a simple 
correction the spectra containing cosmic ray can be easily found out and discarded. 
By contrast to the random occurrence of cosmic ray, it is ubiquitous for the 
fluorescence background in Raman spectra. The fluorescence background is intense; 




 times more intense than Raman scattering (Mosier-
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Boss et al. 1995). Therefore, software-based methods have been developed for 
fluorescence background correction, which comprising purely mathematical or 
chemometric techniques. Among the mathematical methods, polynomial baseline 
fitting is the most commonly used, due to its advantages of speed, simplicity and 
convenience (Zhao et al. 2007). When using this approach it is important to define the 
polynomial order sufficiently low that it can not only reduce the complexity of the fit 
model but also avoid over-fitting. The usual polynomial order values vary between 4 
and 6 (Zhao et al. 2007). 
5.2 Feature extraction 
 Feature means the input variable; the absorbance intensities at each wavenumber 
collected by the spectrometer can be regarded as the total variables in the dataset for 
input to the multivariate data analysis. The feature extraction can be simply 
understood as the procedure to produce a small number of variables which still keep 
the main key information for the original whole set of the wavenumber-variables. 
Thus, multivariate data-analysis techniques have been employed in the feature 
extraction process. Multivariate data analysis involves in the mathematical, statistical 
and computer science to efficiently extract useful information from the spectral data. 
5.2.1 Principal Component Analysis 
Principle component analysis (PCA) is an unsupervised data analysis technique 
employed to reduce dimensionality and generate a visualization of the data (Kelly et al. 
2011).  PCA is a commonly technique that based on evaluating the total variances 
within a dataset via Eigen analysis. PCA method is projecting a higher dimensional 
data matrix “X” (matrix “X” consisting of m object rows and n variable columns, m × 
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n matrix; m objects are observations [i.e., spectra]  and n variables are measurements 
[i.e., wavenumber]) onto a low component subspace; It is a linear transformation of 
the wavenumber dataset operated by the PCA loadings matrix (Kelly et al. 2011).  
And the loadings vectors (commonly called principal components [PCs]) within this 
matrix are eigenvectors of the covariance matrix of the data. These PCs are obtained 
by calculating the eigenvectors and eigenvalues of the covariance matrix obtained 
from the data matrix. The eigenvector with the highest eigenvalue gives rise to the 
first PC (PC1), which is lying on the direction of greatest variance in the data. “PC1” 
is the direction (axis) that maximizes the longitudinal (along axis) variance or the axis 
that minimizes the squared projection (transverse) distances. All PCs are orthogonal to 
each other, which mean each loading forms an angle of 90° with all the other loadings. 
Thus, the PCs are completely uncorrelated and independent. 
For an X-matrix (m × n), the largest number of PCs is either one less than the number 
of objects (m-1) or equal to the number of variables (n), depending on which ever is 
smaller (Gautam et al. 2015). However, the higher-orders of the PCs are regarded as 
noise factors which contain useless noise component for the spectral dataset. To 
understand importance of the PCs order, “percentage of variance explained” has been 
used to determine this (Westerhuis et al. 1998). Usually there is a steep increase in 
percentage of variance explained, followed by a flat line. No matter how many 
spectral channels there are, the relevant information (spectral variance) can be 
explained by the first few dominant PCs while repeated information is present in 
various spectral channels. Commonly, the first three PCs were selected (each 
contributes higher than 5% percentage of variance with total cumulative value of 
above 90 %) for optimum visualization of the spread of the data. 
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PCA is undoubtable a powerful dimension-reduction data analysis technique with 
capability of identifying some important structural information in the data, and it is the 
fundamental basis of many other multivariate data analysis technique. However, PCA 
is only capable of recognising total variance regarding a whole dataset, but without the 
capability to identify within-group and among-group variance due to the fact that it is 
an unsupervised procedure (Wang and Mizaikoff 2008). Often, in order to interpret 
the complex biochemical information from vibrational spectroscopic techniques, it 
requires further data analysis using supervised procedures like LDA, PLS, PCR etc. 
5.2.2 Linear Discriminant Analysis 
LDA is a supervised technique which forms linear combinations of variables 
dependent on differences between the classes in the data set (Kelly et al. 2011). In 
LDA method, data can be projected into the new dimensional space using these axes 
found with LDA. In the new dimensional space, each observation would have fewer 
variables and at the same time observations belonging to the same class will form 
lumps (clusters) and each cluster would be clearly differentiated from the other. A 
particular feature of LDA is that it may achieve maximum separation between classes 
over the within class by carefully establishing the discriminant function(Kelly et al. 
2011). Following LDA applied, the data set will have only c - 1 variables, where c is 
the number of data classes. The Euclidean distance (ED) or Mahalanobis distance 
(MD) is usually calculated. Based on the distance of the unknown samples to the 
centre of each class, they are used in LDA to classify unknown ones. In order to 
establish a reliable classifier using LDA, it requires a much higher number of objects 
than that of variables (Wang and Mizaikoff 2008). Hence, it is necessary to do data 




It is very useful to combine both PCA and LDA approaches (called PCA-LDA model). 
The PCA-LDA model improves the efficiency of classification as it automatically 
finds the most diagnostically significant features. PCA is applied to the original 
dataset first, and only the first few principal component scores are retained for further 
LDA. The resulting Linear Discriminant scores matrix represents compactly the 
original data and very efficiently differentiates one class from another. However, there 
is one important factor for consideration that how many PCs to include when applying 
LDA following PCA. Too few PCs will cause an information missing for the spectral 
dataset, while too many will increase the amount of noise in the data, and may lead to 
LDA overfitting (Kelly et al. 2011). Commonly, 10 factors is a compromise on both 
situations, since that  more than 99% of variance is captured in the first 10 PCs, while 
more than 20 PCs includes too much noise (Kemsley 1996). Similar to PCA, loading 
analysis can also be performed using the PC-LDA model, where each LD loading can 
be represented as a linear combination of PC Loadings. Thus, it can be used to 
understand and identify specific vibrational bands corresponding for the differences 
between classes (Gautam et al. 2015). 
5.3 Visualisation of the processed spectral data 
Following the multivariate data analysis, most of the information in the spectra has 
been extracted. Resulting scores and loadings plots provide a visual representation and 
interpretation of variables responsible for any difference. To simple see the 
differences between the groups, using the factor scores resulting from the analysis 
could easily draw dimensional scores plots graph (e.g., 1-, 2-, or 3-D scatter plots) 
(Figure 8), which facilitate the visualisation of the segregations between classes 
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(Llabjani et al. 2009; Llabjani et al. 2010). Furthermore, coefficients of loadings 
vectors of either technique can be plotted against the wavenumber axis to reveal the 
contributions of each wavenumber to form each corresponding factor for class 
separation and compactness, because the loadings vectors have the same resolution as 
the original spectra. Additionally, the loadings can also show which the most 
distinguishing wavenumbers are. Each distinguished wavenumber is then related to 
the corresponding biochemical and identified as a potential biomarker to specific 
category. 
It is the fact that loadings vectors are found to be more informative when they “pass 
through” data points instead of pointing toward void space (Martin et al. 2007). Thus, 
a cluster vector approach is developed, a geometric construction that can be applied to 
any of the linear techniques described, while it is more often employed following 
PCA-LDA (Kelly et al. 2011). There is only one cluster vector for each data class by 
contrast to the loadings vectors. Each cluster vector is the vector that points from the 
origin to the centre of its corresponding data class in the vector space spanned by the 
loadings vectors. The centre of a given class is calculated by taking the average 
between all points belonging to the class. However, when it requires comparing the 
objective groups with the control ones, this approach will bring inconvenience to 
identify the biomarker differences in the objective groups compared to the control 
ones, because in this approach the “control” class itself has a cluster vector. In order to 
overcome this disadvantages, the cluster vector for the “control” class is transformed 
to the zero vector by shifting the origin of the factors space to the centre of the 
“control” cluster (Llabjani et al. 2010), whereas the other cluster vectors express 
comparisons of data classes against their corresponding vehicle control. This approach 
is particularly useful when there are many classes and interpretation of the scores and 
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loadings plots is both complex and subjective. To simplify the identification of the 
main biomarkers for each class, cluster vector peak plots were used to indicate the 
first few highest peaks in the cluster vector plots (Llabjani et al. 2011). 
6. Aims and objectives 
This thesis is mainly consisting of four research projects, which are focusing on 
utilisation of biospectroscopy in the toxicity assessment of the four types CNPs both 
in vitro and in vivo, as well as a cooperative project of using IR spectroscopy to 
identify the alteration in MCF-7cells by Benzo[a]pyrene. The main objectives of the 
four projects are listed below: 
 To investigate the dose-response effects of the three CNPs (C60, short and long 
MWCNTs) in MCF-7 cells at a low dose treatment by using ATR-FTIR and 
Raman spectroscopy (Chapter 3). 
 To assess the nanotoxicity of the four types CNPs (C60, short and long MWCNTs, 
SWCNTs) in zebrafish with a low-dose chronic exposure and detect alterations in 
tissues by ATR-FTIR and Raman spectroscopy (Chapter 4). 
 To investigate the nanotoxicity of the four types CNPs in A549 cells with 
biospectroscopic techniques of ATR-FTIR and SERS (Chapter 5). 
 To explore the binary effects of C60 and B[a]P in two cell lines (gill cells and 






Aiken, G.R., Hsu-Kim, H. and Ryan, J.N. 2011. Influence of Dissolved 
Organic Matter on the Environmental Fate of Metals, Nanoparticles, and Colloids. 
Environ. Sci. Technol. 45, 3196-3201. 
Albrecht, M.G. and Creighton, J.A. 1977. Anomalously intense Raman spectra 
of pyridine at a silver electrode. J. Am. Chem. Soc. 99, 5215-5217. 
Azevedo Costa, C.L., Chaves, I.S., Ventura-Lima, J., Ferreira, J.L.R., Ferraz, 
L., de Carvalho, L.M. and Monserrat, J.M. 2012. In vitro evaluation of co-exposure of 
arsenium and an organic nanomaterial (fullerene, C60) in zebrafish hepatocytes. 
Comp. Biochem. Physiol., Part C: Toxicol. Pharmacol. 155, 206-212. 
Bagchi, D., Bagchi, M., Hassoun, E.A. and Stohs, S.J. 1995. In vitro and in 
vivo generation of reactive oxygen species, DNA damage and lactate dehydrogenase 
leakage by selected pesticides. Toxicology 104, 129-140. 
Baker, M.J., Trevisan, J., Bassan, P., Bhargava, R., Butler, H.J., Dorling, K.M., 
Fielden, P.R., Fogarty, S.W., Fullwood, N.J., Heys, K.A., Hughes, C., Lasch, P., 
Martin-Hirsch, P.L., Obinaju, B., Sockalingum, G.D., Sule-Suso, J., Strong, R.J., 
Walsh, M.J., Wood, B.R., Gardner, P. and Martin, F.L. 2014. Using Fourier transform 
IR spectroscopy to analyze biological materials. Nature Protocols 9, 1771-1791. 
Bakry, R., Vallant, R.M., Najam-ul-Haq, M., Rainer, M., Szabo, Z., Huck, 
C.W. and Bonn, G.K. 2007. Medicinal applications of fullerenes. Int. J. Nanomed. 2, 
639. 
Baun, A., Sørensen, S.N., Rasmussen, R.F., Hartmann, N.B. and Koch, C.B. 
2008. Toxicity and bioaccumulation of xenobiotic organic compounds in the presence 
of aqueous suspensions of aggregates of nano-C60. Aquat. Toxicol. 86, 379-387. 
Becheri, A., Dürr, M., Lo Nostro, P. and Baglioni, P. 2008. Synthesis and 
characterization of zinc oxide nanoparticles: application to textiles as UV-absorbers. J. 
Nanopart. Res. 10, 679-689. 
 49 
 
Bello, D., Wardle, B., Yamamoto, N., Guzman deVilloria, R., Garcia, E., Hart, 
A., Ahn, K., Ellenbecker, M. and Hallock, M. 2009. Exposure to nanoscale particles 
and fibers during machining of hybrid advanced composites containing carbon 
nanotubes. J. Nanopart. Res. 11, 231-249. 
Benn, T.M. and Westerhoff, P. 2008. Nanoparticle Silver Released into Water 
from Commercially Available Sock Fabrics. Environ. Sci. Technol. 42, 4133-4139. 
Bhargava, R. 2012. Infrared Spectroscopic Imaging: The Next Generation. 
Appl. Spectrosc. 66, 1091-1120. 
Bianco, A., Kostarelos, K. and Prato, M. 2005. Applications of carbon 
nanotubes in drug delivery. Curr. Opin. Chem. Biol. 9, 674-679. 
Bihari, P., Vippola, M., Schultes, S., Praetner, M., Khandoga, A.G., Reichel, 
C.A., Coester, C., Tuomi, T., Rehberg, M. and Krombach, F. 2008. Optimized 
dispersion of nanoparticles for biological in vitro and in vivo studies. Part. Fibre 
Toxicol. 5, 14. 
Bouwmeester, H., Lynch, I., marvin, H.J.P., Dawson, K.A., Berges, M., 
Braguer, D., Byrne, H.J., Casey, A., Chambers, G., Clift, M.J.D., Elia, G., Fernandes, 
T.F., Fjellsbø, L.B., Hatto, P., Juillerat, L., Klein, C., Kreyling, W.G., Nickel, C., 
Riediker, M. and Stone, V. 2011. Minimal analytical characterization of engineered 
nanomaterials needed for hazard assessment in biological matrices. Nanotoxicology 5, 
1-11. 
Brant, J., Lecoanet, H., Hotze, M. and Wiesner, M. 2005. Comparison of 
Electrokinetic Properties of Colloidal Fullerenes (n-C60) Formed Using Two 
Procedures†. Environ. Sci. Technol. 39, 6343-6351. 
Buford, M., Hamilton, R., Jr. and Holian, A. 2007. A comparison of dispersing 
media for various engineered carbon nanoparticles. Part. Fibre Toxicol. 4, 1-9. 
Cabiscol, E., Tamarit, J. and Ros, J. 2010. Oxidative stress in bacteria and 
protein damage by reactive oxygen species. Int. Microbiol. 3, 3-8. 
 50 
 
Camden, J.P., Dieringer, J.A., Wang, Y., Masiello, D.J., Marks, L.D., Schatz, 
G.C. and Van Duyne, R.P. 2008. Probing the Structure of Single-Molecule Surface-
Enhanced Raman Scattering Hot Spots. J. Am. Chem. Soc. 130, 12616-12617. 
Campion, A. and Kambhampati, P. 1998. Surface-enhanced Raman scattering. 
Chem. Soc. Rev. 27, 241-250. 
Cao, Y., Jin, R. and Mirkin, C.A. 2001. DNA-modified core-shell Ag/Au 
nanoparticles. J. Am. Chem. Soc. 123, 7961-7962. 
Casey, A., Herzog, E., Davoren, M., Lyng, F., Byrne, H. and Chambers, G. 
2007a. Spectroscopic analysis confirms the interaction between SWCNT and various 
dyes commonly used to assess cytotoxicity. Carbon 45, 1425 - 1432. 
Casey, A., Herzog, E., Davoren, M., Lyng, F.M., Byrne, H.J. and Chambers, G. 
2007b. Spectroscopic analysis confirms the interactions between single walled carbon 
nanotubes and various dyes commonly used to assess cytotoxicity. Carbon 45, 1425-
1432. 
Cho, W.J., Kim, Y. and Kim, J.K. 2012. Ultrahigh-Density Array of Silver 
Nanoclusters for SERS Substrate with High Sensitivity and Excellent Reproducibility. 
ACS Nano 6, 249-255. 
Christian, P., Von der Kammer, F., Baalousha, M. and Hofmann, T. 2008. 
Nanoparticles: structure, properties, preparation and behaviour in environmental 
media. Ecotoxicology 17, 326-343. 
Clift, M.D., Gehr, P. and Rothen-Rutishauser, B. 2011. Nanotoxicology: a 
perspective and discussion of whether or not in vitro testing is a valid alternative. 
Arch. Toxicol. 85, 723-731. 
Crouzier, D., Follot, S., Gentilhomme, E., Flahaut, E., Arnaud, R., Dabouis, V., 
Castellarin, C. and Debouzy, J.C. 2010. Carbon nanotubes induce inflammation but 
decrease the production of reactive oxygen species in lung. Toxicology 272, 39-45. 
 51 
 
Deguchi, S., Alargova, R.G. and Tsujii, K. 2001. Stable Dispersions of 
Fullerenes, C60 and C70, in Water. Preparation and Characterization. Langmuir 17, 
6013-6017. 
Dhawan, A. and Sharma, V. 2010. Toxicity assessment of nanomaterials: 
methods and challenges. Anal. Bioanal. Chem. 398, 589-605. 
Edgington, A.J., Roberts, A.P., Taylor, L.M., Alloy, M.M., Reppert, J., Rao, 
A.M., Mao, J. and Klaine, S.J. 2010. The influence of natural organic matter on the 
toxicity of multiwalled carbon nanotubes. Environ. Toxicol. Chem. 29, 2511-2518. 
Ellis, D.I. and Goodacre, R. 2006. Metabolic fingerprinting in disease 
diagnosis: biomedical applications of infrared and Raman spectroscopy. Analyst 131, 
875-885. 
Elsaesser, A. and Howard, C.V. 2012. Toxicology of nanoparticles. Adv. Drug 
Del. Rev. 64, 129-137. 
Ferreira, J.L.R., Lonné, M.N., França, T.A., Maximilla, N.R., Lugokenski, 
T.H., Costa, P.G., Fillmann, G., Antunes Soares, F.A., de la Torre, F.R. and Monserrat, 
J.M. 2014. Co-exposure of the organic nanomaterial fullerene C60 with 
benzo[a]pyrene in Danio rerio (zebrafish) hepatocytes: Evidence of toxicological 
interactions. Aquat. Toxicol. 147, 76-83. 
Foucaud, L., Wilson, M.R., Brown, D.M. and Stone, V. 2007. Measurement of 
reactive species production by nanoparticles prepared in biologically relevant media. 
Toxicol. Lett. 174, 1-9. 
Ganesh, R., Smeraldi, J., Hosseini, T., Khatib, L., Olson, B.H. and Rosso, D. 
2010. Evaluation of Nanocopper Removal and Toxicity in Municipal Wastewaters. 
Environ. Sci. Technol. 44, 7808-7813. 
Gautam, R., Vanga, S., Ariese, F. and Umapathy, S. 2015. Review of 
multidimensional data processing approaches for Raman and infrared spectroscopy. 
EPJ Techn Instrum 2, 1-38. 
 52 
 
Girifalco, L.A. and Hodak, M. 2002. Van der Waals binding energies in 
graphitic structures. Phys. Rev. B 65, 125404. 
Girifalco, L.A., Hodak, M. and Lee, R.S. 2000. Carbon nanotubes, buckyballs, 
ropes, and a universal graphitic potential. Phys.l Rev. B 62, 13104-13110. 
Gonzalez, L., Lison, D. and Kirsch-Volders, M. 2008. Genotoxicity of 
engineered nanomaterials: A critical review. Nanotoxicology 2, 252-273. 
Gooding, J.J. 2005. Nanostructuring electrodes with carbon nanotubes: A 
review on electrochemistry and applications for sensing. Electrochim. Acta 50, 3049-
3060. 
Gottschalk, F. and Nowack, B. 2011. The release of engineered nanomaterials 
to the environment. J. Environ. Monit. 13, 1145-1155. 
Gottschalk, F., Sonderer, T., Scholz, R.W. and Nowack, B. 2009. Modeled 
Environmental Concentrations of Engineered Nanomaterials (TiO2, ZnO, Ag, CNT, 
Fullerenes) for Different Regions. Environ. Sci. Technol. 43, 9216-9222. 
Griveau, J.F., Dumont, E., Renard, P., Callegari, J.P. and Le Lannou, D. 1995. 
Reactive oxygen species, lipid peroxidation and enzymatic defence systems in human 
spermatozoa. J. Reprod. Fertil. 103, 17-26. 
Halliwell, B. 1991. Reactive oxygen species in living systems: Source, 
biochemistry, and role in human disease. Am. J. Med. 91, S14-S22. 
Henry, T.B., Menn, F.-M., Fleming, J.T., Wilgus, J., Compton, R.N. and 
Sayler, G.S. 2007. Attributing Effects of Aqueous C60 Nano-Aggregates to 
Tetrahydrofuran Decomposition Products in Larval Zebrafish by Assessment of Gene 
Expression. Environ. Health Perspect. 115, 1059-1065. 
Heraud, P., Wood, B.R., Beardall, J. and McNaughton, D. 2006. Effects of 
pre-processing of Raman spectra on in vivo classification of nutrient status of 
microalgal cells. J. Chemom. 20, 193-197. 
 53 
 
Hering, K., Cialla, D., Ackermann, K., Dörfer, T., Möller, R., Schneidewind, 
H., Mattheis, R., Fritzsche, W., Rösch, P. and Popp, J. 2008. SERS: a versatile tool in 
chemical and biochemical diagnostics. Anal. Bioanal. Chem. 390, 113-124. 
Hirschmugl, C.J. and Gough, K.M. 2012. Fourier Transform Infrared 
Spectrochemical Imaging: Review of Design and Applications with a Focal Plane 
Array and Multiple Beam Synchrotron Radiation Source. Appl. Spectrosc. 66, 475-
491. 
Holder, A.L., Goth-Goldstein, R., Lucas, D. and Koshland, C.P. 2012. 
Particle-Induced Artifacts in the MTT and LDH Viability Assays. Chem. Res. Toxicol. 
25, 1885-1892. 
Huang, J., Zhang, L., Chen, B., Ji, N., Chen, F., Zhang, Y. and Zhang, Z. 2010. 
Nanocomposites of size-controlled gold nanoparticles and graphene oxide: Formation 
and applications in SERS and catalysis. Nanoscale 2, 2733-2738. 
Hungerbuehler, H., Guldi, D.M. and Asmus, K.D. 1993. Incorporation of C60 
into artificial lipid membranes. J. Am. Chem. Soc. 115, 3386-3387. 
Hurt, R.H., Monthioux, M. and Kane, A. 2006. Toxicology of carbon 
nanomaterials: Status, trends, and perspectives on the special issue. Carbon 44, 1028-
1033. 
Jeanmaire, D.L. and Van Duyne, R.P. 1977. Surface Raman 
spectroelectrochemistry: Part I. Heterocyclic, aromatic, and aliphatic amines adsorbed 
on the anodized silver electrode. J. Electroanal. Chem. Interfacial Electrochem. 84, 1-
20. 
Jensen, A.W., Wilson, S.R. and Schuster, D.I. 1996. Biological applications of 
fullerenes. Biorg. Med. Chem. 4, 767-779. 
Jia, G., Wang, H., Yan, L., Wang, X., Pei, R., Yan, T., Zhao, Y. and Guo, X. 
2005. Cytotoxicity of Carbon Nanomaterials:  Single-Wall Nanotube, Multi-Wall 
Nanotube, and Fullerene. Environ. Sci. Technol. 39, 1378-1383. 
 54 
 
Jiang, J., Oberdörster, G. and Biswas, P. 2009. Characterization of size, 
surface charge, and agglomeration state of nanoparticle dispersions for toxicological 
studies. J. Nanopart. Res. 11, 77-89. 
Johnston, H., Pojana, G., Zuin, S., Jacobsen, N.R., Møller, P., Loft, S., 
Semmler-Behnke, M., McGuiness, C., Balharry, D., Marcomini, A., Wallin, H., 
Kreyling, W., Donaldson, K., Tran, L. and Stone, V. 2013. Engineered nanomaterial 
risk. Lessons learnt from completed nanotoxicology studies: potential solutions to 
current and future challenges. Crit. Rev. Toxicol. 43, 1-20. 
Katz, E. and Willner, I. 2004. Biomolecule-Functionalized Carbon Nanotubes: 
Applications in Nanobioelectronics. ChemPhysChem 5, 1084-1104. 
Kayat, J., Gajbhiye, V., Tekade, R.K. and Jain, N.K. 2011. Pulmonary toxicity 
of carbon nanotubes: a systematic report. Nanomed. Nanotechnol. Biol. Med. 7, 40-49. 
Kazarian, S.G. and Chan, K.L.A. 2010. Micro- and Macro-Attenuated Total 
Reflection Fourier Transform Infrared Spectroscopic Imaging. Appl. Spectrosc. 64, 
135A-152A. 
Kazarian, S.G. and Chan, K.L.A. 2013. ATR-FTIR spectroscopic imaging: 
recent advances and applications to biological systems. Analyst 138, 1940-1951. 
Keller, A.A., Wang, H., Zhou, D., Lenihan, H.S., Cherr, G., Cardinale, B.J., 
Miller, R. and Ji, Z. 2010. Stability and Aggregation of Metal Oxide Nanoparticles in 
Natural Aqueous Matrices. Environ. Sci. Technol. 44, 1962-1967. 
Kelly, J.G., Trevisan, J.l., Scott, A.D., Carmichael, P.L., Pollock, H.M., 
Martin-Hirsch, P.L. and Martin, F.L. 2011. Biospectroscopy to metabolically profile 
biomolecular structure: a multistage approach linking computational analysis with 
biomarkers. J. Proteome Res. 10, 1437-1448. 
Kemsley, E.K. 1996. Discriminant analysis of high-dimensional data: a 
comparison of principal components analysis and partial least squares data reduction 
methods. Chemometrics Intellig. Lab. Syst. 33, 47-61. 
 55 
 
Kim, J., Song, K., Lee, J. and Yu, I. 2011. Evaluation of biocompatible 
dispersants for carbon nanotube toxicity tests. Arch. Toxicol. 85, 1499-1508. 
Kiser, M.A., Ryu, H., Jang, H., Hristovski, K. and Westerhoff, P. 2010. 
Biosorption of nanoparticles to heterotrophic wastewater biomass. Water Res. 44, 
4105-4114. 
Kneipp, K., Kneipp, H., Itzkan, I., Dasari, R.R. and Feld, M.S. 1999. 
Ultrasensitive Chemical Analysis by Raman Spectroscopy. Chem. Rev. 99, 2957-2976. 
Kneipp, K., Wang, Y., Kneipp, H., Perelman, L.T., Itzkan, I., Dasari, R.R. and 
Feld, M.S. 1997. Single Molecule Detection Using Surface-Enhanced Raman 
Scattering (SERS). Phys. Rev. Lett. 78, 1667-1670. 
Krafft, C., Steiner, G., Beleites, C. and Salzer, R. 2009. Disease recognition by 
infrared and Raman spectroscopy. J. Biophotonics 2, 13-28. 
Kroll, A., Pillukat, M., Hahn, D. and Schnekenburger, J. 2012. Interference of 
engineered nanoparticles with in vitro toxicity assays. Arch. Toxicol. 86, 1123-1136. 
Kroll, A., Pillukat, M.H., Hahn, D. and Schnekenburger, J. 2009. Current in 
vitro methods in nanoparticle risk assessment: Limitations and challenges. Eur. J. 
Pharm. Biopharm. 72, 370-377. 
Kulakovich, O., Strekal, N., Yaroshevich, A., Maskevich, S., Gaponenko, S., 
Nabiev, I., Woggon, U. and Artemyev, M. 2002. Enhanced Luminescence of CdSe 
Quantum Dots on Gold Colloids. Nano Lett. 2, 1449-1452. 
Lasch, P. 2012. Spectral pre-processing for biomedical vibrational 
spectroscopy and microspectroscopic imaging. Chemometrics Intellig. Lab. Syst. 117, 
100-114. 
Lehto, M., Karilainen, T., Róg, T., Cramariuc, O., Vanhala, E., Tornaeus, J., 
Taberman, H., Jänis, J., Alenius, H., Vattulainen, I. and Laine, O. 2014. Co-Exposure 
with Fullerene May Strengthen Health Effects of Organic Industrial Chemicals. PLoS 
ONE 9, e114490. 
 56 
 
Li, J.F., Huang, Y.F., Ding, Y., Yang, Z.L., Li, S.B., Zhou, X.S., Fan, F.R., 
Zhang, W., Zhou, Z.Y., WuDe, Y., Ren, B., Wang, Z.L. and Tian, Z.Q. 2010. Shell-
isolated nanoparticle-enhanced Raman spectroscopy. Nature 464, 392-395. 
Li, S. and Dai, L. 2011. An Improved Algorithm to Remove Cosmic Spikes in 
Raman Spectra for Online Monitoring. Appl. Spectrosc. 65, 1300-1306. 
Limbach, L.K., Wick, P., Manser, P., Grass, R.N., Bruinink, A. and Stark, W.J. 
2007. Exposure of Engineered Nanoparticles to Human Lung Epithelial Cells:  
Influence of Chemical Composition and Catalytic Activity on Oxidative Stress. 
Environ. Sci. Technol. 41, 4158-4163. 
Liu, K.-Z., Tsang, K.S., Li, C.K., Shaw, R.A. and Mantsch, H.H. 2003. 
Infrared Spectroscopic Identification of β-Thalassemia. Clin. Chem. 49, 1125-1132. 
Liu, Z., Tabakman, S., Welsher, K. and Dai, H. 2009. Carbon nanotubes in 
biology and medicine: In vitro and in vivo detection, imaging and drug delivery. Nano 
Research 2, 85-120. 
Llabjani, V., Crosse, J.D., Ahmadzai, A.A., Patel, I.I., Pang, W., Trevisan, J., 
Jones, K.C., Shore, R.F. and Martin, F.L. 2011. Differential Effects in Mammalian 
Cells Induced by Chemical Mixtures in Environmental Biota As Profiled Using 
Infrared Spectroscopy. Environ. Sci. Technol. 45, 10706-10712. 
Llabjani, V., Jones, K.C., Thomas, G.O., Walker, L.A., Shore, R.F. and Martin, 
F.L. 2009. Polybrominated Diphenyl Ether-Associated Alterations in Cell 
Biochemistry as Determined by Attenuated Total Reflection Fourier-Transform 
Infrared Spectroscopy: a Comparison with DNA-Reactive and/or Endocrine-
Disrupting Agents. Environ. Sci. Technol. 43, 3356-3364. 
Llabjani, V., Trevisan, J., Jones, K.C., Shore, R.F. and Martin, F.L. 2010. 
Binary Mixture Effects by PBDE Congeners (47, 153, 183, or 209) and PCB 
Congeners (126 or 153) in MCF-7 Cells: Biochemical Alterations Assessed by IR 
Spectroscopy and Multivariate Analysis. Environ. Sci. Technol. 44, 3992-3998. 
 57 
 
Lovern, S.B. and Klaper, R. 2006. Daphnia magna mortality when exposed to 
titanium dioxide and fullerene (C60) nanoparticles. Environ. Toxicol. Chem. 25, 
1132-1137. 
Lowry, G.V., Gregory, K.B., Apte, S.C. and Lead, J.R. 2012. Transformations 
of Nanomaterials in the Environment. Environ. Sci. Technol. 46, 6893-6899. 
Lu, Y., Yin, Y., Li, Z.-Y. and Xia, Y. 2002. Synthesis and Self-Assembly of 
Au@SiO2 Core−Shell Colloids. Nano Lett. 2, 785-788. 
Madni, I., Hwang, C.-Y., Park, S.-D., Choa, Y.-H. and Kim, H.-T. 2010. 
Mixed surfactant system for stable suspension of multiwalled carbon nanotubes. 
Colloids Surf. Physicochem. Eng. Aspects 358, 101-107. 
Martin, F.L., German, M.J., Wit, E., Fearn, T., Ragavan, N. and Pollock, H.M. 
2007. Identifying Variables Responsible for Clustering in Discriminant Analysis of 
Data from Infrared Microspectroscopy of a Biological Sample. J. Comput. Biol. 14, 
1176-1184. 
Martin, F.L., Kelly, J.G., Llabjani, V., Martin-Hirsch, P.L., Patel, I.I., Trevisan, 
J., Fullwood, N.J. and Walsh, M.J. 2010. Distinguishing cell types or populations 
based on the computational analysis of their infrared spectra. Nat. Protocols 5, 1748-
1760. 
Matsuda, S., Matsui, S., Shimizu, Y. and Matsuda, T. 2011. Genotoxicity of 
Colloidal Fullerene C60. Environ. Sci. Technol. 45, 4133-4138. 
Mauter, M.S. and Elimelech, M. 2008. Environmental Applications of Carbon-
Based Nanomaterials. Environ. Sci. Technol. 42, 5843-5859. 
Mazet, V., Carteret, C., Brie, D., Idier, J. and Humbert, B. 2005. Background 
removal from spectra by designing and minimising a non-quadratic cost function. 
Chemometrics Intellig. Lab. Syst. 76, 121-133. 
McHedlov-Petrossyan, N.O. 2013. Fullerenes in Liquid Media: An Unsettling 
Intrusion into the Solution Chemistry. Chem. Rev. 113, 5149-5193. 
 58 
 
Meng, H., Xia, T., George, S. and Nel, A.E. 2009. A Predictive Toxicological 
Paradigm for the Safety Assessment of Nanomaterials. ACS Nano 3, 1620-1627. 
Miller, L.M. and Dumas, P. 2006. Chemical imaging of biological tissue with 
synchrotron infrared light. Biochim. Biophys. Acta, Biomembr. 1758, 846-857. 
Monteiro-Riviere, N.A. and Inman, A.O. 2006. Challenges for assessing 
carbon nanomaterial toxicity to the skin. Carbon 44, 1070-1078. 
Monteiro-Riviere, N.A., Inman, A.O. and Zhang, L.W. 2009. Limitations and 
relative utility of screening assays to assess engineered nanoparticle toxicity in a 
human cell line. Toxicol. Appl. Pharmacol. 234, 222-235. 
Mosier-Boss, P.A., Lieberman, S.H. and Newbery, R. 1995. Fluorescence 
Rejection in Raman Spectroscopy by Shifted-Spectra, Edge Detection, and FFT 
Filtering Techniques. Appl. Spectrosc. 49, 630-638. 
Moskovits, M. 1985. Surface-enhanced spectroscopy. Rev. Mod. Phys. 57, 
783-826. 
Nasse, M.J., Walsh, M.J., Mattson, E.C., Reininger, R., Kajdacsy-Balla, A., 
Macias, V., Bhargava, R. and Hirschmugl, C.J. 2011. High-resolution Fourier-
transform infrared chemical imaging with multiple synchrotron beams. Nat Meth 8, 
413-416. 
Naumann, D. 2008. FT-IR spectroscopy of microorganisms at the Robert Koch 
Institute: experiences gained during a successful project. pp. 68530G-68530G-68512. 
Nel, A., Xia, T., Mädler, L. and Li, N. 2006. Toxic Potential of Materials at the 
Nanolevel. Science 311, 622-627. 
Nel, A., Xia, T., Meng, H., Wang, X., Lin, S., Ji, Z. and Zhang, H. 2012. 
Nanomaterial Toxicity Testing in the 21st Century: Use of a Predictive Toxicological 
Approach and High-Throughput Screening. Acc. Chem. Res. 46, 607-621. 
 59 
 
Nel, A.E., Madler, L., Velegol, D., Xia, T., Hoek, E.M.V., Somasundaran, P., 
Klaessig, F., Castranova, V. and Thompson, M. 2009. Understanding 
biophysicochemical interactions at the nano-bio interface. Nat Mater 8, 543-557. 
Nowack, B. and Bucheli, T.D. 2007. Occurrence, behavior and effects of 
nanoparticles in the environment. Environ. Pollut. 150, 5-22. 
Oberdörster, E. 2004a. Manufactured nanomaterials (fullerenes, C60) induce 
oxidative stress in the brain of juvenile largemouth bass. Environ. Health Perspect. 
112, 1058-1062. 
Oberdörster, E. 2004b. Manufactured Nanomaterials (Fullerenes, C(60)) 
Induce Oxidative Stress in the Brain of Juvenile Largemouth Bass. Environ. Health 
Perspect. 112, 1058-1062. 
Pan, B. and Xing, B. 2008. Adsorption Mechanisms of Organic Chemicals on 
Carbon Nanotubes. Environ. Sci. Technol. 42, 9005-9013. 
Park, J.-W., Henry, T.B., Ard, S., Menn, F.-M., Compton, R.N. and Sayler, 
G.S. 2011. The association between nC60 and 17α-ethinylestradiol (EE2) decreases 
EE2 bioavailability in zebrafish and alters nanoaggregate characteristics. 
Nanotoxicology 5, 406-416. 
Park, J.-W., Henry, T.B., Menn, F.-M., Compton, R.N. and Sayler, G. 2010. 
No bioavailability of 17α-ethinylestradiol when associated with nC60 aggregates 
during dietary exposure in adult male zebrafish (Danio rerio). Chemosphere 81, 1227-
1232. 
Petersen, E.J. and Henry, T.B. 2012. Methodological considerations for testing 
the ecotoxicity of carbon nanotubes and fullerenes: Review. Environ. Toxicol. Chem. 
31, 60-72. 
Petersen, E.J., Pinto, R.A., Mai, D.J., Landrum, P.F. and Weber, W.J. 2011a. 
Influence of Polyethyleneimine Graftings of Multi-Walled Carbon Nanotubes on their 
Accumulation and Elimination by and Toxicity to Daphnia magna. Environ. Sci. 
Technol. 45, 1133-1138. 
 60 
 
Petersen, E.J., Zhang, L., Mattison, N.T., O’Carroll, D.M., Whelton, A.J., 
Uddin, N., Nguyen, T., Huang, Q., Henry, T.B., Holbrook, R.D. and Chen, K.L. 
2011b. Potential Release Pathways, Environmental Fate, And Ecological Risks of 
Carbon Nanotubes. Environ. Sci. Technol. 45, 9837-9856. 
Porter, D., Sriram, K., Wolfarth, M., Jefferson, A., Schwegler-Berry, D., 
Andrew, M.E. and Castranova, V. 2008. A biocompatible medium for nanoparticle 
dispersion. Nanotoxicology 2, 144-154. 
Powers, K.W., Palazuelos, M., Moudgil, B.M. and Roberts, S.M. 2007. 
Characterization of the size, shape, and state of dispersion of nanoparticles for 
toxicological studies. Nanotoxicology 1, 42-51. 
Quagliano, L.G. 2004. Observation of Molecules Adsorbed on III-V 
Semiconductor Quantum Dots by Surface-Enhanced Raman Scattering. J. Am. Chem. 
Soc. 126, 7393-7398. 
Ren, L. and Zhong, W. 2010. Oxidation Reactions Mediated by Single-Walled 
Carbon Nanotubes in Aqueous Solution. Environ. Sci. Technol. 44, 6954-6958. 
Ren, W., Fang, Y. and Wang, E. 2011. A Binary Functional Substrate for 
Enrichment and Ultrasensitive SERS Spectroscopic Detection of Folic Acid Using 
Graphene Oxide/Ag Nanoparticle Hybrids. ACS Nano 5, 6425-6433. 
Sager, T.M., Porter, D.W., Robinson, V.A., Lindsley, W.G., Schwegler-Berry, 
D.E. and Castranova, V. 2007. Improved method to disperse nanoparticles for in vitro 
and in vivo investigation of toxicity. Nanotoxicology 1, 118-129. 
Savolainen, K., Alenius, H., Norppa, H., Tuomi, T. and Kasper, G. 2010. Risk 
assessment of engineered nanomaterials and nanotechnologies--a review. Toxicology 
269, 92-104. 
Sayes, C.M., Reed, K.L. and Warheit, D.B. 2007. Assessing Toxicity of Fine 
and Nanoparticles: Comparing In Vitro Measurements to In Vivo Pulmonary Toxicity 
Profiles. Toxicol. Sci. 97, 163-180. 
 61 
 
Serpone, N., Dondi, D. and Albini, A. 2007. Inorganic and organic UV filters: 
Their role and efficacy in sunscreens and suncare products. Inorg. Chim. Acta 360, 
794-802. 
Sharma, B., Frontiera, R.R., Henry, A.-I., Ringe, E. and Van Duyne, R.P. 2012. 
SERS: Materials, applications, and the future. Mater. Today 15, 16-25. 
Shi, H., Hudson, L.G. and Liu, K.J. 2004. Oxidative stress and apoptosis in 
metal ion-induced carcinogenesis. Free Radic. Biol. Med. 37, 582-593. 
Shin, H. and Markey, M.K. 2006. A machine learning perspective on the 
development of clinical decision support systems utilizing mass spectra of blood 
samples. J. Biomed. Inf. 39, 227-248. 
Shinohara, N., Matsumoto, K., Endoh, S., Maru, J. and Nakanishi, J. 2009. In 
vitro and in vivo genotoxicity tests on fullerene C60 nanoparticles. Toxicol. Lett. 191, 
289-296. 
Shvedova, A.A., Pietroiusti, A., Fadeel, B. and Kagan, V.E. 2012. 
Mechanisms of carbon nanotube-induced toxicity: Focus on oxidative stress. Toxicol. 
Appl. Pharmacol. 261, 121-133. 
Simon, A., Maletz, S.X., Hollert, H., Schäffer, A. and Maes, H.M. 2014. 
Effects of multiwalled carbon nanotubes and triclocarban on several eukaryotic cell 
lines: elucidating cytotoxicity, endocrine disruption, and reactive oxygen species 
generation. Nanoscale Res Lett, p. 396. 
Simon, H.U., Haj-Yehia, A. and Levi-Schaffer, F. 2000. Role of reactive 
oxygen species (ROS) in apoptosis induction. Apoptosis 5, 415-418. 
Smith, C.J., Shaw, B.J. and Handy, R.D. 2007. Toxicity of single walled 
carbon nanotubes to rainbow trout, (Oncorhynchus mykiss): Respiratory toxicity, 
organ pathologies, and other physiological effects. Aquat. Toxicol. 82, 94-109. 
Song, M., Wang, F., Zeng, L., Yin, J., Wang, H. and Jiang, G. 2014. Co-
exposure of Carboxyl-Functionalized Single-Walled Carbon Nanotubes and 17α-
 62 
 
Ethinylestradiol in Cultured Cells: Effects on Bioactivity and Cytotoxicity. Environ. 
Sci. Technol. 48, 13978-13984. 
Stiles, P.L., Dieringer, J.A., Shah, N.C. and Van Duyne, R.P. 2008. Surface-
Enhanced Raman Spectroscopy. Annu. Rev. Anal. Chem. 1, 601-626. 
Su, Y., Yan, X., Pu, Y., Xiao, F., Wang, D. and Yang, M. 2013. Risks of 
Single-Walled Carbon Nanotubes Acting as Contaminants-Carriers: Potential Release 
of Phenanthrene in Japanese Medaka (Oryzias latipes). Environ. Sci. Technol. 47, 
4704-4710. 
Tervonen, K., Waissi, G., Petersen, E.J., Akkanen, J. and Kukkonen, J.V.K. 
2010. Analysis of fullerene-C60 and kinetic measurements for its accumulation and 
depuration in Daphnia magna. Environ. Toxicol. Chem. 29, 1072-1078. 
Trevisan, J., Angelov, P.P., Carmichael, P.L., Scott, A.D. and Martin, F.L. 
2012. Extracting biological information with computational analysis of Fourier-
transform infrared (FTIR) biospectroscopy datasets: current practices to future 
perspectives. Analyst 137, 3202-3215. 
Trevisan, J., Angelov, P.P., Patel, I.I., Najand, G.M., Cheung, K.T., Llabjani, 
V., Pollock, H.M., Bruce, S.W., Pant, K., Carmichael, P.L., Scott, A.D. and Martin, 
F.L. 2010. Syrian hamster embryo (SHE) assay (pH 6.7) coupled with infrared 
spectroscopy and chemometrics towards toxicological assessment. Analyst 135, 3266-
3272. 
Turrens, J.F. 2003. Mitochondrial formation of reactive oxygen species. J. 
Physiol. 552, 335-344. 
Vippola, M., Falck, G., Lindberg, H., Suhonen, S., Vanhala, E., Norppa, H., 
Savolainen, K., Tossavainen, A. and Tuomi, T. 2009. Preparation of nanoparticle 
dispersions for in-vitro toxicity testing. Hum. Exp. Toxicol. 28, 377-385. 
Wörle-Knirsch, J.M., Pulskamp, K. and Krug, H.F. 2006. Oops They Did It 




Wang, L., Castranova, V., Mishra, A., Chen, B., Mercer, R.R., Schwegler-
Berry, D. and Rojanasakul, Y. 2010. Dispersion of single-walled carbon nanotubes by 
a natural lung surfactant for pulmonary in vitro and in vivo toxicity studies. Part. Fibre 
Toxicol. 7, 31. 
Wang, L. and Mizaikoff, B. 2008. Application of multivariate data-analysis 
techniques to biomedical diagnostics based on mid-infrared spectroscopy. Anal. 
Bioanal. Chem. 391, 1641-1654. 
Wang, Y., Becker, M., Wang, L., Liu, J., Scholz, R., Peng, J., Gösele, U., 
Christiansen, S., Kim, D.H. and Steinhart, M. 2009. Nanostructured Gold Films for 
SERS by Block Copolymer-Templated Galvanic Displacement Reactions. Nano Lett. 
9, 2384-2389. 
Warheit, D.B. 2006. What is currently known about the health risks related to 
carbon nanotube exposures? Carbon 44, 1064-1069. 
Warheit, D.B., Sayes, C.M. and Reed, K.L. 2009. Nanoscale and Fine Zinc 
Oxide Particles: Can in Vitro Assays Accurately Forecast Lung Hazards following 
Inhalation Exposures? Environ. Sci. Technol. 43, 7939-7945. 
Westerhuis, J.A., Kourti, T. and MacGregor, J.F. 1998. Analysis of multiblock 
and hierarchical PCA and PLS models. J. Chemom. 12, 301-321. 
Wohlleben, W., Brill, S., Meier, M.W., Mertler, M., Cox, G., Hirth, S., von 
Vacano, B., Strauss, V., Treumann, S., Wiench, K., Ma-Hock, L. and Landsiedel, R. 
2011. On the Lifecycle of Nanocomposites: Comparing Released Fragments and their 
In-Vivo Hazards from Three Release Mechanisms and Four Nanocomposites. Small 7, 
2384-2395. 
Xia, Q., Yin, J.J., Cherng, S.-H., Wamer, W.G., Boudreau, M., Howard, P.C. 
and Fu, P.P. 2006. UVA photoirradiation of retinyl palmitate—Formation of singlet 
oxygen and superoxide, and their role in induction of lipid peroxidation. Toxicol. Lett. 
163, 30-43. 
Yang, K., Zhu, L. and Xing, B. 2006. Adsorption of Polycyclic Aromatic 
Hydrocarbons by Carbon Nanomaterials. Environ. Sci. Technol. 40, 1855-1861. 
 64 
 
Zhang, D. and Ben-Amotz, D. 2002. Removal of Cosmic Spikes from Hyper-
spectral Images Using a Hybrid Upper-Bound Spectrum Method. Appl. Spectrosc. 56, 
91-98. 
Zhang, Y., Chen, Y., Westerhoff, P. and Crittenden, J. 2009. Impact of natural 
organic matter and divalent cations on the stability of aqueous nanoparticles. Water 
Res. 43, 4249-4257. 
Zhang, Z., Xu, F., Yang, W., Guo, M., Wang, X., Zhang, B. and Tang, J. 2011. 
A facile one-pot method to high-quality Ag-graphene composite nanosheets for 
efficient surface-enhanced Raman scattering. Chem. Commun. 47, 6440-6442. 
Zhao, J. 2003. Image Curvature Correction and Cosmic Removal for High-
Throughput Dispersive Raman Spectroscopy. Appl. Spectrosc. 57, 1368-1375. 
Zhao, J., Lui, H., McLean, D.I. and Zeng, H. 2007. Automated 
Autofluorescence Background Subtraction Algorithm for Biomedical Raman 







Dose-related alterations of carbon nanoparticles in mammalian cells 
detected using biospectroscopy: Potential for real-world effects  
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ABSTRACT: Nanotechnologies generate a wide range of engineered
nanomaterials that enter into our ecosystem, especially carbon-based
nanoparticles (CNPs). As these novel materials acquire ever increasing
numbers of applications, they may pose a risk to organisms, including
humans. However, our knowledge of nanoparticle-induced effects remains
limited. We are yet to understand the interaction between nanoparticles
and organisms, and classical toxicology fails to provide models for risk
assessment. Biospectroscopy techniques were employed to identify the
effects induced by real-world levels of a panel of CNPs. MCF-7 cells
concentrated in S-phase or G0/G1-phase were treated for 24 h with short
or long multiwalled carbon nanotubes (MWCNTs) or Fullerene (C60) at
the following concentrations: 0.0025 mg/L, 0.005 mg/L, 0.01 mg/L, 0.025
mg/L, 0.05 mg/L, and 0.1 mg/L. Attenuated total reflection Fourier-
transform infrared (ATR-FTIR) spectroscopy coupled with computational analysis was then applied to interrogate the cells and
significant dose-related effects were detected. From derived infrared spectra, distinct spectral biomarkers of cell alteration induced
by each CNP type were identified. Additionally, Raman spectroscopy was applied and allowed us to determine that reactive
oxygen species (ROS) were generated by CNPs. These observations highlight the potential of biospectroscopy techniques to
determine CNP-induced alterations in target mammalian cells at ppb levels.
1. INTRODUCTION
Nanomaterials are engineered materials designed to nanoscale
size with at least one dimension in the 1−100 nm range. This
tiny size gives nanomaterials unique physicochemical proper-
ties, resulting in diverse applications in areas such as
pharmaceutics and even daily consumable products.1,2 While
the properties of bulk materials and chemical molecules have
been well understood, there remains a gap in knowledge in the
nanozone between molecule and bulk. Therefore, there is
growing concern as to whether these novel materials will pose
potential risk in organisms, including humans.3
Among the most promising engineered materials, carbon
nanotubes (CNTs) and Fullerene (C60) represent two of the
most widely investigated carbon nanoparticles (CNPs).
Generally, multiwalled carbon nanotubes (MWCNTs) consist-
ing of two or more cylinders of graphite sheets are uniquely
small with a high aspect ratio consisting of a diameter at
nanometre scale and μm length.4 C60, with a spherically
enclosed structure of 60 carbon atoms, is the most prominent
fullerene derivative in general use or under scientific
investigation.5 As it has been predicted that these CNPs will
have enormous use, there is no doubt the risk of exposure will
increase dramatically for humans and the whole environment.6
Therefore, assessment of the toxic effects of CNPs is urgently
required.
Recently, a range of studies have shown that CNPs generate
toxic effects both in vitro and in vivo, such as cell membrane
disruption, tissue inflammation, and lung lesions.7−9 Among the
mechanisms involved in CNP toxicology, generation of reactive
oxygen species (ROS) is regarded as a major factor.10 ROS can
have a direct impact on the cells or lead to secondary processes
causing protein alteration, membrane injury, and even DNA
damage.11 However, some conventional in vitro cytotoxicity
assays encounter challenges in investigating nanotoxicology due
to the interaction between nanoparticles and the assay itself.
Classical dye-based assays such as MTT and neutral red can
give invalid results if the dye is adsorbed by or interacts with
CNPs.12 Therefore, the introduction of new methodologies to
assess nanotoxicity is required, in addition to the establishment
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of a new paradigm in conventional assays. In toxicology, dose is
an important parameter for both in vitro and in vivo
experiments. Although acute effects are likely to be observed
following high-dose exposures, understanding the consequen-
ces of low-dose exposure over a lifetime is necessary to help
understand the possible public health risk of CNPs.
As a powerful noninvasive technique, attenuated total
reflection Fourier-transform infrared (ATR-FTIR) spectrosco-
py can be used to detect alterations induced by chemical agents
at environmentally relevant levels within cells.13,14 An infrared
(IR) beam is transmitted through an internal reflection element
(IRE; e.g., diamond, zinc selenide, germanium, silicon) in
contact with the sample and penetrates a small distance beyond
the reflecting surface into the sample.15 The mid-IR (λ = 2−20
μm) absorbance of cellular biomolecules via vibrational
transitions generates biochemical-cell fingerprint spectra
(1800−900 cm−1). In particular, peaks are identified as lipid
[1750 cm−1 (CO vibration)], Amide I (1650 cm−1), Amide
II (1550 cm−1), Amide III (1260 cm−1), and DNA/RNA [1225
cm−1 (νasPO2
−; asymmetric phosphate stretching vibrations),
1080 cm−1 (νsPO2
−; symmetric phosphate stretching vibra-
tions)]. Raman spectroscopy is another noninvasive tool with
the ability to detect a wide range of chemical bonds, not only
polar bonds. On the basis of a different working theory, Raman
can be used as a complement to ATRFTIR spectroscopy.
Analyzing the large amount of data derived from IR or Raman
spectroscopy is a challenge by conventional methods, but with
the help of computational analyses using multivariate
techniques including principal component analysis-linear
discriminant analysis (PCA-LDA), information can efficiently
be extracted from the data.
In this study, we employed ATR-FTIR spectroscopy coupled
with computational analysis to investigate dose-related effects
of CNPs in mammalian MCF-7 cells. This is an estrogen
receptor-positive breast cancer cell line, which has previously
been used to investigate toxic effects of either endocrine
disruptors or chemicals requiring bioactivation (an excellent
characteristic in this regard is that they express phase I and II
enzymes).13 Through this work, we intended to detect
alterations in MCF-7 cells following exposure to short or
long MWCNTs and Fullerene C60 at concentrations of 0.0025,
0.005, 0.01, 0.025, 0.05, and 0.1 mg/L. The differences in the
toxic effects induced by the three CNPs types were also
investigated. Additionally, Raman spectroscopy was used to
detect the ratio of cysteine-to-protein in order to evaluate
reactive oxygen species (ROS) levels in treated cells. Such
studies were designed in order to shed insights into CNP-
induced toxic mechanisms at environmentally relevant exposure
levels.
2. MATERIALS AND METHODS
Chemicals and Nanoparticles. Cell culture consumables
were obtained from Invitrogen Life Technologies (Paisley,
U.K.). Bovine serum albumin (BSA) obtained from Sigma was
≥98% pure. All CNPs were purchased from Sigma; data
regarding their toxicity remains limited, but they are thought to
possess asbestos-like properties. Both short and long
MWCNTs were >90% pure, while C60 had purity >99.5%.
As stated by the company, short MWCNTs were >90% pure
with a size of 10−15 nm in diameter and 0.1−10 μm in length.
Long MWCNTs were >90% pure as well, but with a larger size,
110−170 nm diameter and 5−9 μm length. C60 had a purity
>99.5% and particle diameter of 1 nm. All dispersed CNPs were
characterized using scanning electron microscopy (SEM) [JSM
5600 (JEOL)] and images were taken (Figure 1). The two
MWCNTs showed sizes approximating that stated by the
company, while C60 appeared almost in agglomeration.
Additionally, the CNPs were analyzed by Raman spectroscopy
(Renishaw PLC, Gloucestershire, U.K.) with a 785 nm laser,
which confirmed their high purity (Figure 1).
Cell Culture. The MCF-7 cell line was grown in Dulbecco’s
modified essential medium supplemented with 10% heat-
inactivated fetal bovine serum (FBS), penicillin (100 U/mL),
and streptomycin (100 μg/mL) in a humidified atmosphere
with 5% CO2 in air at 37 °C. MCF-7 cells were routinely
cultured in T75 flasks and disaggregated with trypsin (0.05%)/
EDTA (0.02%) solution before incorporation into experiments.
Following this, cells were immediately resuspended in complete
medium and then seeded in T25 flasks, whereupon they were
concentrated in either S-phase (grown for 24-h) or G0/G1-
phase (grown for 96-h) followed by a further-24-h treatment
with or without test agents. For each testing protocol, three
independent experiments were conducted with either duplicate
or triplicate flasks per treatment condition [see Supporting
Information (SI)].
CNPs Treatment and ATR-FTIR Spectroscopy. CNPs
were suspended in 1% BSA solution in order to assist in
suspension and dispersion during treatment, contributing to
maximum contact of cells and CNPs. All concentration ranges
were diluted with 1% BSA solution from a concentrated stock,
Figure 1. Scanning electron microscopy (SEM) images with
corresponding Raman spectra of (a) short MWCNTs; (b) long
MWCNTs; and (c) Fullerene (C60).
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and 50 μL CNPs were delivered to cells in each flask with 5 mL
medium. The flasks were gently shaken to make sure the CNPs
were well dispersed before being put back in the incubator.
Meanwhile, several flasks of cells were exposed to 1% BSA
alone as a vehicle control. Following 24-h treatment, cells were
again disaggregated into cell suspension and immediately fixed
in 70% ethanol for 1 h. Cell samples were then washed three
times and applied to glass slides, and allowed to air-dry prior to
storage in a desiccator. Cell samples were interrogated using a
Bruker TENSOR 27 FTIR spectrometer (Bruker Optics Ltd.,
Coventry, U.K.) with Helios ATR attachment (containing a
diamond IRE; incidence angle of the IR beam: 45°).
Instrument settings included 32 scans, 8 cm−1 resolution, 2×
zero-filling. For each slide, 10 IR spectra were acquired, giving
rise to eight data sets (see SI, Table S1). The ATR crystal was
cleaned with deionized water and a background was taken prior
to starting a new slide. Estimated penetration depth of the IR
beam into the sample was calculated at 1.11 and 2.23 μm at
1800 cm−1 and 900 cm−1, respectively.16
ATR-FTIR spectroscopy gave rise to eight data sets, which
were computationally analyzed separately (see SI, Table S1).
Data sets DR-1 to DR-6 were generated to study the dose
response of nanoparticles, whereas NP-1 and NP-2 allowed for
a comparison between the effects of different nanoparticles (see
SI, Table S1). Each resulting spectrum had a total of 235 data
points within the 1800−900 cm−1 region for a 3.84 cm−1
spacing.
Data Preprocessing and PCA-LDA. The acquired IR
spectral data were processed using the IRootLab toolbox
(http://irootlab.googlecode.com)17 running on MATLAB
r2008a (http://www.mathworks.com). Each spectrum was
preprocessed by first cutting to the biochemical-cell fingerprint
range (1800−900 cm−1), followed by rubberband baseline
correction, and normalization to the Amide I peak (around
1650 cm−1). Following preprocessing, cross-calculated PCA-
LDA18 was applied to each data set separately, and the resulting
scores and cluster vectors were visualized. PCA-LDA is a
composite technique where principal component analysis
(PCA) is applied to the spectral data set to reduce the number
of variables, and linear discriminant analysis (LDA) is
subsequently applied to derive orthogonal variables from
which the between-class variance is maximized over the
within-class variance.19 “Cross-calculation” of scores is applied
to eliminate the risk of LDA overfitting. It utilizes leave-one-out
cross-validation to train the PCA-LDA loadings using n − 1
samples (n = number of samples in data set) and subsequently
calculate the scores for the remaining sample,18 repeating until
all scores are calculated. The loadings are derived as averages
between the n PCA-LDA loadings models. Cluster vectors are
derived through pointing from the mean of the control class
toward the mean of each treatment class, thus obtaining one
vector representing biochemical alterations (“pseudospectrum”
wavenumber × coefficient) for each class (excluding Con-
trol).20,21 The number of principal components (PCs) for
PCA-LDA was found for each data set separately through an
optimization procedure using classification (see SI, Figure S1
and Table S2).
PCA-LDA output data (variables called “PCA-LDA scores”)
can be visualized as 1-D or 2-D scatterplots (“scores plots”). In
these scores plots, nearness between the treatment class and the
control class indicates similarity in biochemical structure, while
the distance indicates dissimilarity. This allows for a dose−
response curve to be derived based on the distance between
each treatment mean and the control mean in the scores plot.
Interpolation was carried out using cubic splines in Graphpad
Prism 4. ANOVA and post hoc tests on PCA-LDA scores were
carried out, as well in the same software.
The cluster vectors are derived to study the biomarkers
responsible for the biochemical alteration in each class.22,23 In
order to simplify the identification of the alterations induced by
chemical agents, the six most important peaks of each cluster
vector were detected to derive a “peak locations” plot where the
marker size is proportional to the height of its corresponding
peak.
Use of Raman Spectra to Assess ROS Level in Cells
Induced by CNPs. Raman spectra were recorded using an In
Via Renishaw Raman spectrometer (Renishaw plc, Gloucester-
shire, U.K.) equipped with a 785 nm streamline focus laser and
a Renishaw-automated 100 nm encoded XYZ stage. The
spectrometer’s entrance slit of 50 μm combined with a 1200
lines/mm (∼1.0 cm−1 spectral resolution) diffraction grating
dispersing Raman signals onto a master Renishaw Pelletier
cooled charge coupled detector (CCD). A white light camera
mounted on the microscope was used to visualize the locations
of the spectral acquisition. System calibration was carried out
using an internal Renishaw silicon calibration source for
wavenumber shift. All spectra were acquired using a Leica
×50 objective lens (numeral aperture 0.75), 10 s of 50% laser
power (100 mW) exposure with three repeat acquisitions and
spectral range covering 2000−500 cm−1. Generally, 30 spectra
were obtained from each sample.
Cysteine (Cys) can protect cells from oxidative stress and
free radical with its sulfhydryl (-SH) group of high electron-
donating capacity.24 Cysteine and its oxidized form disulfide
cystine (CySS) constitute the major redox pools playing an
important role in cytoprotection.25,26 Cys/CySS couple is
usually regulated at a homeostatic state in cells, and can be used
to indicate the oxidative stress.27 In this study, raw Raman
spectra resulting from the MCF-7 cells treated with or without
CNPs were used to calculate the ratio of CySS to protein as a
biomarker for ROS level in cells. The intensity at two particular
peaks was used to measure the CySS-to-protein ratio. The
intensity at 668 cm−1 (C−S stretching mode of CySS) was used
as a marker for CySS, while that at 1447 cm−1 (CH2 bending
mode of protein) was used as a marker for protein.
■ RESULTS AND DISCUSSION
Throughout the biochemical-cell fingerprint region (1800−900
cm−1) in the raw IR spectra, no differences can be simply
observed. However, the use of multivariate computational
analysis applied to the large number of the spectra generated
allows differences to be more clearly viewed. PCA-LDA scores
plots help one visualize the segregation between classes. To
avoid overfitting with LDA, we applied a “cross-calculated”
version of PCA-LDA (CC PCA-LDA) in this study. Cross-
calculated results are nonetheless consistent with direct PCA-
LDA results (see SI, Figure S2). Most class separation was seen
along LD1, whereas separation was negligible along LD2 for
most data sets (see SI, Figures S1). In both methods, clearer
category segregation was noted with CNP-treated cells
concentrated in G0/G1-phase cells compared to those in S-
phase [see SI, Figure S2]. To determine whether the treatment
groups were significantly different from the corresponding
control group, repeated-measures one-way analysis of variance
(ANOVA) with Dunnett’s post hoc tests were conducted to
examine the treated vs. control cells in both LD1 and LD2
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space (see SI, Figure S2). According to the P-value calculated,
the CNP-induced effects observed in LD1 space differed
significantly (P < 0.01) in all treatment groups (Figure 2).
The scores plot in LD1 space clearly shows segregation
between each treatment and corresponding control (Figure 2).
When MCF-7 cells were treated with CNPs, their response was
nonlinear and varied with concentration. The dose−response
shows that the response of cells in S-phase was more variable
than those concentrated in G0/G1-phase. The highest response
induced by the three CNPs in cells concentrated in G0/G1-
phase appeared at the highest concentration treatment, while in
the S-phase cells exposed to short MWCNTs the response peak
was located at lower concentrations of 0.0025 mg/L. This could
be explained as low-dose stimulation and high-dose inhibition
of response.28 These clear low-dose effects observed with
exposure to short MWCNTs could be a major concern in
hazard assessment.29
Figure 3 shows the cluster vectors peaks for the dose−
response data sets. Exposure of MCF-7 cells concentrated in S-
phase to the three CNPs types suggested that each CNP type
shared a similar mode of action, with the induced effects mainly
on proteins [Amide I (∼1650 cm−1), Amide II (∼1550 cm−1)],
lipid (1705−1750 cm−1), and DNA (∼1225 cm−1, ∼1080
cm−1). In G0/G1-phase cells, similar alterations appeared
associated with protein and lipid regions for different CNP
types. However, C60 treatment resulted in a high-level of
alterations in the DNA/RNA spectral region in cells in either
phase; these effects following exposure to short or long
MWCNTs were markedly lower, even to a negligible level
compared with those induced by C60.
In order to determine the difference in the toxic effects
induced by the three CNPs, another experiment was conducted
to test the CNPs on MCF-7 cells (concentrated in S- or G0/G1-
phase) at a concentration of 0.1 mg/L. Clear segregation was
observed in both 1-D and 2-D scores plots, and G0/G1-phase
cells displayed a clearer segregation between the control and
treatment groups (Figure 4a). ANOVA with Newman-Keuls’
post hoc test was applied to examine the significance between
all pairs of groups in both spaces (see SI, Figure S6). Scores
plots in LD1 space showed that the treatment-induced cell
alterations ranked as C60 > long MWCNTs > short MWCNTs
in both S-phase and G-phase cells (Figure 4b; see SI, Figure
S8a). This is contrary to the cytotoxicity test of carbon
nanomaterials in alveolar macrophages, which suggested that
the effects of MWCNTs are more distinct than those of C60;30
however, the dose applied was much higher than that employed
in our study, which might make a big difference. The cluster
vectors plots derived from both CC PCA-LDA and PCA-LDA
showed that in both cell cycles all CNPs induced biochemical
alterations in MCF-7 cells in the protein region (1690−1400
cm−1) and lipid region (1750−1700 cm−1), while DNA/RNA
changes were also evident in the spectral profile (Figure 5; see
SI, Figures S7 and S8).
In S-phase cells, exposure to C60 induced specific alterations
in protein [∼1400 cm−1; e.g., −COO− (carboxylate)], Amide I
(∼1650 cm−1), Amide III (∼1280 cm−1), and DNA/RNA
Figure 2. One-dimensional cross-calculated PCA-LDA scores plot in
1st space of infrared (IR) spectra derived from MCF-7 cells (S-phase
or G0/G1-phase) treated with carbon nanoparticles (CNPs) and
concentration compared to the vehicle control. The horizontal line in
the center of each plot represents the mean value.
Figure 3. Cluster vectors peaks plot indicating the wavenumber basis
for segregation following treatment of MCF-7 cells with CNPs. Each
treatment was compared to the control. The size of the symbol in the
cluster vector peaks plot is proportional to the height of the
corresponding peaks, which are relative to the extent of biochemical
alteration compared to the vehicle control. The hint line represents a
typical infrared (IR) spectrum of the biochemical-fingerprint region
(1800−900 cm−1).
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(∼1225 cm−1; νasPO2−), in ranked order of peak height (Figure
5). According to the cluster vectors peak plot, both long and
short MWCNTs induced a similar level of alterations in S-
phase cells. The long MWCNTs resulted in specific alterations
in protein (∼1400 cm−1, −COO− stretching of amino acids),
Amide I (∼1650 cm−1), Amide III (∼1280 cm−1), DNA/RNA
(∼1225 cm−1; νasPO2−), and Amide II (∼1550 cm−1), while
less distinct alterations were induced by short MWCNTs; these
latter were associated with Amide I (∼1650 cm−1), protein
(∼1400 cm−1), Amide III (∼1280 cm−1), C−O stretch (∼1138
cm−1), and Amide II (∼1550 cm−1).
In G0/G1-phase cells, the main spectral biomarkers altered by
C60 included protein (∼1400 cm−1), Amide I (∼1650 cm−1),
lipid (∼1720 cm−1), and DNA/RNA (∼1080 cm−1; νsPO2−)
(Figure 5). Alterations induced by long or short MWCNTs
appeared similar to share the same profile, resulting in
alterations in protein (∼1400 cm−1), Amide I (∼1650 cm−1),
DNA/RNA (∼1080 cm−1; νsPO2−) and Amide II (∼1550
cm−1). It was observed that short MWCNTs invoked much
lower alterations than the other two CNP types tested.
To investigate whether ROS contributed to the toxic effects
of different CNPs in MCF-7 cells, Raman spectroscopy was
applied to the treated cell samples and CySS-to-protein ratio
was calculated from derived spectra. An elevated CySS-to-
protein ratio was observed in cells following exposure to CNPs
(Figure 6). An ANOVA with Newman-Keuls’ post hoc tests
was conducted to compare all pairs of the CySS-to-protein
ratios of treated groups; significance was observed (see SI,
Figure S9). As the elevation of CySS-to-protein ratio is
proportional to ROS levels generated in cells, it can be used as a
biomarker for this effect. Surprisingly, in both S-phase and G0/
G1-phase cells, short MWCNTs induced the most pronounced
ROS generation, while the IR spectral profiles showed that in
G0/G1-phase cells short MWCNTs induced much less
pronounced effects than the other two CNPs. This may
suggest that short MWCNTs exert toxic effects mainly through
ROS generation, while effects of long MWCNTs may be
induced through other mechanical mechanisms, such as direct
contact and damage.
IR spectral profiles indicate that cell components were
broadly affected by CNPs, including alterations in protein, lipid,
and DNA/RNA. Protein and lipid alterations were highlighted
as the most pronounced effects induced by CNPs in MCF-7
cells, which is suggestive that outer cell components are
primary cellular targets.31 Our findings showed that compared
with the short or long MWCNTs, C60 was more likely to alter
the DNA/RNA region. Even in G0/G1-phase cells, which
appear to be less susceptible to DNA damage compared with S-
phase cells,32 DNA/RNA alterations following exposure to C60
occurred at a high level. The mechanism of DNA damage here
is still not fully understood; it could possibly be as a
consequence of the spherical shape and size of C60
nanoparticles. Given its spherical shape coupled with nano-
scaled size, C60 may be able to penetrate deeper into areas
within cells and exert effects indirectly via ROS generation or
other direct pathways. The direct interaction between C60 and
DNA/RNA may be an important factor accounting for its
propensity to induce DNA/RNA alterations; it has been
reported that C60 could be statically hybridized with DNA/
RNA and induce structural changes in DNA/RNA,33 and also
that it could interfere with DNA replication leading to DNA
damage and even mutation.34 By contrast the two carbon
nanotubes, possessing a much larger size with a long tube
shape, have a more limited ability to alter the DNA/RNA
region, especially in G0/G1-phase cells. Generally, from derived
spectral data sets the most pronounced CNP-induced cellular
alterations were associated with outer cellular components; this
was especially so in cells concentrated in G0/G1-phase
compared with those concentrated in S-phase. Interestingly,
in both S-phase and G0/G1-phase cells, the effects of exposure
Figure 4. Cross-calculated PCA-LDA scores plots derived from MCF-
7 cells (S-phase or G0/G1-phase) treated with carbon nanoparticles
(CNPs) at concentration of 0.1 mg/L. (a) Scores plots in two
dimensions (90% confidence ellipsoids); and (b) Scores plot in 1st
space.
Figure 5. Cross-calculated PCA-LDA cluster vectors peaks plot
indicating the wavenumber basis for segregation following treatment of
MCF-7 cells with CNPs at concentration of 0.1 mg/L. Each treatment
was compared to the control. The size of the symbol in cluster vector
peaks plot is proportional to the height of the corresponding peaks,
which is relative to the extent of biochemical alteration compared to
the vehicle control. The hint line represents a typical infrared (IR)
spectrum of the biochemical-fingerprint region (1800−900 cm−1).
Figure 6. Ratio of CySS (cystine; 668 cm−1) to protein (1447 cm−1)
derived from Raman spectra, mean ± standard deviation.
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to short MWCNTs appeared to be much lower than that of
long MWCNTs. This is consistent with a study conducted in a
THP-1 cell line, which showed that longer CNTs induced a
stronger inflammatory response in target cells than shorter
ones.35 It is possible that this may be due to the CNP’s
morphology. As shown in the SEM images (Figure 1), long
MWCNTs with a longer and thicker structure exhibit minimal
agglomeration, while short MWCNTs are observed to be more
likely to intertwine and agglomerate. Elevated agglomeration
could dramatically decrease surface ratio, which plays an
important role in the toxic effects of nanoparticles. In G0/G1-
phase, after 96-h growth, this cell population reached
confluence, which may enhance the opportunity of contact
between cells and nanoparticles but as well decrease the
proportion of nanoparticle quantity to cell number. This could
increase the contact between cells and long MWCNTs leading
to direct damage in cells, but a higher cell density might dilute
the effects of ROS generated from short MWCNTs. Addition-
ally, previous research showed that cells concentrated in G0/G1-
phase exhibit higher antioxidant enzyme activities compared
with those in S-phase,36 which indicates that cells in G0/G1-
phase are more likely to protect intracellular components from
ROS invasion. However, a high level of protein alterations
observed in CNP-exposed G0/G1-phase cells still verified their
ability to generate ROS.
This study applied biospectroscopy in the investigation of
nanotoxicology to detect dose-related effects induced by three
CNPs in MCF-7 cells. It was determined that this approach is a
novel and powerful tool, capable of identifying the biochemical
alterations in cells resulting from exposure to CNPs.31 Further
study could be conducted to reveal more information
underlying these alterations. These could include a cytokine-
sis-block micronucleus assay to assess genotoxicity of CNPs in
cells. Additional experiments using biospectroscopy could
examine nanoparticle-induced effects in sentinel organisms.
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0.025, 0.05 and 
0.1 mg·L-1
S 63 630
DR2 Long S 63 630
DR3 Short S 63 630
DR4 C60 G0/G1 63 630
DR5 Long G0/G1 63 630
DR6 Short G0/G1 63 630
NP1 Control, C60, 
Long, Short 0.1 mg·L
-1 S 24 240
NP2 G0/G1 24 240
Total 426 4260






One sample, then 10 IR spectra 
acquired using ATR-FTIR
spectroscopy
• Each DR or NP dataset 
consisted of three 
independent experiments.
• Each DR experiment 
consisted of 6 treatments 
and one control (i.e., 7 
concentrations), each in 
triplicate per experiment.
• Each NP experiment 
consisted of 6 treatments 
and one control (i.e., 7 









DR: dose response datasets




Figure S1. Illustration of optimization of number of principal components 
(PCs) to use in Cross-Calculated PCA-LDA. The dataset in this illustration 
was the NP-8 dataset (refer to Table S1). This procedure was repeated 
similarly with all the other seven datasets. The optimization searches for the 
optimal number of PCs for the PCA stage of a PCA-LDC classifier [PCA as 
feature extraction, followed by a Linear discriminant classifier (LDC)]. The 
search space is from 1 to 199 PCs and the number of PCs with highest average 
classification rate is selected for Cross-Calculated PCA-LDA. Classification 
rates were obtained through 10-fold cross-validation. The thick line is the 
average classification rate, and the hachured area represents the ±standard 
deviation range.
A step-by-step protocol is available at http://irootlab.googlecode.com, 
allowing for reproduction of the PCA-LDC optimization on a different dataset.
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0.005, 0.01, 0.025, 
0.05 and 0.1 mg·L-1
28
DR2 Long (S-phase) 55
DR3 Short (S-phase) 22
DR4 C60 (G0/G1-phase) 28
DR5 Long (G0/G1-phase) 58
DR6 Short (G0/G1-phase) 28
NP1 All CNPs (S-phase)
0.1 mg·L-1
49
NP2 All CNPs (G0/G1-phase) 28
Table S2. Optimal 
number of principal 
























Cells treated with C60 (by Cross-Calculated PCA-LDA)
One-way ANOVA with Dunnett's Multiple 
Comparison Test
S-phase G0/G1-phase
LD1 LD2 LD1 LD2
Control vs. 0.0025 mg/L P <0.01 P >0.05 P <0.01 P <0.01
Control vs. 0.005 mg/L P <0.01 P >0.05 P <0.01 P <0.05
Control vs. 0.01 mg/L P <0.01 P >0.05 P <0.01 P <0.05
Control vs. 0.025 mg/L P <0.01 P >0.05 P <0.01 P >0.05
Control vs. 0.05 mg/L P <0.01 P >0.05 P <0.01 P >0.05
Control vs. 0.1 mg/L P <0.01 P >0.05 P <0.01 P >0.05
Cells treated with C60 (by PCA-LDA)
One-way ANOVA with Dunnett's Multiple 
Comparison Test
S-phase G0/G1-phase
LD1 LD2 LD1 LD2
Control vs. 0.0025 mg/L P <0.01 P <0.05 P <0.01 P <0.01
Control vs. 0.005 mg/L P <0.01 P >0.05 P <0.01 P <0.01
Control vs. 0.01 mg/L P <0.01 P >0.05 P <0.01 P <0.01
Control vs. 0.025 mg/L P <0.01 P <0.01 P <0.01 P >0.05
Control vs. 0.05 mg/L P <0.01 P >0.05 P <0.01 P >0.05
Control vs. 0.1 mg/L P <0.01 P <0.01 P <0.01 P >0.05
Figure S2. (a) Two-dimensional scores plot (90% Confidence ellipsoids) derived from MCF-
7 cells treated with C60, with P-value for each dimension calculated by one-way ANOVA 
























Cells treated with Long MWCNTs (by Cross-Calculated PCA-LDA)
One-way ANOVA with Dunnett's Multiple 
Comparison Test
S-phase G0/G1-phase
LD1 LD2 LD1 LD2
Control vs. 0.0025 mg/L P <0.01 P <0.01 P <0.01 P >0.05
Control vs. 0.005 mg/L P <0.01 P >0.05 P <0.01 P >0.05
Control vs. 0.01 mg/L P <0.01 P >0.05 P <0.01 P <0.01
Control vs. 0.025 mg/L P <0.01 P >0.05 P <0.01 P >0.05
Control vs. 0.05 mg/L P <0.01 P >0.05 P <0.01 P >0.05
Control vs. 0.1 mg/L P <0.01 P >0.05 P <0.01 P >0.05
Cells treated with Long MWCNTs (by PCA-LDA)
One-way ANOVA with Dunnett's Multiple 
Comparison Test
S-phase G0/G1-phase
LD1 LD2 LD1 LD2
Control vs. 0.0025 mg/L P <0.01 P >0.05 P >0.05 P >0.05
Control vs. 0.005 mg/L P <0.01 P <0.01 P <0.01 P >0.05
Control vs. 0.01 mg/L P <0.01 P >0.05 P <0.01 P <0.01
Control vs. 0.025 mg/L P <0.01 P >0.05 P <0.01 P >0.05
Control vs. 0.05 mg/L P <0.01 P <0.01 P <0.01 P >0.05
Control vs. 0.1 mg/L P <0.01 P >0.05 P <0.01 P >0.05
Figure S2. (b) Two-dimensional scores plot (90% Confidence ellipsoids) derived from MCF-
7 cells treated with Long MWCNTs, with P-value for each dimension calculated by one-way 
























Cells treated with Short MWCNTs (by Cross-Calculated PCA-LDA)
One-way ANOVA with Dunnett's Multiple 
Comparison Test
S-phase G0/G1-phase
LD1 LD2 LD1 LD2
Control vs. 0.0025 mg/L P <0.01 P >0.05 P <0.01 P >0.05
Control vs. 0.005 mg/L P <0.01 P <0.01 P <0.01 P >0.05
Control vs. 0.01 mg/L P <0.01 P >0.05 P <0.01 P >0.05
Control vs. 0.025 mg/L P <0.01 P <0.01 P <0.01 P >0.05
Control vs. 0.05 mg/L P <0.01 P >0.05 P <0.01 P >0.05
Control vs. 0.1 mg/L P <0.01 P >0.05 P <0.01 P >0.05
Cells treated with Short MWCNTs (by PCA-LDA)
One-way ANOVA with Dunnett's Multiple 
Comparison Test
S-phase G0/G1-phase
LD1 LD2 LD1 LD2
Control vs. 0.0025 mg/L P <0.01 P >0.05 P <0.01 P >0.05
Control vs. 0.005 mg/L P <0.01 P <0.01 P <0.01 P <0.01
Control vs. 0.01 mg/L P <0.01 P <0.01 P <0.01 P <0.01
Control vs. 0.025 mg/L P <0.01 P >0.05 P <0.01 P >0.05
Control vs. 0.05 mg/L P <0.01 P <0.05 P <0.01 P >0.05
Control vs. 0.1 mg/L P <0.01 P >0.05 P <0.01 P >0.05
Figure S2. (c) Two-dimensional scores plot (90% Confidence ellipsoids) derived from MCF-
7 cells treated with Short MWCNTs, with P-value for each dimension calculated by one-way 
ANOVA with Dunnett’s post hoc test.
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Figure S3. Cluster vectors plot by Cross-Calculated PCA-LDA indicating the 
wavenumber basis for segregation following treatment of MCF-7cells with CNPs. Each 
treatment was compared to the vehicle control. The height of the cluster vector peak is 
proportional to the extent of biochemical alteration compared to the vehicle control.
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Figure S4. Cluster vectors plot by PCA-LDA indicating the wavenumber basis for 
segregation following treatment of MCF-7cells with CNPs. Each treatment was compared to 
the vehicle control. The height of the cluster vector peak is proportional to the extent of 











Figure S5. Cluster vectors peaks plot by PCA-LDA indicating the wavenumber
basis for segregation following treatment of MCF-7 cells with CNPs. Each 
treatment was compared to the vehicle control. The size of the symbol in cluster 
vector peaks plot is proportional to the height of the corresponding peaks, which 
are relative to the extent of biochemical alteration compared to the vehicle 
control. The hint line represents a typical IR spectrum in the biochemical-




One-way ANOVA with Newman-Keuls
Multiple Comparison Test
S-phase G0/G1-phase
LD1 LD2 LD1 LD2
Control vs. C60 P <0.001 P >0.05 P <0.001 P <0.001
Control vs. Long P <0.001 P >0.05 P <0.001 P <0.001
Control vs. Short P <0.01 P >0.05 P <0.001 P <0.01
Short vs. C60 P <0.001 P >0.05 P <0.001 P <0.01
Short vs. Long P <0.01 P >0.05 P <0.001 P >0.05
Long vs. C60 P <0.001 P >0.05 P <0.001 P <0.05
PCA-LDA
One-way ANOVA with Newman-Keuls
Multiple Comparison Test
S-phase G0/G1-phase
LD1 LD2 LD1 LD2
Control vs. C60 P <0.001 P <0.01 P <0.001 P <0.001
Control vs. Long P <0.001 P >0.05 P <0.001 P <0.001
Control vs. Short P <0.001 P <0.001 P <0.001 P <0.01
Short vs. C60 P >0.05 P <0.001 P <0.001 P <0.001
Short vs. Long P <0.01 P <0.001 P <0.001 P >0.05























Figure S6. Two-dimensional scores plot (90% Confidence ellipsoids) derived from MCF-7 
cells treated with three Carbon Nanoparticles at 0.1 mg/L, with P-value for each dimension 
calculated by one-way ANOVA with Newman-Keuls’ post hoc test.
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Figure S7. Cluster vectors plot by Cross-Calculated PCA-LDA 




Figure S8. (a) One-dimensional scores plot; (b) cluster vectors plot; and, (c)
cluster vectors peak plot derived from MCF-7 cells treated with three Carbon 






Figure S9.  P-value of CySS-to-protein ratio calculated by one-way 
ANOVA with Newman-Keuls’ post hoc test.
S13




Control vs. C60 P <0.001 P <0.001
Control vs. Long P >0.05 P <0.001
Control vs. Short P <0.001 P <0.001
C60 vs. Long P <0.001 P >0.05
C60 vs. Short P >0.05 P <0.05
Long vs. Short P <0.001 P <0.01
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Figure S10. One-dimensional scores plot by PCA-LDA derived from MCF-7 
cells treated with Carbon Nanoparticles.
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Dose-response curve derived from LD1 space of PCA-
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Real-world carbon nanoparticle exposures induce
brain and gonadal alterations in zebrafish
(Danio rerio) as determined by biospectroscopy
techniques†
Junyi Li,a Guang-Guo Ying,b Kevin C. Jonesa and Francis L. Martin*a
Carbon-based nanoparticles (CNPs) have emerged as novel man-made materials with diverse appli-
cations, which may present significant risks to organisms. To bridge the gap in our knowledge of nano-
toxicology, a number of in vitro or in vivo studies have been carried out. However, toxicity data remains
limited. Herein, we employed a biospectroscopy approach to assess CNP-induced effects in zebrafish
(Danio rerio). Zebrafish were exposed to Fullerene (C60), long or short multi-walled carbon nanotubes
(MWCNTs), or single-walled carbon nanotubes (SWCNTs) for 21 days at two concentrations: 0.1 mg L−1 or
0.001 mg L−1. Following exposure, the brain, gills, gonads and liver from zebrafish were interrogated by
attenuated total reflection Fourier-transform infrared (ATR-FTIR) or Raman spectroscopy. Computational
analysis was then applied to the acquired infrared (IR) spectra, and distinct biochemical segregations
between the exposed tissues vs. control were observed with spectral biomarkers of alterations identified.
In addition, lipid-to-protein ratios in all four tissues were calculated by the IR spectra; unsaturated lipid
levels in brain and gonad were assessed by Raman spectroscopy. Marked lipid alterations were observed.
These findings show that biospectroscopy approaches have the potential to detect CNP-induced
biochemical alterations in zebrafish.
1. Introduction
Nanotechnology has introduced a wide range of man-made
materials into the environment. Fullerene (C60) and carbon
nanotubes (CNTs) are the most promising manufactured
carbon-based nanomaterials. With their unique physico-
chemical properties, these materials offer extraordinary oppor-
tunities for applications in industry, biomedicine or everyday
life.1–5 Increasing interest commercially or scientifically is
leading to massive production and application of these
materials. However, little is known of their potential toxicity,
or even how these materials will behave during the manufac-
turing process and in the environment.6,7 Consequently, this
emerging issue is drawing more and more attention worldwide
from scientists and governments.
Increasingly, numerous investigators are examining the
toxic interactions of carbon nanoparticles (CNPs) with cells.
Jia et al. observed that carbon nanomaterials (SWCNTs,
MWCNTs or C60) with different geometric structures induce
varying levels of cytotoxicity in alveolar macrophages.8
Additional studies showed that CNPs cause cytotoxicity in
HaCat human keratinocytes,9 human osteoblasts and fibro-
blasts,10 and human T-lymphocytes.11 Other biological models
such as bacteria,12,13 algae,14 Daphnia magna15 and, even,
fish16 or rats17 have been employed to study such adverse
effects. However, in vitro observations do not always faithfully
extrapolate to the in vivo situation. Also, sometimes conven-
tional assays are limited in their ability to assess nanoparti-
cles.18 To date, the understanding of CNPs’ toxicity remains
limited and a paradigm-shifting methodology is required to
offset such challenges.
Spectroscopy is increasingly used as a powerful tool in bio-
logical research. Infrared (IR) spectroscopy, including attenu-
ated total reflection Fourier-transform infrared (ATR-FTIR)
spectroscopy, has been applied in disease diagnosis19 and
toxic assessment of environmental contamination within
cells.20,21 In ATR-FTIR instrumentation, a mid-IR beam (λ =
2–20 µm) is transmitted through an internal reflection
element (e.g., diamond, zinc selenide, germanium, silicon) in
contact with the samples and penetrates a small distance
beyond the sample surface, allowing the generation of bio-
†Electronic supplementary information (ESI) available. See DOI: 10.1039/
c4an02227k
aCentre for Biophotonics, Lancaster Environment Centre, Lancaster University,
Lancaster LA1 4YQ, UK. E-mail: f.martin@lancaster.ac.uk; Tel: +44 (0)1524 510206
bState Key Laboratory of Organic Geochemistry, Guangzhou Institute of
Geochemistry, Chinese Academy of Sciences, Guangzhou 510640, China
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chemical fingerprint spectra (1800–900 cm−1). Raman spec-
troscopy is a complimentary spectral method, which can also
detect a wide range of chemical bonds in cells and tissues.22
Some excellent studies have already shown that Raman
spectroscopy can also be applied to assess nanotoxicity.23,24
Such biospectroscopy tools employed in biological investi-
gations may generate a large amount of spectral data,
which requires computational analysis in order to extract
information.25
Previously, we employed ATR-FTIR spectroscopy coupled
with computational analysis to detect CNP-induced alterations
in MCF-7 cells; dose-related effects were observed.26 This
suggests biospectroscopy as a novel tool capable of identifying
the effects of CNPs.27 Aquatic environments may act as a sink
for environmental contaminants including CNPs,28 and some
studies have already reported that single-walled CNTs and C60
exert toxic effects in rainbow trout (Oncorhynchus mykiss),29
and that MWCNTs induce toxicity in zebrafish embryos.30
Thus, it is essential to develop sensitive and reliable methods
to assess biological effects of CNPs in fish. Additionally, zebra-
fish are a well-established model organism widely applied in
biological medicine31 and toxicological assessment.32 In order
to address the limitations of in vitro tests and extrapolate to
the in vivo situation, we conducted tests on zebrafish (Danio
rerio) following exposure to CNPs and interrogated the tissues
using spectroscopy. In this study, zebrafish were exposed to
four CNPs (C60, short and long MWCNTs or SWCNTs) at con-
centrations of 0.1 mg L−1 or 0.001 mg L−1. Following 21-day
exposure, alterations in tissues including brain, gills, gonads
and liver were then assessed via biospectroscopy with compu-
tational analysis. Our aim was to ascertain real-world CNP
effects in a model system.
2. Materials and methods
Chemicals and carbon nanoparticles
Bovine serum albumin (BSA) obtained from Sigma was ≥98%.
All CNPs were purchased from Sigma. Short MWCNTs were
>90% pure being 10–15 nm in diameter and 0.1–10 µm in
length. Long MWCNTs were >90% pure also, but were
110–170 nm in diameter and 5–9 µm in length. C60 had a
purity >99.5% and particle size of 1 nm. SWCNTs were
described as CarboLex AP-grade (the purity of AP-grade pro-
ducts ranges from 50% to 70% by volume); major impurities
are carbon nanospheres and carbon-encapsulated catalyst
nanoparticles – the diameter was 1.2–1.5 nm. All CNPs were
analysed by Raman spectroscopy (Renishaw PLC, UK) with a
785 nm laser, and determined to be of high purity. Addition-
ally, images of CNPs were taken using a scanning electron
microscope (SEM) [JSM 5600 (JEOL)] [see ESI Fig. S1†]. CNPs
were dispersed in 1% BSA solution with a 15 min ultrasonica-
tion and stock solutions were made at concentrations of
100 mg L−1 and 1 mg L−1. CNT solutions were stable and well-
dispersed, while C60 appeared to agglomerate.
Fish maintenance and experimental conditions
All experiments were carried out following approval from the
local Institutional Review Board. Zebrafish were maintained in
the Aquatic Toxicology Laboratory at the Guangzhou Institute
of Geochemistry, Chinese Academy of Sciences. All fish were
kept in 50 L flow-through tanks filled with dechlorinated
tap water in a temperature-controlled room maintained at
27 ± 1 °C. The room was on a 14 : 10 h light : dark cycle, and
fish were fed once a day with a quantity of commercial food at
5% of the wet weight.
Fish exposures were conducted in 10 L glass tanks, and
each experimental tank contains 5 L dechlorinated tap water
and 4 fish (2 males, 2 females). Prior to exposure, zebrafish in
50 L tanks were randomly transferred to the experimental tank
for a 7-day adaptive period. Following this, CNP exposure was
initiated and run for 21 days. There were nine randomly
assigned tanks for each exposure (control and treatment with
one of four CNPs at 0.1 mg L−1 or 0.001 mg L−1). Exposure
concentrations were chosen based on previous in vitro
studies,26 which showed that speculated real-world environ-
mental levels induced alterations in exposed cell populations
detectable by biospectroscopy techniques. To minimize con-
tamination, fish were only fed in the morning every day and in
the afternoon, each tank was cleaned to eliminate fish faeces
and food remains by siphoning the water out of the tanks.
Then all tanks were filled with fresh water and treatment. All
fish were terminated at the end of the exposure and were sacri-
ficed within seconds by immersion in melting ice prior to
body size measurements (weight and length) (see ESI Fig. S2†).
From each fish, gills, brain, liver and gonads were indepen-
dently harvested and fixed in 70% ethanol. Exposure experi-
ments were conducted in triplicate.
Biospectroscopy analysis
Each fixed fish tissue for spectral interrogation was thinly
sliced by hand and mounted on IR-reflective low-E slides
(Kevley Technologies, USA), allowed to air-dry and stored in a
desiccator prior to spectral acquisition. All tissue samples were
interrogated using a Bruker TENSOR 27 FTIR spectrometer
(Bruker Optics Ltd., UK) equipped with a Helios ATR attach-
ment containing a diamond internal reflection element (IRE).
Instrument parameters were set at 32 scans, 16 cm−1 resolu-
tion. For each slide, 10 IR spectra were acquired at different
points across the sample. Prior to starting a new slide, the ATR
crystal was cleaned with deionized water and a background
taken. Additionally, the brain and gonad tissues from the
control group and the high-dose treatment groups for the four
CNPs were further interrogated by Raman spectroscopy.
Raman spectra were recorded using an InVia Renishaw Raman
spectrometer (Renishaw plc, UK) equipped with a 785 nm
streamline focus laser and a Renishaw-automated 100 nm
encoded XYZ stage. The system parameters consisted of 50 µm
entrance slit, 830 lines mm−1 (∼1.69 cm−1 spectral resolution)
diffraction grating dispersing Raman signal onto a master
Renishaw Pelletier cooled charge detector (CCD, 1024 pixel ×
Paper Analyst























































































pixel). The system calibration was carried out using an internal
Renishaw silicon calibration source for wavenumber shift. A
white light camera mounted on the microscope was used to
visualize the locations of the spectral acquisition. Spectra were
collected using a Leica ×50 objective lens (numeral aperture
0.75) at 50% laser power (≤100 mW prior to lens) of 20-second
exposure and spectral range covering 2000–500 cm−1. Approxi-
mately 30 spectra were obtained from different sites from each
sample.
Data analysis
All spectral data acquired from both ATR-FTIR and Raman
spectroscopy were processed using our IRootLab toolbox
(http://irootlab.googlecode.com)33 running on MATLAB r2010a
(The MathWorks, Inc., US). IR spectra were pre-processed as
follows: cut to 1800–900 cm−1 (the biochemical fingerprint
range), rubberband baseline correction and normalization to
the Amide I peak (1650 cm−1). Computational analysis using
multivariate techniques including principal component analy-
sis (PCA) and linear discriminant analysis (LDA) can efficiently
analyse such large spectral datasets. Following pre-processing,
cross-calculated PCA-LDA was applied to the dataset; infor-
mation was extracted and visualised as scores plots and cluster
vectors. PCA is an unsupervised technique employed to reduce
the dimensions of the data, and then the PCA scores are used
as input for the subsequent LDA, where the class’ information
contributes to differentiation of the derived clusters. To elim-
inate the risk of LDA overfitting, “cross-calculation” was
applied to the PCA-LDA scores (see ESI Fig. S3†). It utilizes
leave-one-out cross-validation to train the PCA-LDA loadings
using n-1 (n = number of spectra in the dataset) samples and
subsequently calculates the scores for the remaining sample,
repeating this process until all scores are calculated. The load-
ings are derived as averages between the n PCA-LDA loadings
model. Additionally, the number of principal components
(PCs) for PCA-LDA was calculated by classification with an
optimization procedure. The output data derived from
PCA-LDA can be then visualized as 1-D, 2-D or 3-D scatterplots
(“scores plots”). In scores plots, nearness between two groups
means similarity, while increasing distance indicates dissimi-
larity. To reveal the biochemical alterations associated with
each group in the dataset, PCA-LDA cluster vectors were develo-
ped.25 To simplify the identification of the main biochemical
alteration of each group, cluster vectors plots were used to
indicate the first eight highest peaks; tentative assignments of
the peak wavenumbers are listed (see ESI,† pages 25–46),
ranked by peak height.
Lipid accumulation and unsaturated levels in tissues exposed
to CNPs
Lipid accumulation in tissues was calculated by measuring the
lipid-to-protein ratio using the intensity absorbance at two
vibration modes derived from the pre-processed IR spectra.
The intensity absorbance at 1400 cm−1 corresponding to CvO
symmetric stretching of amino acid was used as a protein
marker, while the intensity absorbance at 2924 cm−1 was
associated with νasCH2 for lipid. In Raman spectra, the inten-
sity at 1445 cm−1 was assigned to CH2 bending for lipid and
the intensity at 1670 cm−1 was assigned to ν(CvC) in lipid.
The ratio of (CvC)/(CH2) can be used to calculate the lipid
unsaturated level.34
Repeated-measures one-way analysis of variance (ANOVA)
with Dunnett’s post hoc tests were used to examine whether
the alteration of the tissues observed in scores plots (LD1 and
LD2), and the ratios of lipid/protein and (CvC)/(CH2) differed
significantly between the exposure vs. control groups. It’s not
necessary to transform data to meet the underlying assump-
tion of homogeneity between categories and normality of
residuals. P-values below 0.05 were considered statistically sig-
nificant. All ANOVA tests were conducted in GraphPad Prism 4
(GraphPad Software, USA).
3. Results and discussion
When zebrafish were exposed to one of the four CNPs tested,
the response for each tissue examined was different and varied
with exposure. CNP-specific dose responses compared to the
control group were observed in all tissues examined, including
brain, gills, gonads and liver (see ESI Fig. S4–S7†). Addition-
ally, ANOVA tests showed that these were significant for the
majority of exposures (see ESI Tables S1 and S2†). In the
scores plots along the LD1 dimension, most category separ-
ation was observed; these simply show the effects for each
tissue resulting from two different CNP exposures (Fig. 1 and
2). It is clearly noted that along LD1, the gills and brain exhibit
a similar response pattern to the four different CNPs. In con-
trast, the gonads and liver display an inverse response to these
exposures, with the lower dose inducing more pronounced
effects than the higher. On a physiologically-based toxic-
kinetics (PBTK) model, the gills are considered the initial site
for uptake and elimination of CNPs, while brain, gonads and
liver connected with the gills via arterial blood are perturbed
by CNPs.35 It is noted that in zebrafish, blood circulating in
veins from the gonads will reach the liver, which may explain
why these tissues respond similarly to CNPs. To highlight the
main biochemical alterations induced by CNPs, a cluster
vectors method was employed following cross-calculated
PCA-LDA. CNP exposures generate a range biochemical altera-
tions associated with lipid, protein, glycogen and DNA/RNA
(see ESI†).
To reveal the profile of effects induced by CNPs, a dataset
was developed to profile alterations in zebrafish tissues follow-
ing CNP exposures at a concentration of 0.1 mg L−1 compared
to the control group. Segregation in 2-D cross-calculated
PCA-LDA scores plots showed that long MWCNTs, possessing
a relatively larger size, exert the most pronounced alterations
in the four tissues studied compared to the other three CNPs
(Fig. 3). The cluster vectors plots indicate that long MWCNTs-
induced effects in tissues are mainly to lipid and protein, with
limited alterations in the DNA/RNA region (Fig. 4). However,
C60 appears to induce a high level of alterations in the DNA/
Analyst Paper























































































RNA region, especially in the brain. SWCNTs- and short
MWCNTs-induced alterations in zebrafish appear to be
similar. To investigate the brain and gonads further,
Raman spectroscopy was employed to interrogate these
two tissues; significant post-exposure alterations were again
observed.
IR spectra allow an estimation of the lipid-to-protein ratio
in tissues. This showed that female fish display a higher lipid-
to-protein ratio, except in the gonads. Among all tissue types,
male gonads exhibited the highest lipid-to-protein ratio
(Fig. 5). Additionally, the unsaturated levels of lipid in brain
and gonads were assessed by calculating the ratio of (CvC)/
(CH2) in Raman spectra. It showed that there was a higher
unsaturated lipid level in male fish than females (Fig. 6).
As the initial site of uptake and elimination of contami-
nation, the gills would be expected to directly interact with
Fig. 1 One-dimensional (1-D) cross-calculated PCA-LDA scores plots in 1st space of infrared (IR) spectra derived from brain or gill of zebrafish [male
(M) or female (F)] exposed to carbon nanoparticles (CNPs) at two concentrations compared to the vehicle control. The horizontal line in the centre
of each plot represents the mean value. C60, C60 (fullerene); long, long MWCNTs; short, short MWCNTs; single, SWCNTs.
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CNPs. Therefore, CNPs would exert effects by direct physical
injury and indirectly by generating reactive oxidative species
(ROS) and free radicals,36 resulting in gill inflammation.37,38
Exposure to CNPs induced significant alterations in Amide I,
Amide II, lipid and protein in both female and male fish.
Additionally, slight alterations in DNA/RNA region (νasPO2
−,
∼1225 cm−1; νsPO2−, ∼1080 cm−1) were observed as well. The
lipid-to-protein ratio was most highly elevated in gills exposed
to long MWCNTs. Short MWCNTs and SWCNTs seemed to
elicit a lower lipid-to-protein ratio in gills, while C60 showed no
significant effect (P > 0.05). This suggests that the size of the
CNPs plays a major role in inducing inflammation in the gill,
with larger sizes causing higher levels of damage.39 Though it
was reported that CNPs would be precipitated on gill mucus,40
Fig. 2 One-dimensional (1-D) cross-calculated PCA-LDA scores plots in 1st space of infrared (IR) spectra derived from gonad or liver of zebrafish
[male (M) or female (F)] exposed to carbon nanoparticles (CNPs) at two concentrations compared to the vehicle control. The horizontal line in the
centre of each plot represents the mean value. C60, C60 (fullerene); long, long MWCNTs; short, short MWCNTs; single, SWCNTs.
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CNPs could still penetrate the gill and be transported into the
fish circulation. Even if tight junctions between gill cells dra-
matically reduce the permeability to CNPs, inflammation
factors at the site could still facilitate their transported into
the circulation to exert further effects on other organs.
Post-exposure to CNPs, the brain also showed significant
alterations. Both IR and Raman spectra showed that long
MWCNTs caused the most pronounced alterations in brain for
both genders. In contrast, there appeared to be no significant
effect of long MWCNTs on the lipid-to-protein ratio compared
with control, while C60 induced a significant elevation of lipid-
to-protein ratio, as well as short MWCNTs and single-walled
CNTs. Because of their larger size, it may be difficult for long
MWCNTs to penetrate through the tight junctions between the
gill cells, which could also limit their ability to cross the
blood–brain barrier (BBB).41 However, with high levels of oxi-
dative stress and even inflammation factors induced by long
MWCNTs, they still dramatically altered brain spectral signa-
tures. Raman spectra showed that male fish display higher
lipid unsaturated levels than females, which could contribute
to the fluidity of the cell membrane. Interestingly, C60 caused
contrasting effects on unsaturated lipid levels of brain in both
genders. In female fish, the unsaturated lipid level was
increased, while it was decreased in males, both significantly.
As the brain in male fish has a lower lipid-to-protein ratio but
higher unsaturated levels compared with that to female fish, it
means that the male brain contains less lipid, but possibly
greater fluidity due to an elevated content of unsaturated
lipid.42 Thus, it is more likely that the highly lipophilic C60 will
penetrate further into the lipid region,43 and exert oxidative
damage not only to lipid, but also to further biochemical con-
stituents such as protein and DNA/RNA. However, the three
CNTs resulted in a significant increase of unsaturated lipid
levels in the female brain, while only SWCNTs caused a signifi-
cant elevation in males. Due to the lower lipid-to-protein ratio
in male brain compared to female, possibly implicating that
the male has a thinner layer of lipid, CNPs may exert a wider
range of effects in cells. This was exhibited by the IR spectra
indicating a trend for CNPs to induce more effects on the
DNA/RNA spectral region derived from male brain compared
to female. Profiled by both the IR and Raman spectra, all
CNPs widely and highly induced alterations in the protein and
lipid spectral region. Complimentary to IR, Raman spectra
Fig. 3 Cross-calculated PCA-LDA scores plots in 2 dimensions (90%
confidence ellipsoids) derived from tissues of zebrafish exposed to
carbon nanoparticles (CNPs) at concentration of 0.1 mg L−1 and the
vehicle control. C60, C60 (fullerene); long, long MWCNTs; short, short
MWCNTs; single, SWCNTs.
Fig. 4 Cluster vectors peak plots indicating the wavenumber basis for
segregation corresponding to the tissues exposed to CNPs (0.1 mg L−1).
Each exposed tissue was compared with the vehicle control. The size of
the symbol in cluster vectors peaks plot is proportional to the height of
the corresponding peaks in the cluster vector plots, which relative to the
extent of alteration compared with the vehicle control. The hint line rep-
resents a typical IR spectrum of the biochemical-fingerprint region
(1800 cm−1–900 cm−1) of the tissue. C60, C60 (fullerene); long, long
MWCNTs; short, short MWCNTs; single, SWCNTs.
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also indicated that CNPs caused significant effects in the
spectral range associated with S–S (∼524 cm−1), C–S
(∼662 cm−1) in protein and CvC in lipid (∼1655 cm−1). It is
accepted that ROS generation is a key pathway in nanoparticle
toxicity. High ROS levels could increase the depletion of thiol
groups in proteins, especially glutathione (GSH), and increase
the oxidized forms such as GSSG.44,45
The interference of CNPs in brain could perturb the hypo-
thalamic-pituitary-gonadal axis and affect the gonads further,
in addition to direct effects on these tissues. It is evidenced by
IR spectra that CNP exposures resulted in significant altera-
tions in lipids, proteins and DNA/RNA. Raman spectra also
confirmed this and showed that CNPs could induce alterations
associated with C–S (∼662 cm−1) in female fish rather than in
males. With both higher lipid-to-protein ratios and higher
unsaturated lipid levels, male fish are more likely to protect
protein from CNP-induced oxidative stress through the antioxi-
dant function at the lipid region. These gonadal alterations
would possibly further affect reproductive activity.
As an important organ for active metabolism and detoxifi-
cation, the liver seems quite sensitive to CNP exposure.
IR spectra show that the most pronounced alterations induced
by C60 were associated with DNA/RNA region (vsPO2
−,
∼1080 cm−1) in both genders, followed by alterations located
in the protein and lipid spectral regions. Limited effects in
DNA/RNA caused from short MWCNTs and SWCNTs were
observed as well. In contrast, long MWCNTs seemed to have a
weak capability to affect the liver in the DNA/RNA region, but
caused significant alterations in lipids and proteins. The lipid-
to-protein ratio in liver was significantly elevated by long
MWCNTs in both genders. C60 and short MWCNTs reduced
the lipid-to-protein ratio in female fish, in the absence of sig-
nificant effects in males, while SWCNTs only elevated that
ratio in males. The change in lipid-to-protein ratio in liver
could be caused from the direct interference of CNPs, while
the lipid accumulation was possibly due to CNP-induced
inflammatory stress; long MWCNTs especially appear to
disrupt cholesterol trafficking in liver tissue.46
Fig. 5 Ratio of lipid to protein derived from IR spectra, Mean ± standard deviation: (a) Comparison of different tissues from female (F) and male (M)
zebrafish without exposure; and, (b) comparison of tissues exposed to CNPs with the control. C60, C60 (fullerene); long, long MWCNTs; short, short
MWCNTs; single, SWCNTs.
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Herein, biospectroscopy is presented as a global approach to
nanotoxicity assessment, providing one with a profile of CNP-
induced alterations. IR and Raman spectra show that CNPs
can induce significant alterations in fish, and also highlights
the differing effects of four CNPs. Although it could not be
shown that the CNPs passed through the bio-barrier (e.g., BBB)
and moved to further tissues in fish, such as brain and
gonads, the fact that these organs were affected is a key indi-
cator from the perspective of biological effects. Possibly the
alterations observed in the brain and gonads demonstrate that
CNPs do exert potential toxic effects on both nervous and
reproductive systems.47–50 In addition, the alterations in DNA/
RNA spectral regions caused by CNPs, especially by C60,
suggested that DNA methylation could be perturbed following
the CNP exposure. It is necessary to conduct further investi-
gations to assess the DNA methylation levels in tissues of
exposed fish. These effects may be extrapolated to other organ-
isms.51 Furthermore, future studies need to examine whether
the effects of CNPs impact on reproductive activity and test if
transgenerational effects might arise.
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Figure S1 Scanning electron microscopy (SEM) images of (a) C60 fullerene; 
(b) long MWCNTs; (c) short MWCNTs; and, (d) single-walled CNTs. For 




Weight (g) Length (mm) Weight (g) Length (mm)
Mean 1.221 45.431 0.782 41.225
SD 0.214 2.342 0.081 1.533
Figure S2 The wet body weight and length of zebrafish.
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Figure S3. Illustration of optimization of number of principal components 
(PCs) to use in PCA-LDA. The dataset in this illustration was the NP-8 dataset 
(refer to Table S1). This procedure was repeated similarly with all the other seven 
datasets. The optimization searches for the optimal number of PCs for the PCA 
stage of a PCA-LDC classifier [(PCA as feature extraction, followed by a linear 
discriminant classifier (LDC)]. The search space is from 1 to 199 PCs and the 
number of PCs with highest average classification rate is selected for PCA-LDA. 
Classification rates were obtained through 10-fold cross-validation. The thick 
line is the average classification rate, and the hachured area represents the ±
standard deviation range.
A step-by-step protocol is available at http://irootlab.googlecode.com, allowing 
for reproduction of the PCA-LDC optimization on a different dataset.
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Figure S4 Two-dimensional cross-calculated PCA-LDA scores plot (90% 
confidence ellipsoids) derived from zebrafish tissues exposed to C60
interrogated by ATR-FTIR spectroscopy.
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Figure S5 Two-dimensional cross-calculated PCA-LDA scores plot 
(90% confidence ellipsoids) derived from zebrafish tissues exposed to 
long MWCNTs interrogated by ATR-FTIR spectroscopy.
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Figure S6 Two-dimensional cross-calculated PCA-LDA scores plot 
(90% confidence ellipsoids) derived from zebrafish tissues exposed to 
short MWCNTs interrogated by ATR-FTIR spectroscopy.
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Figure S7 Two-dimensional cross-calculated PCA-LDA scores plot 
(90% confidence ellipsoids) derived from zebrafish tissues exposed to 
single-walled CNTs interrogated by ATR-FTIR spectroscopy.
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Figure S8 Cross-calculated PCA-LDA cluster vectors plots responsible for 
the wavenumber basis for segregation of zebrafish brain, gill, gonads and 
liver exposed to C60 or long MWCNTs by ATR-FTIR spectroscopy. Each 
treatment was compared to the control. The size of the marker symbol is 
proportional to the height of corresponding cluster vectors peak. 
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Figure S9 Cross-calculated PCA-LDA cluster vectors plots responsible for 
the wavenumber basis for segregation of zebrafish brain, gill, gonads and 
liver exposed to short MWCNTs or single-walled CNTs by ATR-FTIR 
spectroscopy. Each treatment was compared to the control. The size of the 




Figure S10 Cross-calculated PCA-LDA cluster vectors plots indicating the 
wavenumber basis for segregation of zebrafish tissues exposed to C60 by 
ATR-FTIR spectroscopy. Each treatment was compared to the control. The 
height of the cluster vectors peak is proportional to the extent of 
biochemical alteration compared to the vehicle control.
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Figure S11 Cross-calculated PCA-LDA cluster vectors plots indicating the 
wavenumber basis for segregation of zebrafish tissues exposed to long 
MWCNTs by ATR-FTIR spectroscopy. Each treatment was compared to the 
control. The height of the cluster vectors peak is proportional to the extent of 
biochemical alteration compared to the vehicle control. 
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Figure S12 Cross-calculated PCA-LDA cluster vectors plots indicating the 
wavenumber basis for segregation of zebrafish tissues exposed to short 
MWCNTs by ATR-FTIR spectroscopy. Each treatment was compared to 
the control. The height of the cluster vectors peak is proportional to the 
extent of biochemical alteration compared to the vehicle control. 
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Figure S13 Cross-calculated PCA-LDA cluster vectors plots indicating the 
wavenumber basis for segregation of zebrafish tissues exposed to single-
walled CNTs by ATR-FTIR spectroscopy. Each treatment was compared to 
the control. The height of the cluster vectors peak is proportional to the 
extent of biochemical alteration compared to the vehicle control. 
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Figure S14 Cross-calculated PCA-LDA cluster vectors plots indicating the 
wavenumber basis for segregation of zebrafish tissues exposed to CNPs by 
ATR-FTIR spectroscopy. Each treatment was compared to the control. The 
height of the cluster vectors peak is proportional to the extent of 
biochemical alterations compared to the vehicle control. 
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Figure S15 Two-dimension cross-calculated PCA-LDA scores plot (90% 
confidence ellipsoids) derived from zebrafish brain and gonad exposed to 
CNPs at concentration of 0.1 mg/L interrogated by Raman spectroscopy.
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Figure S16 Cross-calculated PCA-LDA cluster vectors plots indicating the 
wavenumber basis for segregation of zebrafish tissues exposed to CNPs at 
concentration of 0.1 mg/L by Raman spectroscopy. Each treatment was 
compared to the control. The height of the cluster vectors peak is 




Figure S17 Cross-calculated PCA-LDA cluster vectors plots responsible for 
the wavenumber basis for segregation of zebrafish brain and gonads
exposed to CNPs at concentration of 0.1 mg/L by Raman spectroscopy. 
Each treatment was compared to the control. The size of the marker symbol 
is proportional to the height of corresponding cluster vectors peak. 
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Tissues of zebrafish exposed to C60 (by cross-calculated PCA-LDA) by 
ATR-FTIR spectroscopy
One-way ANOVA with Dunnett's Multiple 
Comparison Test
Female Male
LD1 LD2 LD1 LD2
Brain Control vs. 0.001 mg/L P <0.0001 P <0.0001 P >0.05 P <0.0001
Control vs. 0.1 mg/L P <0.0001 P <0.0001 P <0.0001 P <0.0001
Gill Control vs. 0.001 mg/L P <0.0001 P <0.0001 P <0.0001 P <0.0001
Control vs. 0.1 mg/L P <0.0001 P <0.0001 P <0.0001 P <0.0001
Gonad Control vs. 0.001 mg/L P <0.0001 P <0.01 P <0.0001 P <0.0001
Control vs. 0.1 mg/L P <0.0001 P <0.0001 P <0.01 P <0.0001
Liver Control vs. 0.001 mg/L P <0.0001 P <0.001 P <0.0001 P <0.0001
Control vs. 0.1 mg/L P <0.0001 P <0.0001 P <0.0001 P <0.0001
Tissues of zebrafish exposed to Long MWCNTs (by cross-calculated 
PCA-LDA) by ATR-FTIR spectroscopy
One-way ANOVA with Dunnett's Multiple 
Comparison Test
Female Male
LD1 LD2 LD1 LD2
Brain Control vs. 0.001 mg/L P <0.0001 P <0.0001 P <0.0001 P <0.0001
Control vs. 0.1 mg/L P <0.0001 P <0.0001 P <0.0001 P <0.0001
Gill Control vs. 0.001 mg/L P <0.0001 P <0.0001 P <0.0001 P <0.0001
Control vs. 0.1 mg/L P <0.0001 P <0.0001 P <0.0001 P <0.0001
Gonad Control vs. 0.001 mg/L P <0.0001 P <0.0001 P <0.001 P <0.0001
Control vs. 0.1 mg/L P <0.0001 P <0.0001 P <0.0001 P <0.0001
Liver Control vs. 0.001 mg/L P <0.0001 P <0.0001 P <0.0001 P <0.0001
Control vs. 0.1 mg/L P <0.0001 P <0.0001 P <0.0001 P <0.0001
Table S1 P-value for each dimension calculated by one-way ANOVA with 
Dunnett’s post-hoc test for 2-D cross-calculated PCA-LDA scores plots. 
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Tissues of zebrafish exposed to Short MWCNTs (cross-calculated PCA-
LDA) by ATR-FTIR spectroscopy
One-way ANOVA with Dunnett's Multiple 
Comparison Test
Female Male
LD1 LD2 LD1 LD2
Brain Control vs. 0.001 mg/L P <0.0001 P <0.0001 P <0.0001 P <0.0001
Control vs. 0.1 mg/L P <0.0001 P <0.0001 P <0.0001 P <0.0001
Gill Control vs. 0.001 mg/L P <0.0001 P <0.0001 P <0.0001 P <0.0001
Control vs. 0.1 mg/L P <0.01 P <0.0001 P <0.0001 P <0.0001
Gonad Control vs. 0.001 mg/L P <0.0001 P <0.0001 P <0.0001 P <0.0001
Control vs. 0.1 mg/L P <0.0001 P <0.0001 P >0.05 P <0.0001
Liver Control vs. 0.001 mg/L P <0.0001 P <0.0001 P <0.0001 P <0.0001
Control vs. 0.1 mg/L P <0.001 P <0.0001 P <0.01 P <0.0001
Tissues of Zebrafish exposed to single-walled CNTs (cross-calculated 
PCA-LDA) by ATR-FTIR spectroscopy
One-way ANOVA with Dunnett's Multiple 
Comparison Test
Female Male
LD1 LD2 LD1 LD2
Brain Control vs. 0.001 mg/L P > 0.05 P < 0.0001 P < 0.0001 P < 0.0001
Control vs. 0.1 mg/L P < 0.0001 P < 0.0001 P < 0.0001 P < 0.0001
Gill Control vs. 0.001 mg/L P < 0.01 P < 0.0001 P < 0.0001 P < 0.0001
Control vs. 0.1 mg/L P < 0.0001 P < 0.0001 P < 0.0001 P < 0.0001
Gonad Control vs. 0.001 mg/L P < 0.0001 P < 0.0001 P < 0.0001 P < 0.0001
Control vs. 0.1 mg/L P > 0.05 P < 0.0001 P < 0.0001 P < 0.0001
Liver Control vs. 0.001 mg/L P < 0.0001 P < 0.0001 P < 0.0001 P < 0.0001
Control vs. 0.1 mg/L P < 0.0001 P < 0.0001 P < 0.0001 P < 0.0001
Table S2 P-value for each dimension calculated by one-way ANOVA with 
Dunnett’s post-hoc test for 2-D cross-calculated PCA-LDA scores plots.
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Tissues of zebrafish exposed to CNPs (by cross-calculated PCA-LDA) 
interrogated by ATR-FTIR spectroscopy
One-way ANOVA with Dunnett's Multiple 
Comparison Test
Female Male
LD1 LD2 LD1 LD2
Brain Control vs. C60 0.1 mg/L P <0.0001 P <0.001 P <0.001 P >0.05
Control vs. Long 0.1 mg/L P <0.0001 P <0.0001 P <0.0001 P <0.001
Control vs. Short 0.1 mg/L P <0.0001 P <0.0001 P >0.05 P <0.0001
Control vs. Single 0.1 mg/L P <0.0001 P <0.0001 P <0.0001 P <0.001
Gill Control vs. C60 0.1 mg/L P <0.0001 P <0.001 P <0.001 P >0.05
Control vs. Long 0.1 mg/L P <0.0001 P <0.001 P <0.0001 P >0.05
Control vs. Short 0.1 mg/L P <0.0001 P <0.001 P <0.0001 P <0.0001
Control vs. Single 0.1 mg/L P <0.001 P <0.0001 P <0.0001 P <0.0001
Gonad Control vs. C60 0.1 mg/L P <0.0001 P <0.0001 P >0.05 P <0.0001
Control vs. Long 0.1 mg/L P <0.0001 P >0.05 P <0.0001 P <0.0001
Control vs. Short 0.1 mg/L P <0.0001 P <0.0001 P <0.01 P <0.0001
Control vs. Single 0.1 mg/L P <0.0001 P <0.0001 P <0.01 P <0.0001
Liver Control vs. C60 0.1 mg/L P <0.001 P <0.0001 P <0.0001 P >0.05
Control vs. Long 0.1 mg/L P <0.0001 P <0.0001 P <0.0001 P <0.01
Control vs. Short 0.1 mg/L P >0.05 P <0.0001 P <0.0001 P <0.0001
Control vs. Single 0.1 mg/L P >0.05 P <0.0001 P <0.0001 P <0.01
Table S3 P-value for each dimension calculated by one-way ANOVA with 
Dunnett’s post-hoc test for 2-D cross-calculated PCA-LDA scores plots. 
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Tissues of zebrafish exposed to CNPs (by cross-calculated PCA-LDA) 
interrogated by Raman spectroscopy
One-way ANOVA with Dunnett's Multiple 
Comparison Test
Female Male
LD1 LD2 LD1 LD2
Brain Control vs. C60 0.1 mg/L P <0.0001 P <0.001 P >0.05 P <0.0001
Control vs. Long 0.1 mg/L P <0.0001 P <0.0001 P <0.0001 P <0.0001
Control vs. Short 0.1 mg/L P <0.0001 P <0.0001 P <0.001 P <0.0001
Control vs. Single 0.1 mg/L P <0.0001 P <0.001 P <0.0001 P <0.0001
Gonad Control vs. C60 0.1 mg/L P <0.0001 P <0.0001 P <0.0001 P <0.0001
Control vs. Long 0.1 mg/L P <0.0001 P <0.0001 P >0.05 P <0.0001
Control vs. Short 0.1 mg/L P <0.0001 P <0.0001 P <0.0001 P <0.0001
Control vs. Single 0.1 mg/L P <0.0001 P <0.0001 P <0.0001 P <0.0001
Table S4 P-value for each dimension calculated by one-way ANOVA with 
Dunnett’s post-hoc test for 2-D cross-calculated PCA-LDA scores plots. 
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Lipid-to-protein ratios derived from IR spectra following ATR-FTIR 
spectroscopy
One-way ANOVA with Dunnett's Multiple 
Comparison Test Female Male
Brain Control vs. C60 0.1 mg/L P <0.01 P <0.01
Control vs. Long 0.1 mg/L P >0.05 P >0.05
Control vs. Short 0.1 mg/L P <0.001 P <0.01
Control vs. Single 0.1 mg/L P <0.0001 P <0.001
Gill Control vs. C60 0.1 mg/L P >0.05 P >0.05
Control vs. Long 0.1 mg/L P <0.0001 P <0.0001
Control vs. Short 0.1 mg/L P <0.001 P <0.0001
Control vs. Single 0.1 mg/L P <0.0001 P <0.0001
Gonads Control vs. C60 0.1 mg/L P >0.05 P <0.001
Control vs. Long 0.1 mg/L P <0.0001 P <0.0001
Control vs. Short 0.1 mg/L P <0.0001 P >0.05
Control vs. Single 0.1 mg/L P <0.0001 P <0.01
Liver Control vs. C60 0.1 mg/L P <0.01 P >0.05
Control vs. Long 0.1 mg/L P <0.001 P <0.01
Control vs. Short 0.1 mg/L P <0.01 P >0.05
Control vs. Single 0.1 mg/L P >0.05 P <0.01
Table S5 P-value for each dimension calculated by one-way ANOVA with 
Dunnett’s post-hoc test for lipid-to-protein ratios derived from IR spectra.
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Liver F Liver M
Brain F P <0.0001 P <0.0001 P >0.05 P >0.05 P <0.0001 P <0.0001 P <0.01
Brain M P <0.0001 P <0.0001 P <0.0001 P <0.0001 P <0.0001 P <0.0001 P <0.01
Gill F P <0.0001 P <0.0001 P <0.0001 P <0.0001 P <0.001 P <0.01 P <0.0001
Gill M P >0.05 P <0.0001 P <0.0001 P >0.05 P <0.0001 P <0.0001 P <0.01
Gonads 
F
P >0.05 P <0.0001 P <0.0001 P >0.05 P <0.0001 P <0.0001 P <0.0001
Gonads 
M
P <0.0001 P <0.0001 P <0.001 P <0.0001 P <0.0001 P <0.0001 P <0.0001
Liver F P <0.0001 P <0.0001 P <0.01 P <0.0001 P <0.0001 P <0.0001 P <0.0001
Liver M P <0.01 P <0.01 P <0.0001 P <0.01 P <0.001 P <0.0001 P <0.0001
Table S6 P-value for each dimension calculated by one-way ANOVA 
with Newman-Keuls’ post-hoc test for lipid-to-protein ratios in different 
tissues derived from IR spectra.
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Ratio of C=C/CH2 derived from Raman spectra
One-way ANOVA with Dunnett's Multiple 
Comparison Test Female Male
Brain Control vs. C60 0.1 mg/L P <0.0001 P <0.001
Control vs. Long 0.1 mg/L P <0.0001 P >0.05
Control vs. Short 0.1 mg/L P <0.01 P >0.05
Control vs. Single 0.1 mg/L P <0.0001 P <0.001
Gonad Control vs. C60 0.1 mg/L P >0.05 P <0.01
Control vs. Long 0.1 mg/L P <0.0001 P <0.0001
Control vs. Short 0.1 mg/L P <0.01 P <0.0001
Control vs. Single 0.1 mg/L P >0.05 P <0.01
Table S7 P-value for each dimension calculated by one-way ANOVA with 
post-hoc test for C=C/CH2 ratios derived from Raman spectra.
Ratio of C=C/CH2 derived from Raman spectra
One-way ANOVA with Newman-Keuls’ Multiple 
Comparison Test P-value
Brain F vs. Gonad M P <0.0001
Brain F vs. Gonad F P <0.0001
Brain F vs. Brain M P <0.0001
Brain M vs. Gonad M P <0.0001
Brain M vs. Gonad F P <0.0001
Gonad F vs. Gonad M P <0.0001
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Cluster vectors plots for zebrafish brain tissues derived from IR




Tentative assignments Wavenumber 
(cm-1)
Tentative assignments
C60 1740 Lipid, v(C=O) 1065 vsPO2-
1220 vasPO2- 1543 Amide II
1065 vsPO2- 1145 Carbohydrates, v(C-O)
1508 Amide II 1710 Lipid, v(C=O)
1130 Carbohydrates, v(C-O) 1655 Amide I
960 Protein phosphorylation 1750 Lipid, v(C=O)
1450 Proteins, vasCH3 1103 vsPO2-
1312 Amide III 1245 vasPO2-
Long 
MWCNTs
1616 Amide I 1650 Amide II
1747 Lipid, v(C=O) 1716 vsPO2-
1180 Carbohydrates, v(C-O) 1543 Amide II
1454 Proteins, vasCH3 1122 Carbohydrates, v(C-O)
1265 Amide III 1087 vsPO2-
1000 Protein phosphorylation 1038 Glycogen
1582 Amide II 1392 v(COO-)
1320 Amide III 1238 vasPO2-
Short 
MWCNTs
1740 Lipid, v(C=O) 1650 Amide I
1530 Amide II 1065 vsPO2-
1045 Glycogen 1728 Lipid, v(C=O)
1130 Carbohydrates, v(C-O) 1543 Amide II
1616 Amide I 1680 Amide I
960 Protein phosphorylation 1245 Amide III
1412 Proteins, vasCH3 1103 vsPO2-




1528 Amide II 1065 vsPO2-
1658 Amide I 1732 Lipid, v(C=O)
1045 Glycogen 1650 Amide I
1477 Proteins, vasCH3 1543 Amide II
1744 Lipid, v(C=O) 1690 Amide I
1226 vasPO2- 1145 Carbohydrates, v(C-O)
964 Protein phosphorylation 1103 vsPO2-
1427 Proteins, vasCH3 930 Protein phosphorylation
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Cluster vectors plots for zebrafish gill tissues derived from IR




Tentative assignments Wavenumber 
(cm-1)
Tentative assignments
C60 1647 Amide I 1616 Amide I
1504 Amide II 1690 Amide I
1573 Amide II 1496 Amide II
1710 Lipid, v(C=O) 1554 Amide II
1049 Glycogen 1118 Carbohydrates, v(C-O)
1462 Proteins, vasCH3 1369 v(COO-)
964 Protein phosphorylation 1199 vasPO2-
1750 Lipid, v(C=O) 1743 Lipid, v(C=O)
Long 
MWCNTs
1647 Amide I 1539 Amide II
1528 Amide II 1647 Amide I
1747 Lipid, v(C=O) 1477 Proteins, vasCH3
1469 Proteins, vasCH3 1700 Lipid, v(C=O)
1180 Carbohydrates, v(C-O) 1207 vasPO2-
1705 Lipid, v(C=O) 1303 Amide III
1080 vsPO2- 1597 Amide I
1373 v(COO-) 1747 Lipid, v(C=O)
Short 
MWCNTs
1710 Lipid, v(C=O) 1539 Amide II
1550 Amide II 1492 Proteins, vasCH3
1470 Proteins, vasCH3 1650 Amide I
1211 vasPO2- 1616 Amide I
1392 v(COO-) 952 Protein phosphorylation
1612 Amide I 995 Protein phosphorylation
1064 vsPO2- 1199 vasPO2-




1647 Amide I 1535 Amide II
1708 Lipid, v(C=O) 1651 Amide II
1465 Proteins, vasCH3 1447 Proteins, vasCH3
1550 Amide II 1296 Amide III
1392 v(COO-) 995 Amide III
1018 Glycogen 1050 Glycogen
1211 vasPO2- 1728 Lipid, v(C=O)
1311 Amide III 1200 vasPO2-
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Cluster vectors plots for zebrafish gonad tissues derived from 




Tentative assignments Wavenumber 
(cm-1)
Tentative assignments
C60 1724 Lipid, v(C=O) 1774 Lipid, v(C=O)
1442 Proteins, vasCH3 1110 vsPO2-
1068 vsPO2- 948 Protein phosphorylation
1647 Amide I 1254 Amide III
1346 v(COO-) 1540 Amide II
1512 Amide II 1076 vsPO2-
922 Protein phosphorylation 1477 Amide II
960 Protein phosphorylation 1708 Lipid, v(C=O)
Long 
MWCNTs
1720 Lipid, v(C=O) 1261 Amide III
1774 Lipid, v(C=O) 1546 Amide II
1342 v(COO-) 1681 Amide I
1430 Proteins, vasCH3 1076 vsPO2-
1543 Amide II 1616 Amide I
1226 vasPO2- 1755 Lipid, v(C=O)
1296 Amide III 1504 Amide II
1670 Amide I 1130 Carbohydrates, v(C-O)
Short 
MWCNTs
1543 Amide II 948 Protein phosphorylation
1740 Lipid, v(C=O) 1774 Lipid, v(C=O)
1690 Amide I 1685 Amide I
1651 Amide I 1597 Amide I
991 Protein phosphorylation 1512 Amide II
1774 Lipid, v(C=O) 1253 Amide III
1508 Amide II 1550 Amide II




1446 Proteins, vasCH3 1774 Lipid, v(C=O)
1651 Amide I 1616 Amide I
1760 Lipid, v(C=O) 1685 Amide I
1573 Amide II 945 Protein phosphorylation
1068 vsPO2- 1072 vsPO2-
1724 Lipid, v(C=O) 1392 v(COO-)
1512 Amide II 1512 Amide II
1346 v(COO-) 1550 Amide II
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Cluster vectors plots for zebrafish liver tissues derived from IR




Tentative assignments Wavenumber 
(cm-1)
Tentative assignments
C60 1064 vsPO2- 1103 vsPO2-
1535 Amide II 1504 Amide II
1450 Proteins, vasCH3 933 Protein phosphorylation
1743 Lipid, v(C=O) 1705 Lipid, v(C=O)
1168 Carbohydrates, v(C-O) 1770 Lipid, v(C=O)
1589 Amide I 1620 Amide I
1408 v(COO-) 1408 v(COO-)
1685 Amide I 1342 v(COO-)
Long 
MWCNTs
1543 Amide II 1485 Proteins, vasCH3
1654 Amide I 1786 Lipid, v(C=O)
1041 Glycogen 1681 Amide I
1728 Lipid, v(C=O) 1720 Lipid, v(C=O)
1766 Lipid, v(C=O) 1037 Glycogen
1492 Proteins, vasCH3 1539 Amide II
987 Protein phosphorylation 1369 v(COO-)
1411 Proteins, vasCH3 1269 Amide III
Short 
MWCNTs
1535 Amide II 1049 Glycogen
1450 Proteins, vasCH3 1732 Lipid, v(C=O)
1172 Carbohydrates, v(C-O) 1092 vsPO2-
1766 Lipid, v(C=O) 1469 Proteins, vasCH3
1041 Glycogen 991 Protein phosphorylation
1384 v(COO-) 1346 v(COO-)
1685 Amide I 1562 Amide II




1446 Proteins, vasCH3 1504 Amide II
1535 Amide II 1770 Lipid, v(C=O)
1616 Amide I 1705 Lipid, v(C=O)
1654 Amide I 1465 Proteins, vasCH3
1060 vsPO2- 1411 Proteins, vasCH3
1404 v(COO-) 1037 Glycogen
1743 Lipid, v(C=O) 1616 Amide I
1230 vasPO2- 1188 Carbohydrates, v(C-O)
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Cluster vectors plots for zebrafish brain tissues derived from 




Tentative assignments Wavenumber 
(cm-1)
Tentative assignments
C60 1008 Phenylalanine 994 Phenylalanine
1402 Lipid, CH2 510 Collagen, S-S stretching      
1202 Amide III 753 DNA, nucleic acid
817 DNA/RNA,phosphodiester 1424 Lipid, CH2
1716 Lipid, C=O 1685 Lipid, C=C
730 DNA, nucleic acid 1743 Lipid, C=O
635 Protein, v(C-S) 1361 Lipid/protein, CH3/CH2
1655 Lipid, C=C 1190 Protein
Long 
MWCNTs
638 Protein, v(C-S) 1006 Phenylalanine
681 DNA, ringbreathing modes 1207 Amide III
505 Collagen, S-S stretching 506 Collagen, S-S stretching
1584 Phenylalanine, C=C 1406 Lipid, CH2
552 v(S-S) 558 v(S-S)
1542 Amide II 1685 Lipid, C=C
1655 Lipid, C=C 837 Protein
1105 Carbohydrates 1320 Lipid/protein, CH3/CH2
Short 
MWCNTs
1010 Phenylalanine 879 Protein
1409 Lipid, CH2 1009 Phenylalanine
1354 Lipid/protein, CH3/CH2 727 DNA, nucleic acid
637 Protein, v(C-S) 1413 Lipid, CH2
814 DNA/RNA,phosphodiester 1112 Carbohydrates
556 v(S-S) 1565 Amide II
1638 Amide I 810 DNA/RNA,phosphodiester




1010 Phenylalanine 1211 Amide III
812 Collagen, C-C stretching 879 Protein
858 Collagen, C-C stretching 1010 Phenylalanine
1410 Lipid 1690 Lipid, C=C
1486 Lipid 1409 Lipid, CH2
557 v(S-S) 727 DNA, nucleic acid
1354 Lipid/protein, CH3/CH2 1297 Lipid
616 Protein, v(C-S) 1171 Protein
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Cluster vectors plots for zebrafish Gonad tissues derived from 




Tentative assignments Wavenumber 
(cm-1)
Tentative assignments
C60 1263 Amide III 1111 Carbohydrates
821 DNA/RNA,phosphodiester 732 DNA, nucleic acid
1673 Lipid, C=C 826 DNA/RNA,phosphodiester
940 Protein 998 Phenylalanine
1469 Lipid, CH2 1557 Amide II
1007 Phenylalanine 1593 Phenylalanine
1068 Carbohydrates 1441 Lipid, CH2
650 Protein, v(C-S) 1147 Protein
Long 
MWCNTs
818 DNA/RNA,phosphodiester 732 DNA, nucleic acid
780 DNA, nucleic acid 1656 Lipid, C=C
1131 Protein 813 DNA/RNA,phosphodiester
1658 Lipid, C=C 1002 Phenylalanine
1030 Phenylalanine 1235 Amide III
1315 Lipid/protein, CH3/CH2 1589 Phenylalanine
1693 Lipid, C=C 1444 Lipid, CH2
1447 Lipid, CH2 901 Protein
Short 
MWCNTs
1009 Phenylalanine 736 DNA, nucleic acid
1469 Lipid, CH2 1000 Phenylalanine
1263 Amide III 1129 Carbohydrates
820 DNA/RNA,phosphodiester 819 DNA/RNA,phosphodiester
732 DNA, nucleic acid 901 Protein
1669 Lipid, C=C 1244 Amide III
635 Protein, v(C-S) 1451 Lipid, CH2




1009 Phenylalanine 1445 Lipid, CH2
1117 Carbohydrates 739 DNA, nucleic acid
1171 Protein 937 Protein
1409 Lipid, CH2 1639 Lipid, C=C
649 Protein, v(C-S) 809 DNA/RNA,phosphodiester
819 DNA/RNA,phosphodiester 1571 Phenylalanine
1497 Lipid, CH2 1235 Amide III
1568 Amide II 996 Phenylalanine
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Cluster vectors plots for zebrafish brain exposed to C60 at two 






Tentative assignments Wavenumber 
(cm-1)
Tentative assignments
0.001 1705 Lipid, v(C=O) 1539 Amide II
1114 Carbohydrates, v(C-O) 1654 Amide I
1504 Amide II 1454 Proteins, vasCH3
1438 Proteins, vasCH3 1080 vsPO2-
1053 Glycogen 1122 Carbohydrates, v(C-O)
1786 Lipid, v(C=O) 1280 Amide III
1003 Glycogen 1616 Amide I
1654 Amide I 950 Protein phosphorylation
0.1 1504 Amide II 1504 Amide II
1705 Lipid, v(C=O) 1700 Lipid, v(C=O)
1118 Carbohydrates, v(C-O) 1438 Proteins, vasCH3
1616 Amide I 1650 Amide I
1539 Amide II 1388 v(COO-)
1750 Lipid, v(C=O) 1616 Amide I
1654 Amide I 1041 Glycogen
1438 Proteins, vasCH3 1207 vasPO2-
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Cluster vectors plots for zebrafish gill exposed to C60 at two 







Tentative assignments Wavenumber 
(cm-1)
Tentative assignments
0.001 1114 Carbohydrates, v(C-O) 1523 Amide II
1685 Amide I 1670 Amide I
1543 Amide II 1126 Carbohydrates, v(C-O)
1477 Proteins, vasCH3 980 Protein phosphorylation
1045 Glycogen 1218 vasPO2-
968 Protein phosphorylation 1080 vsPO2-
1392 v(COO-) 1712 Lipid, v(C=O)
1176 Carbohydrates, v(C-O) 1766 Lipid, v(C=O)
0.1 1485 Proteins, vasCH3 1458 Proteins, vasCH3
1342 v(COO-) 1701 Lipid, v(C=O)
1014 Glycogen 1570 Amide II
1716 Lipid, v(C=O) 1616 Amide I
1539 Amide II 1504 Amide II
1681 Amide I 1257 Amide III
1770 Lipid, v(C=O) 1651 Amide I
1126 Carbohydrates, v(C-O) 1022 Glycogen
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Cluster vectors plots for zebrafish gonads exposed to C60 at two 






Tentative assignments Wavenumber 
(cm-1)
Tentative assignments
0.001 1647 Amide I 1647 Amide I
1554 Amide II 1697 Lipid, v(C=O)
1697 Lipid, v(C=O) 1539 Amide II
1130 Carbohydrates, v(C-O) 983 Protein phosphorylation
1415 Proteins, vasCH3 1110 vsPO2-
1164 Carbohydrates, v(C-O) 1419 Proteins, vasCH3
1755 Lipid, v(C=O) 1029 Glycogen
975 Protein phosphorylation 1072 vsPO2-
0.1 1134 Carbohydrates, v(C-O) 1701 Lipid, v(C=O)
1396 v(COO-) 1651 Amide I
972 Protein phosphorylation 1543 Amide II
1647 Amide I 950 Protein phosphorylation
1589 Amide I 1612 Amide I
1010 Glycogen 1265 Amide III
1068 vsPO2- 1774 Lipid, v(C=O)
1315 Amide III 983 Protein phosphorylation
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Cluster vector plots for zebrafish liver exposed to C60 at two 







Tentative assignments Wavenumber 
(cm-1)
Tentative assignments
0.001 1504 Amide II 1654 Amide I
1685 Amide I 1705 Lipid, v(C=O)
1720 Lipid, v(C=O) 1543 Amide II
1539 Amide II 1504 Amide II
1651 Amide I 1107 vsPO2-
1454 Proteins, vasCH3 1346 v(COO-)
1000 Protein phosphorylation 1577 Amide II
920 Protein phosphorylation 1616 Amide I
0.1 1685 Amide I 1408 v(COO-)
1041 Glycogen 1446 Proteins, vasCH3
1076 vsPO2- 1276 Amide III
1635 Amide I 1728 Lipid, v(C=O)
1400 v(COO-) 1639 Amide I
933 Protein phosphorylation 1334 v(COO-)
1554 Amide II 1033 Glycogen
1504 Amide II 1689 Amide I
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Cluster vectors plots for zebrafish brain exposed to long







Tentative assignments Wavenumber 
(cm-1)
Tentative assignments
0.001 1504 Amide II 1458 Proteins, vasCH3
1654 Amide I 1392 v(COO-)
1743 Lipid, v(C=O) 1543 Amide II
1454 Proteins, vasCH3 1685 Amide I
1616 Amide I 1728 Lipid, v(C=O)
1697 Lipid, v(C=O) 1346 v(COO-)
941 Protein phosphorylation 1600 Amide I
1346 v(COO-) 1643 Amide I
0.1 1512 Amide II 1647 Amide I
1126 Carbohydrates, v(C-O) 1122 Carbohydrates, v(C-O)
1774 Lipid, v(C=O) 1180 Carbohydrates, v(C-O)
1361 v(COO-) 1527 Amide II
1712 Lipid, v(C=O) 1392 v(COO-)
1477 Proteins, vasCH3 1716 Lipid, v(C=O)
1053 Glycogen 1485 Proteins, vasCH3
1573 Amide II 1265 Amide III
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Cluster vectors plots for zebrafish gill exposed to Long 







Tentative assignments Wavenumber 
(cm-1)
Tentative assignments
0.001 1539 Amide II 1639 Amide I
1651 Amide I 1539 Amide II
1492 Proteins, vasCH3 1010 Glycogen
948 Protein phosphorylation 1377 v(COO-)
1257 Amide III 1689 Amide I
1701 Lipid, v(C=O) 1296 Amide III
1789 Lipid, v(C=O) 1500 Amide II
1585 Amide I 1091 vsPO2-
0.1 1539 Amide II 1720 Lipid, v(C=O)
1492 Proteins, vasCH3 995 Protein phosphorylation
1651 Amide I 1627 Amide I
1584 Amide I 1330 v(COO-)
948 Protein phosphorylation 1450 Proteins, vasCH3
1107 vsPO2- 1554 Amide II
1257 Amide III 1161 Carbohydrates, v(C-O)
1411 Proteins, vasCH3 1774 Lipid, v(C=O)
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Cluster vectors plots for zebrafish gonads exposed to long 







Tentative assignments Wavenumber 
(cm-1)
Tentative assignments
0.001 1654 Amide I 1539 Amide II
1700 Lipid, v(C=O) 1689 Amide I
1554 Amide II 1647 Amide I
1172 Carbohydrates, v(C-O) 1770 Lipid, v(C=O)
1504 Amide II 1504 Amide II
1130 Carbohydrates, v(C-O) 1006 Glycogen
1766 Lipid, v(C=O) 1728 Lipid, v(C=O)
1041 Glycogen 1612 Amide I
0.1 1064 vsPO2- 1720 Lipid, v(C=O)
1720 Lipid, v(C=O) 1670 Amide I
1276 Amide III 1388 v(COO-)
1427 Proteins, vasCH3 1539 Amide II
1342 v(COO-) 1504 Amide II
1543 Amide II 1172 Carbohydrates, v(C-O)
1473 Proteins, vasCH3 1126 Carbohydrates, v(C-O)
1620 Amide I 948 Protein phosphorylation
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Cluster vectors plots for zebrafish liver exposed to long 







Tentative assignments Wavenumber 
(cm-1)
Tentative assignments
0.001 1504 Amide II 1485 Proteins, vasCH3
1056 vsPO2- 1697 Lipid, v(C=O)
1404 v(COO-) 1049 Glycogen
1091 vsPO2- 1519 Amide II
1465 Proteins, vasCH3 1654 Amide I
1218 vasPO2- 1099 vsPO2-
1697 Lipid, v(C=O) 1000 Protein phosphorylation
1647 Amide I 1134 Carbohydrates, v(C-O)
0.1 1766 Lipid, v(C=O) 1054 Glycogen
1504 Amide II 1080 vsPO2-
1543 Amide II 1477 Proteins, vasCH3
1049 Glycogen 1786 Lipid, v(C=O)
1091 vsPO2- 1690 Amide I
1188 Carbohydrates, v(C-O) 1728 Lipid, v(C=O)
1469 Proteins, vasCH3 1361 v(COO-)
1732 Lipid, v(C=O) 1539 Amide II
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Cluster vectors plots for zebrafish brain exposed to short 







Tentative assignments Wavenumber 
(cm-1)
Tentative assignments
0.001 1442 Proteins, vasCH3 1720 Lipid, v(C=O)
1523 Amide II 1064 vsPO2-
1716 Lipid, v(C=O) 1408 v(COO-)
1670 Amide I 1681 Amide I
1562 Amide II 1612 Amide I
1056 vsPO2- 1523 Amide II
1176 Carbohydrates, v(C-O) 914 Protein phosphorylation
1770 Lipid, v(C=O) 1141 Carbohydrates, v(C-O)
0.1 1473 Proteins, vasCH3 1064 vsPO2-
1126 Carbohydrates, v(C-O) 1716 Lipid, v(C=O)
1056 vsPO2- 1408 v(COO-)
1589 Amide I 1523 Amide II
1002 Glycogen 1631 Amide I
1693 Amide I 1681 Amide I
1550 Amide II 1242 vasPO2-
1365 v(COO-) 1141 Carbohydrates, v(C-O)
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Cluster vectors plots for zebrafish gill exposed to short 







Tentative assignments Wavenumber 
(cm-1)
Tentative assignments
0.001 1543 Amide II 1377 v(COO-)
1338 v(COO-) 1662 Amide I
1790 Lipid, v(C=O) 914 Protein phosphorylation
1705 Lipid, v(C=O) 1539 Amide II
1396 v(COO-) 1716 Lipid, v(C=O)
1083 vsPO2- 1624 Amide I
1458 Proteins, vasCH3 1338 v(COO-)
1635 Amide I 1176 Carbohydrates, v(C-O)
0.1 1543 Amide II 1647 Amide I
1766 Lipid, v(C=O) 1257 Amide III
1724 Lipid, v(C=O) 1072 vsPO2-
1083 vsPO2- 1504 Amide II
1577 Amide II 1543 Amide II
1408 v(COO-) 979 Protein phosphorylation
1323 Amide III 1689 Amide I
1678 Amide I 1377 v(COO-)
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Cluster vectors plots for zebrafish gonads exposed to short 







Tentative assignments Wavenumber 
(cm-1)
Tentative assignments
0.001 1504 Amide II 1681 Amide I
1685 Amide I 1504 Amide II
1647 Amide I 1647 Amide I
1739 Lipid, v(C=O) 1435 Proteins, vasCH3
1543 Amide II 1546 Amide II
1577 Amide II 1207 vasPO2-
1249 Amide III 1747 Lipid, v(C=O)
1392 v(COO-) 1026 Glycogen
0.1 1685 Amide I 1681 Amide I
1543 Amide II 941 Protein phosphorylation
1504 Amide II 1103 vsPO2-
1396 v(COO-) 1141 Carbohydrates, v(C-O)
1199 vasPO2- 1485 Proteins, vasCH3
1438 Proteins, vasCH3 1176 Carbohydrates, v(C-O)
941 Protein phosphorylation 1539 Amide II
1766 Lipid, v(C=O) 1716 Lipid, v(C=O)
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Cluster vectors plots for zebrafish liver exposed to short 







Tentative assignments Wavenumber 
(cm-1)
Tentative assignments
0.001 1654 Amide I 1543 Amide II
1701 Lipid, v(C=O) 1180 Carbohydrates, v(C-O)
1543 Amide II 1701 Lipid, v(C=O)
1188 Carbohydrates, v(C-O) 1381 v(COO-)
1504 Amide II 1647 Amide I
960 Protein phosphorylation 1743 Lipid, v(C=O)
1080 vsPO2- 1612 Amide I
1766 Lipid, v(C=O) 1477 Proteins, vasCH3
0.1 1554 Amide II 1381 v(COO-)
968 Protein phosphorylation 1180 Carbohydrates, v(C-O)
1697 Lipid, v(C=O) 1546 Amide II
1381 v(COO-) 1608 Amide I
1654 Amide I 1041 Glycogen
1188 Carbohydrates, v(C-O) 1141 Carbohydrates, v(C-O)
1415 Proteins, vasCH3 1705 Lipid, v(C=O)
1755 Lipid, v(C=O) 1419 Proteins, vasCH3
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Cluster vectors plots for zebrafish brain exposed to single-







Tentative assignments Wavenumber 
(cm-1)
Tentative assignments
0.001 1404 v(COO-) 1720 Lipid, v(C=O)
1068 vsPO2- 1543 Amide II
1658 Amide I 1157 Carbohydrates, v(C-O)
1697 Lipid, v(C=O) 1053 Glycogen
1134 Carbohydrates, v(C-O) 1654 Amide I
1176 Carbohydrates, v(C-O) 1392 v(COO-)
1261 Amide III 1191 vasPO2-
929 Protein phosphorylation 1107 vsPO2-
0.1 1006 Glycogen 1720 Lipid, v(C=O)
1064 vsPO2- 1581 Amide II
1431 Proteins, vasCH3 1469 Proteins, vasCH3
1107 vsPO2- 1191 vasPO2-
1261 Amide III 1639 Amide I
1357 v(COO-) 1157 Carbohydrates, v(C-O)
1612 Amide I 1064 vsPO2-
1697 Lipid, v(C=O) 1400 v(COO-)
S44
141
Cluster vectors plots for zebrafish gill exposed to single-







Tentative assignments Wavenumber 
(cm-1)
Tentative assignments
0.001 1720 Lipid, v(C=O) 1639 Amide I
1454 Proteins, vasCH3 1774 Lipid, v(C=O)
1053 Glycogen 1539 Amide II
1404 v(COO-) 1693 Amide I
1369 v(COO-) 1257 Amide III
1087 vsPO2- 1492 Proteins, vasCH3
1651 Amide I 972 Protein phosphorylation
1755 Lipid, v(C=O) 918 Protein phosphorylation
0.1 1103 vsPO2- 1585 Amide I
1766 Lipid, v(C=O) 1662 Amide I
1427 Proteins, vasCH3 1701 Lipid, v(C=O)
1261 Amide III 1083 vsPO2-
1627 Amide I 1338 v(COO-)
1500 Amide II 1180 Carbohydrates, v(C-O)
1539 Amide II 1462 Proteins, vasCH3
948 Protein phosphorylation 1257 Amide III
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Cluster vectors plots for zebrafish gonads exposed to single-







Tentative assignments Wavenumber 
(cm-1)
Tentative assignments
0.001 1504 Amide II 1419 Proteins, vasCH3
1697 Lipid, v(C=O) 1681 Amide I
1647 Amide I 1184 Carbohydrates, v(C-O)
1554 Amide II 1110 vsPO2-
1438 Proteins, vasCH3 1539 Amide II
1612 Amide I 983 Protein phosphorylation
1068 vsPO2- 1724 Lipid, v(C=O)
1377 v(COO-) 1473 Proteins, vasCH3
0.1 1446 Proteins, vasCH3 1701 Lipid, v(C=O)
1651 Amide I 1666 Amide I
1184 Carbohydrates, v(C-O) 1188 Carbohydrates, v(C-O)
1759 Lipid, v(C=O) 1735 Lipid, v(C=O)
1481 Proteins, vasCH3 1110 vsPO2-
1724 Lipid, v(C=O) 1419 Proteins, vasCH3
1056 vsPO2- 1504 Amide II
1573 Amide II 1381 v(COO-)
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Cluster vectors plots for zebrafish liver exposed to single-







Tentative assignments Wavenumber 
(cm-1)
Tentative assignments
0.001 1504 Amide II 1685 Amide I
1693 Amide I 1504 Amide II
1651 Amide I 1130 v(COO-)
1438 Proteins, vasCH3 1045 Glycogen
956 Protein phosphorylation 983 Protein phosphorylation
1558 Amide II 1357 v(COO-)
1404 v(COO-) 921 Protein phosphorylation
1083 vsPO2- 1562 Amide II
0.1 1504 Amide II 1477 Proteins, vasCH3
1651 Amide I 1512 Amide II
1693 Amide I 1639 Amide I
1766 Lipid, v(C=O) 1693 Amide I
1438 Proteins, vasCH3 1411 Proteins, vasCH3
956 Protein phosphorylation 968 Protein phosphorylation
1130 Carbohydrates, v(C-O) 1261 Amide III
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Nanotechnology has introduced us many types of manufactured carbon-based 
nanoparticles (CNPs), together with a debate on the risks and benefits of these 
materials. Numerous investigations have been carried out in nanotoxicology, and toxic 
effects of nanoparticles have been observed by the scientific community. However, 
there is still a gap in the knowledge of nanotoxicology. In this study, we assessed the 
global alterations induced by CNPs in A549 cells using biospectroscopic techniques, 
including attenuated total reflection Fourier-transformation infrared and surface-
enhanced Raman spectroscopy. A549 cells were treated with Fullerene (C60), long or 
short multi-walled carbon nanotubes, or single-walled carbon nanotubes at 
concentrations of 0.1 mg/L, 0.01 mg/L and 0.001 mg/L. The exposed cells were then 
interrogated by ATR-FTIR and SERS. Spectra were then processed via computational 
analysis, and information of biochemical alterations in the treated cells were extracted 
and visualised. Additionally, global DNA methylation level in the cells exposed to 
CNPs at 0.1 mg/L was determined by using HPLC-MS and genetic regulators for 
DNA methylation was checked by quantitative real-time PCR. It was found that CNPs 
could exert toxic effects in A549 cells, and also contributed to the promotion of global 








The rapid development of nanotechnology has introduced numerous nanomaterials 
with an extraordinary dimension to our world. Consequently, the potential exposure to 
nanomaterials for public is supposed to increase dramatically. Especially, carbon-
based materials (CNMs) are currently used widely in both our daily life and industry
1-
4
. Thus, it is urgent to know the health hazards related to their exposure prior to 
pushing their applications forward
5,6
. 
Recently, carbon-based materials are one of the most attractive nanomaterials due to 
their unique physicochemical property with different forms, such as fullerenes (C60), 
single- and multi-walled carbon nanotubes (MWCNTs). Numerous investigations has 
been carried out to assess these carbon nanoparticles (CNPs), and toxic effects both in 
vitro and in vivo were reported
7-10
. Commonly, generation of reactive oxygen species 
(ROS) is considered as a major factor involved in the toxicity of CNPs
11. However, 
there is still a knowledge gap between nanotoxicology and real-world toxic effects of 
the CNPs
12. The applications of conventional toxicology assays in the assessment of 
nanotoxicity are challenged, and thus new paradigm for these assays is required to be 
established while novel methodologies are introduced
13
. 
Raman or attenuated total reflection Fourier-transform infrared (ATR-FTIR) 
techniques are vibrational spectroscopic approaches capable of deriving biochemical 
information from biological samples
14
. Vibrational spectroscopy approaches without 
any specific agents, of the capability to cheaply, rapidly and non-invasively analyze 
biological samples, have been used to investigate cancer and assess toxic effects of 
environmental pollution
15-21
. Infrared (IR) spectroscopy is the measurement of the 
energy absorption of the chemical bond vibrational movement occurring at a specific 
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energy level. This produces spectra with peaks presenting the chemical bond in the 
sample. The mid-IR region (1800-900 cm
-1
 in wavenumbers), known as the 
“biochemical fingerprint” region, is where the majority IR absorption occurs in the 
biochemical structure. As a scattering technique, Raman spectroscopy has the inherent 
advantage of being unaffected by aqueous, providing a complementary spectra in 
samples. Surface-enhanced Raman spectroscopy (SERS), based on the normal Raman, 
is a technique possessing extremely high detection sensitivity and has a capability of 
providing fingerprint spectra of various molecules
22,23
. The high detection sensitivity 
is relying on the strong electromagnetic enhancement, typically produced by Ag or Au 
NPs, while Raman signals of molecules close to these NPs can be enhanced by more 
than 6 orders of magnitude
24,25
. This makes SERS an ultrasensitive detection tool; 
even the single molecule level can be detected
26
. 
The objective of this study was to perform a cytotoxicity assessment of four types 
CNPs (C60, Long and Short MWCNTs, single-walled CNTs) by using 
biospectroscopic techniques. Due to the tiny size, these CNPs can easily become 
airborne and inhaled and induce pulmonary injury. Hence, A549 cells, a human 
epithelial-like lung cell line, have been employed as an in vitro bio-model in this study. 
For both in vitro and in vivo toxicological test, dose is a key parameter to help us 
know the real-world situation better. Although acute effects are more likely to be 
observed following the high-dose exposure, recording the consequences of low-dose 
exposure over a lifetime is necessary to help us understand the possible risk of CNPs 
for the public. Thus, cells were exposed to CNPs at ppb level with a dose range at the 
concentration of 0.1 mg/L, 0.01 mg/L and 0.001 mg/L. Following the exposure, ATR-
FTIR and SERS were then employed to interrogate the cells. Additionally, the global 
DNA methylation level in the cells exposed to 0.1 mg/L CNPs was determined by 
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HPLC-MS, as the disruption of genetic methylation in cells is considered to be linked 
to diseases such as cancer
27-29
. This study aims to assess the toxic effects induced by 
CNPs at ppb level. 
Results 
ATR-FTIR spectral dataset. The spectra derived from ATR-FTIR were inputted to 
PCA method following an appropriate pre-processing. PCA scores plots help to 
visualise the segregations among classes displayed as 1-D or 2-D scores plots 
(supporting information Figure S2). This allows observing a dose-response in the 1-D 
scores plots from PC1 space (Figure 2), where the scores in PC1 space contribute to 
most of variance in spectral data. To determine whether the treatment groups were 
significantly different from the corresponding control group, repeated-measures one-
way analysis of variance (ANOVA) with Dunnett’s post hoc tests were conducted to 
examine the treated vs. the control cells in PC1 space (supporting information Table 
S4). It showed that in all treatment groups the CNP-induced effects observed in PC1 
space differed significantly (P <0.05) from the control group. 
Loadings plots derived from the PC1 space identify the distinguishing wavenumbers 
corresponding for the most important variances in PC1 for each CNP treatment. The 
first eight primary wavenumbers in each the loadings plot were marked. For each CNP 
exposure, the wavenumbers ranked as following: 1624, 1658, 1589, 1547,1493, 1709, 
1396 and 1103 cm
-1
 in C60 treatment group; 1539, 1501, 1624, 1585, 1662, 1466, 
1732 and 1065 cm
-1
 in Long MWCNTs group; 1620, 1547, 1501, 1655, 1585, 1462, 
1717 and 1400 cm
-1
 in Short MWCNTs group; and 1508, 1466, 1678, 1732, 1061, 
1582, 1018 and 1115 cm
-1
 in SWCNTs group, respectively. These wavenumbers 
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contributes to most of the segregations in the PC1 space (The tentative assignments 
were listed in supporting information Table S1). 
Another dataset was set up to compare the cellular response when cells were exposed 
to different types of CNPs at 0.1 mg/L. Following the PCA method, LDA was applied 
to the dataset as well, which would take the category information into the analytical 
model. The scores in the first three LD space were used for visualisation (Figure 4a 
and 4b). The separations between groups were significant. Moreover, cluster vector 
plots derived from the PCA-LDA result were used to indicate the biochemical 
alterations in cells induced by different CNPs (Supporting information Figure S4). To 
simplify the identification of the most pronounced wavenumbers related to the 
biochemical alterations, peak detector was employed and a cluster vector peak plot 
was generated (Figure 5a, and the tentative assignments of the first seven 
wavenumbers were listed in supporting information Table S3). 
SERS spectral dataset. Following a similar workflow, the SERS spectral data was 
properly processed for further analysis. The PC1 scores plots showed significant 
separations between the treatment groups and the control one (Figure 3, and statistical 
results in supporting information Table S4). Similarly, the first eight primary 
wavenumbers in the loadings plots were marked as below: 1454, 1006, 930, 1364, 
1621, 1423, 858 and 1487 cm
-1
 for C60 exposure; 1055, 518, 1586, 463, 761, 1522, 
625 and 1335 cm
-1
 for Long MWCNTs exposure; 1006, 1456, 1341, 1372, 765, 946, 
1718 and 1623 cm
-1
 for Short MWCNTs exposure; and 1623, 442, 1179, 802, 938, 
1030, 1417 and 728 cm
-1
 for SWCNTs exposure (The tentative assignments were 
listed in supporting information Table S2). 
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Combination approach of PCA-LDA gave rise to the visualisation in both 2-D and 3-
D scores plots (Figure 4c and 4d). Significant segregations were observed between the 
CNPs treatment groups and the control one. Furthermore, cluster vector peak plot 
displayed the main biochemical alterations induced by different CNPs (Figure 5b, and 
the tentative assignments of the first seven wavenumbers were listed in supporting 
information Table S3). 
Global DNA methylation level determined by HPLC-MS. The global DNA 
methylation levels in the A549 cells following CNPs (0.1 mg/L) exposure tended to 
increase, as it was determined by using HPLC-MS method that the mean level of 
global genomic methylation was 0.88% in the control group, while the mean values 
were increased to 0.9967%, 0.9867%, 1.003% and 0.93% following exposure to C60, 
long or short MWCNTs, and SWCNTs, respectively (Figure 6). The statistical results 
showed that global DNA methylation level was significantly elevated by C60 (P 
<0.05) and short MWCNTs (P <0.05) treatment (Statistical results in supporting 
information Table S5). 
Quantitative real-time PCR. Quantitative real-time PCR was used to assess the gene 
expression level of DNMTs in A549 cells exposed to CNPs at 0.1 mg/L. As a result 
from CNPs exposure, the expression level of DNMT1 was determined as 1.001 (C60), 
0.8905 (Long), 0.9297 (Short), and 0.9284- fold (Single) of the control group. 
Similarly, the gene expression of DNMT3a was determined as 1.036 (C60), 0.7928 
(Long), 0.9018 (Short), and 0.9606- fold (Single) of the control group, and the level of 
DNMT3b was decreased to 0.9849 (C60), 0.8198 (Long), 0.8171 (Short), and 0.7553- 
fold (Single) of the control group (Figure 7). 
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Generally, a down regulating tendency in DNMTs gene transcription in A549 cells 
following CNPs exposure was observed expect for those by C60. However, 
significance (P <0.05) was only observed in the downregulation of DNMT3b 
expression by SWCNTs treatment (Statistical results in supporting information Table 
S6). 
Discussions 
When A549 cells were exposed to CNPs, the IR spectra profiled that most of their 
response was non-linear and varied with concentration except those derived from cells 
treated with the long MWCNTs (Figure 2). Similarly, Spectral dataset from SERS also 
indicated highly non-linear response from the cells following exposure (Figure 
3).Such non-linear responses were usually associated with the low-dose effects, which 
is significant in eco-toxicology assessment as environmental contaminations typically 
emerges at low concentrations. It has determined that biospectroscopy is of the ability 
to detect non-linear responses or low-dose effects in cells
17,18
. 
However, more pronounced segregations between exposure groups and the control 
were observed in SERS scores plot than the IR one (Figure 3). Based on different 
theory, these two techniques worked on two different ways. The IR spectra is the 
measurement of absorption after IR beam transmitted into the cells, and thus the 
spectra collected by ATR-FTIR would be containing the global information of the 
biochemical constitution in cells. However, the dominant contributor to most SERS 
processes is the electromagnetic enhancement mechanism, the maximum SERS 
enhancing region decreases dramatically rapidly with distance (r
-10
 for spheres), and 
the largest enhancement can be found only in a few nanometre closest to the Au 
nanoparticle surface
24
. This manifested that most of the signal collected by SERS was 
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derived from biochemical compounds touched around the surface of Au nanoparticle, 
which is possibly the cell membrane and the internal biochemical material leaking 
from cells that may attach to Au nanoparticle during the vortexing. Therefore, SERS 
reported us a partially information about the cells, but with a much higher sensitivity 
because of the extremely high enhancement of the Raman signal. These two 
techniques could be mutually complementary. 
In order to determine how the CNPs affected the cells, loadings plots for the PCA of 
the spectral dataset were employed to highlight the important wavenumbers related to 
biochemical alterations in exposed cells compared with the control ones. Both the 
loadings plots derived from the PC1 (Figure 2 and 3) and PC2 (Supporting 
information) space were used, since loadings in these two PC factors can explain most 
of variance contributing to the segregations among groups in 2-D scores plots 
(Supporting information). In each loadings curve, the first eight primary peaks were 
marked corresponding to the main biomarkers for the dose-response in cells treated 
with CNPs (All wavenumbers and their tentative assignments were listed in 
supporting information). The loadings plots for both IR and SERS spectra showed that 
four types of CNPs shared a similar mode of toxic effects. Dataset derived from IR 
spectra showed that significant alterations were widely induced in Amide I (~1650 
cm
-1
), Amide II (~1500 cm
-1
), lipid (~1750 cm
-1
) and protein (~1400 cm
-1
) by CNPs, 









) were observed as well (Figure 2), which suggested that CNPs may exert 
genotoxicity in cells.  Although signal collected by SERS only interpreted partial 
information in the cells, significant alterations were observed in lipid and Amide I 
region (v(C=C), ~1640 cm
-1
; CH2 bending, ~1440 cm
-1
), Phenylalanine (~1001 cm
-1
) 
and DNA (~720 cm
-1
) (Figure 3). All spectral profiles indicated that alterations 
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induced by CNPs were mainly located in the outer region of cells
21,30
.  It is considered 
that the generation of reactive oxygen species (ROS) and subsequent oxidative stress 
(OS) is the predominant mechanism leading to nanotoxicity
31,32
. Thus, it could 
directly or indirectly cause genomic damage inside the cell with no necessity for 
CNPs to reach the nucleus
33,34
. 
To compare the toxic effects induced by different types of CNPs, a parallel 
experiment was carried out that A549 cells were exposed to the four types CNPs at 
then concentration of 0.1 mg/L. Cells then were then collected for biospectroscopic 
analysis, and as well as further global DNA methylation assessment. Following the 
application of PCA-LDA analysis, both 3-D and 2-D scores plots derived from IR and 
SERS spectra were performed for visualisation (Figure 4).  IR spectra indicated that 
long MWCNTs induced the most pronounced alterations in A549 cells, while C60 
seemed to be less harmful to cells; the C60 treated group presented a relatively high 
overlap with the control group (Figure 4a and 4b). Moreover, the 2-D scores plot 
derive from the IR spectra also showed that short MWCNTs and SWCNTs exerted 
toxic effects on cells to a similar extent, but possible presenting a few difference 
underlying the mechanism due to the significant segregation between these two 
groups (Figure 4b). This result was consisting with our previous investigations that 
CNPs with larger size may induce more pronounced alterations
35,36
.  In contrast to IR 
spectra, SERS spectra indicated that short MWCNTs induced the highest response in 
cells, followed by SWCNTs, and long MWCNTs as ranked, while large overlap 
between the C60 exposed group and the control group was observed, suggesting that 
C60 did less harm to cells (Figure 3d). Both spectral dataset determined that C60 was 
the least toxic one among the four CNPs
37
. In general, cluster vector derived from IR 
spectra showed that most of the alterations were located in the lipid, Amide I and 
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protein region, while DNA/RNA region was slightly affected. Both IR and SERS 
spectra profiled that the most pronounced biochemical alteration in cells after C60 
exposure were in lipid region, which could be a result of the sphere shape of the C60 
and its relatively lipophilic property. Moreover, the SERS detected high alteration in 
DNA region (intensity approximately at 760 cm
-1
) induced by the three types of CNTs. 
It was possibly due to the factor that CNTs may penetrate the membrane of the cells 
and caused a leak of internal material in the cells, which may be then detected by 
SERS. 
Beyond the global biochemical information provided by biospectroscopy, global DNA 
methylation levels in cells treated with CNPs at 0.1 mg/L were measured using 
HPLC-MS
38
. The results showed that global DNA methylation levels in cells were 
significantly elevated by C60 and short MWCNTs treatment, while an increasing 
trend was observed in global genetic methylation ratio of the cells following long 
MWCNTs and SWCNTs exposure, but without statistically significance (Figure 6, 
statistical results in supporting information Figure S8). Additionally, utilization of 
quantitative real-time PCR determined how CNPs impacted on the DNA methylation 
processing in the cells. As the target genes for q-PCR, the DNMTs are positive 
regulators for DNA methylation, which can mediate the DNA methylation by 
catalysing the transfer of a methyl group to DNA. DNMT1 is mainly contributing to 
maintain the pre-existing methylation pattern during replication, while DNMT3a and 
DNMT3b are mostly involved in de novo methylation
39
, which is considered to be 
implicated in cell growth and differentiation, and also in abnormal methylation in 
tumorigenesis
40
. Generally, a down regulating tendency in DNMTs gene transcription 
in A549 cells after CNPs exposure was observed. Based on the statistical calculation, 
it indicated that only the gene transcription level of DNMT3b was decreased 
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significantly by SWCNTs. However, this was complicated with the increased global 
DNA methylation level, while the mechanism still required further investigation. 
Conclusion 
In this study, biospectroscopy, both ATR-FTIR and SERS, was presented as a novel 
powerful approach for nanotoxicity assessment, which also provided biochemical 
information underlying CNPs inducing cellular alterations. Both IR and SERS spectra 
determined that C60, Long and Short MWCNTs, single-walled CNTs could exert 
toxic effects in A549 cells and induce alterations in lipid, protein and even the 
genomic region. Additionally, it was also determined that CNPs at 0.1 mg/L could 
exert a potential negative impact on the gene expression of DNMTs, but contributed to 
the  global genomic hypermethylation, which suggested that CNPs exposure may 
contribute to risk of  diseases such as cancer
29,41
. Further study could be conducted to 
investigate how CNPs impact on specific genes. 
Methods 
Chemicals and carbon nanoparticles 
All CNPs were purchased from Sigma. As stated, short MWCNTs were >90% pure 
being 10-15 nm in diameter and 0.1-10 µm in length. Long MWCNTs were >90% 
pure also, but were 110-170 nm in diameter and 5-9 µm in length. C60 had a 
purity >99.5% and particle size of 1 nm. Single-walled CNTs were described as 
CarboLex AP-grade (the purity of AP-grade products ranges from 50% to 70% by 
volume); major impurities are carbon nanospheres and carbon-encapsulated catalyst 
nanoparticles - the diameter was 1.2-1.5 nm. All CNPs were analysed by Raman 
spectroscopy (Renishaw PLC, Gloucestershire, UK) with a 785 nm laser, and 
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determined to be of high purity. Additionally, images of CNPs were taken using a 
scanning electron microscope (SEM) [JSM 5600 (JEOL)] [see Electronic Supporting 
Information (ESI) Figure S1]. Bovine serum albumin (BSA) obtained from Sigma was 
≥98%.  CNPs were dispersed in 1% BSA solution with a 15-min ultrasonication 
bathed in ice water and stock solutions were made at concentrations of 100 mg/L. 
CNT solutions were stable and well-dispersed, while C60 appeared to agglomerate. 
Gold nanoparticles (Au NPs) for SERS were synthesized using trisodium citrate as the 
reductants (Supporting Information Figure S5),
 42,43
 which were prepared and 
characterised by Dr Li Cui in her lab, IUE, China. 
Cell culture and CNPs treatment 
Human lung epithelial cells, A549 were routinely maintained in RPMI 1640 medium 
at PH7.2, supplemented with 10% inactivated fetal bovine serum and 1% 
penicillin/streptomycin and were grown in humidified atmosphere supplied with 5% 
CO2 in air at 37℃.  A549 cells were cultured in 60mm dishes prior to incorporation 
into experiments. Following this, cells were disaggregated with trypsin 
(0.05%)/EDTA (0.02%) solution, and were immediately resuspended in complete 
medium and seeded in 30mm dishes. Then cells were grown for 24-h to attach and 
followed by a further 24-h treatment or without test agents. The four CNPs were 
introduced in the treatment with exposure dose at concentration 0.1 mg/L, 0.01 mg/L 
and 0.001 mg/L. The control and each exposure group was triplicate. 
After exposure, A549 cells were washed three times with cold PBS, scraped and 
centrifuged at 1000g for 3 min. The resulting cell pellets were fixed with 4% formalin 
in PBS for 30min. The fixed cells were washed using distilled water and then added to 
Low-E glass slides (Kevley Technologies, Chesterland, OH, USA), air dried and 
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stored in desiccator prior to acquirement of ATR-FTIR spectroscopy. For SERS 
interrogation, the fixed and washed cells were mixed with Au NPs. After vortexing, an 
aliquot of 10 µL of the mixture were dropped onto a glass slides for SERS 
measurement. 
Spectroscopy acquisition 
All A549 cell samples on Low-E slides were interrogated using a Bruker TENSOR 27 
FTIR spectrometer (Bruker Optics Ltd., Coventry, UK) equipped with a Helios ATR 
attachment containing a diamond internal reflection element (IRE). Instrument 
parameters were set at 32 scans, 8 cm
-1
 resolution. For each slide, 10 IR spectra were 
acquired at different points across the sample. Prior to starting a new slide, the ATR 
crystal was cleaned with deionized water and a background was then taken. 
SERS spectra were acquired by using a LabRAM Aramis (HORIBA JobinYvon) 
confocal micro-Raman system equipped with a 1200 g/mm grating, He-Ne 632.8 nm 
laser (laser power ≤ 70 mW prior to lens). The system calibration was carried out 
using a silicon calibration source for wavenumber shift. A50X objective (Olympus) 
with a numerical aperture of 0.55 was used to focus the laser beam and collect Raman 
signal with a working distance of about 8 mm. In order to reduce the possible damage 
of laser to cells, DuoScan in the micromapping mode with a scanning area of 30 µm × 
30 µm was applied with an acquisition time of 5 s. 
Computational analysis of spectral data 
Spectral data processing, acquired from both ATR-FTIR and Raman spectroscopy, 
were performed using IRootLab toolbox (http://irootlab.googlecode.com) running on 
MATLAB r2010a (The MathWorks, Inc., US)
44
.  IR spectra were pre-processed as 
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followings: cut to 1800-900 cm
-1
 (the biochemical fingerprint range), 2
nd
 
differentiation, and vector normalised, While SERS spectra were pre-processed 




 differentiation, and vector 
normalised
45
. Computational analysis using multivariate techniques including 
principal component analysis (PCA) and linear discriminate analysis (LDA) can 
efficiently analyse the large spectral dataset
46,47
. The main difference between PCA 
and LDA is that PCA is an unsupervised method, while LDA is a supervised method. 
PCA looks for projections to maximize variance and LDA looks for projections that 
maximize the ratio of between-class to within-class scatter
48
. Following pre-
processing, PCA was applied to the dataset. PCA, as an unsupervised technique, has 
capability to reduce the dimensions of the data. Undoubtedly PCA is capable of 
identifying important information in the spectral data, but it has less discrimination 
power due to the fact that it is an unsupervised procedure. Often, in order to interpret 
of the complex biochemical information with labelled classes obtained through 
vibrational spectroscopic techniques, it requires further data analysis using supervised 
procedures like LDA. The output data derived from PCA or PCA-LDA can be then 
visualized as 1-D, 2-D or 3-D scatterplots (“scores plots”). In scores plots, nearness 
between two groups means similarity, while the distance indicates dissimilarity. To 
reveal the biochemical alterations associated with each group in the dataset, both 
loadings plots and cluster vectors
16
 were developed. To simplify the identification of 
the main biochemical alteration of each group, peak detector were used to indicate the 





Global DNA methylation determined by HPLC-MS 
A549 cells exposed to four CNPs at the high dose (0.1 mg/L) were collected, and 
stored in PBS at -20℃ prior to q-PCR and DNA methylation analysis. 
The DNA was extracted from A549 cells by DNeasy Cell Kit (Qiagen, Germany) 
following the manufacturer’s instruction. RNase A was added to the columns in the kit 
to remove RNA residue. DNA hydrolysis was conducted by using a mixture 
degradase kit (DNA Degradase Plus, Zymo Research, USA) DNA following the 
manufacturer’s protocol. To confirm the complete hydrolysis of DNA, agarose gel 
electrophoresis was employed to test the result of the DNA hydrolysis. The DNA 
hydrolysis mixtures were then stored at -20℃ for mass spectrometric analysis. 
To perform chromatographic separation, a Kinetex C18 column (100 mm × 4.6 mm, 
2.6 µm, Phenomenex, USA) was employed a HPLC system (LC-20AD, Shimadzu, 
Japan). The injection volume was 20 µL. The mobile phase consisted of water (A) and 
methanol (B). A gradient elution project was used as follows: 0–0.01 min, 3%B; 0.01–
5.00 min, 5%B; 3.00–12.00 min, 50%B; 12.00–15.00 min, 100%B; 15.00–25.00 min, 
3%B at a flow rate of 0.5 mL.min
-1
. For the mass spectrometric analysis, an 
electrospray ionization tandem mass spectrometry (LCMS-8030, Shimadzu, Japan) 
system was used, operating in positive ionization mode and conditioned at a capillary 
temperature of 400◦C and medium N2 curtain gas. Optimized multiple reaction 
monitoring (MRM) conditions were set up to evaluate dC from m/z 228.1 to 111.9 and 
5mdC from m/z 242.1 to 126.0. Data acquisition and processing were performed via 
Analyst software. The global DNA methylation ratio (MR) was determined by MR = 




Quantitative real-time polymerase chain reaction 
Total RNAs were extracted using RNeasy
@
 Mini Kit (Qiagen, Venlo, Netherlands) 
from cells. Subsequently, reverse transcription of cDNA synthesis was performed with 
1 µg total RNA using PrimeScript
@
 RT reagent kit with gDNA Eraser cDNA 
synthesis kits (Takara, Otsu, Shiga, Japan). Real-time PCR was carried out in a 20 µL 
reaction mixture and triplicated, using SYBR Green Master Mix reagents (Roche, 
Basel, Switzerland) on a Roche LightCycle
@
 480llreal-time PCR system following the 
manufacturer’s protocol (95◦C for 10 min followed by 40 cycles at 95◦C for 15 s, and 
60◦C for 30 s). The sequences of primers specific for the DNMT1, DNMT3a, 
DNMT3b, and GAPDH genes were designed using the primer5 software (supporting 
information Table S7). Gene expression levels were normalised to GAPDH gene 
expression. The relative levels of each target mRNA transcripts to the control GAPDH 
were analysed by 2
-△△Ct method and expressed as fold change. 
Statistical analysis 
The data are all expressed as the means±SD. Significant differences among multiple 
groups were determined using a one-way analysis of variance (ANOVA) followed by 
Dunnett’s post hoc tests. Probabilities of P <0.05 were considered as statistically 
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Figure 1. a) General graph for brief introduction of the nanotoxicity and the operation 
principle of ATR-FTIR and SERS used in this project; b) Raw spectra in “biochemical 
fingerprint region” from A549 cells collected by ATR-FTIR; c) Raw spectra from 





Figure 2. One dimensional (1 D) PCA scores plots in PC1 space of ATR-FTIR 
spectral dataset derived from A549 cells exposed to carbon nanoparticles at each 
concentration compared with the vehicle control. Their corresponding loadings plots 




Figure 3. One dimensional (1 D) PCA scores plots in PC1 space of SERS spectral 
dataset derived from A549 cells exposed to carbon nanoparticles at each concentration 
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compared with the vehicle control. Their corresponding loadings plots are on right 
side. 
 
Figure 4. Scores plots by PCA-LDA derived from spectral dataset of the A549 cells 
exposed to CNPs at 0.1 mg/L compared with the vehicle control (90% confidence 
ellipsoids). a) Three dimensional (3 D) and b) 2-D PCA-LAD scores plots from the 
ATR-FTIR spectral dataset; c) Three dimensional (3 D) and d) 2-D PCA-LAD scores 





Figure 5. Cluster vector peak plots by PCA-LDA indicating the wavenumber basis for 
segregation corresponding to A549 cells exposed to CNPs at 0.1 mg/L. Cells exposed 
to each CNP was compared with the vehicle control. The size of the symbol in cluster 
vector peaks plot is proportional to the height of the corresponding peaks in the cluster 
vector plots, which relative to the extent of biochemical alteration compared with the 
vehicle control. a) Cluster vector peak plot derived from ATR-FTIR spectral dataset; 







Figure 6. Global DNA methylation levels in A549 cells exposed to CNPs at 0.1 mg/L 




Figure 7. Quantitative real-time polymerase chain reaction analysis of gene 
expression in A549 cells exposed to CNPs at 0.1 mg/L. Total RNA was isolated, 
reverse transcribed, and amplified with the specific primers. Relative quantification of 
each gene expression level was normalized according to GAPDH gene expression. 
The data of exposure groups were calibrated to the control values (control=1), values 







Figure S1. Scanning electron microscopy (SEM) images of (a) C60 fullerene; (b) 
Long MWCNTs; (c) Short MWCNTs, and (d) Single-Walled CNTs with Raman 





Figure S2. Two-dimension PCA scores plots (90% Confidence ellipsoids)  and 
loading plots in PC2 derived from A549 cells exposed to CNPs interrogated by ATR-





Figure S3. Two-dimension PCA scores plots (90% Confidence ellipsoids)  and 
loadings plots in PC2 derived from A549 cells exposed to CNPs interrogated by 





Figure S4. Cluster vector indicating the wavenumber basis for segregation 
corresponding to A549 cells exposed to CNPs at 0.1 mg/L. Cells exposed to CNPs at 
0.1 mg/L was compared with the vehicle control. The height of the cluster vector peak 
is proportional to the extent of biochemical alteration compared to the vehicle control. 





Synthesis of Au NPs. Au NPs were prepared according to Frens’ method. 
Briefly,100 mL of 0.01% (wt/vol) HAuCl4 aqueous solution was heated to boil under 
vigorous stirring, 
followed by the immediate addition of 0.6 mL of 1% (wt/vol) trisodium citrate 
solution. The solution was kept boiling for about 1 h. Then the Au NPs solution cool 
down for further application. 
Prior to being applied with the cell samples, Au NPs solution were washed by de-ion 






Table S1 Primary wavenumbers in loadings plots derived from PCA of ATR-FTIR 
spectral dataset 













C60 1624 Amide I 1508 Amide II 
1659 Amide I 1543 Amide II 
1589 Amide I 1636 Amide I 
1547 Amide II 1470 Proteins, vasCH3 
1493 Proteins, vasCH3 1697 Lipid, v(C=O) 










  1582 Amide II 
Long 1539 Amide II 1655 Amide I 
1501 Amide II 1620 Amide I 
1624 Amide I 1508 Amide II 
1585 Amide I 1693 Amide I 
1663 Amide I 1585 Amide I 
1466 Proteins, vasCH3 1736 Lipid, v(C=O) 
1732 Lipid, v(C=O) 1543 Amide II 
1065 vsPO2
-
  1462 Proteins, vasCH3 
Short 1620 Amide I 1508 Amide II 
1547 Amide II 1713 Lipid, v(C=O) 
1501 Amide II 1624 Amide I 
1655 Amide I 1543 Amide II 
1585 Amide I 1242 vasPO2
-
  
1462 Proteins, vasCH3 1204 vasPO2
-
  
1717 Lipid, v(C=O) 1589 Amide I 
1400 v(COO
-
) 1678 Amide I 
Single 1508 Amide II 1732 Lipid, v(C=O) 
1466 Proteins, vasCH3 1539 Amide II 
1678 Amide I 1624 Amide I 
1732 Lipid, v(C=O) 1585 Amide I 
1061 vsPO2
-
  1767 Lipid, v(C=O) 
1582 Amide II 1053 Glycogen 
1018 Glycogen 1126 v(CO) 




 Table S2 Primary wavenumbers in loadings plots derived from PCA of SERS 
spectral dataset 













C60 1454 Lipid, CH2 1594 Lipid, C=C 
1006 Phenylalanine 977 Protein 
930 Protein 1631 Lipid, C=C 
1364 Tryptophan, protein 444 Glycogen 
1621 Lipid, C=C 800 DNA, nucleic acid 
1423 Lipid, CH2 1183 Protein 
858 Collagen 1382 Tryptophan, protein 
1487 Lipid, CH2 732 DNA, nucleic acid 
Long 1055 Protein 1004 Phenylalanine 
518 v(S-S) 623 v(C-S) 
1586 v(C=C) 944 Protein 
463 Glycogen 1456 Lipid, CH2 
761 DNA, nucleic acid 668 Protein, v(C-S) 
1522 -C=C-, Amide II 1718 Lipid, v(C=O) 





Short 1006 Phenylalanine 1450 Lipid, CH2 





1372 Tryptophan, protein 860 Collagen 
765 DNA, nucleic acid 1633 Lipid, C=C 
946 Protein 777 DNA, nucleic acid 
1718 Lipid, v(C=O) 1553 -C=C-, Amide II 
1623 Lipid, C=C 1187 Protein 
Single 1623 Lipid, C=C 1454 Lipid, CH2 
442 Glycogen 923 Protein 
1179 Protein 1006 Phenylalanine 
801 DNA, nucleic acid 806 DNA, nucleic acid 
938 Protein 858 Collagen 
1030 Phenylalanine 716 DNA, nucleic acid 
1417 Lipid, CH2 1370 Tryptophan, protein 




 Table S3 Cluster vector peaks plot derived from PCA-LDA of spectral dataset 













C60 1732 Lipid, v(C=O) 1590 v(C=C) 
1663 Amide I 1004 Phenylalanine 
1462 Proteins, vasCH3 765 DNA, nucleic acid 




  1524 -C=C-, Amide II 




    
Long 1620 Amide I 1596 C=N/C=C, protein 
1659 Amide I 761 DNA, nucleic acid 
1582 Amide II 1047 Glycogen 
1242 vasPO2
-




  1525 -C=C-, Amide II 
1516 Amide II 716 DNA, nucleic acid 
1099 vsPO2
-
  1160 Protein 
    
Short 1620 Amide I 759 DNA, nucleic acid 
1736 Lipid, v(C=O) 1621 Lipid, C=C 
1462 Proteins, vasCH3 1428 Lipid, CH2 
1655 Amide I 1008 Phenylalanine 
1508 Amide II 928 Protein 
1558 Amide II 1526 -C=C-, Amide II 
1238 vasPO2
-
  726 DNA, nucleic acid 
    
Single 1620 Amide I 761 DNA, nucleic acid 
1508 Amide II 1594 C=N/C=C, protein 
1543 Amide II 944 Protein 
1655 Amide I 1020 Phenylalanine 
1242 vasPO2
-
  1448 Lipid, CH2 
1096 vsPO2
-
  1530 -C=C-, Amide II 
1462 Proteins, vasCH3 716 DNA, nucleic acid 





Table S4 Scores plots in PC1 space following PCA analysis of  spectra derived 
from A549 cells exposed to CNPs 
One-way ANOVA with Dunnett's 
Multiple Comparison Test 
C60 Long Short Single 
ATR-
FTIR 
Control vs. 0.001 mg/L P <0.001 P <0.001 P <0.001 P <0.001 
Control vs. 0.01 mg/L P <0.001 P <0.001 P <0.001 P <0.001 
Control vs. 0.1 mg/L P <0.001 P <0.001 P <0.001 P <0.001 
SERS Control vs. 0.001 mg/L P <0.001 P <0.001 P <0.001 P <0.001 
Control vs. 0.01 mg/L P <0.001 P <0.001 P <0.001 P <0.001 





Table S5 Global DNA methylation levels of A549 cells exposed to CNPs (0.1 mg/L) 
assessed by HPLC-MS 
One-way ANOVA with Dunnett's 
Multiple Comparison Test 
C60 Long Short Single 





Table S6 Relative mRNA level of A549 cells exposed to CNPs (0.1 mg/L) assessed 
by q-PCR 
One-way ANOVA with Dunnett's 
Multiple Comparison Test 
C60 Long Short Single 
DNMT1 Control vs. CNP P >0.05 P >0.05 P >0.05 P >0.05 
DNMT3a Control vs. CNP P >0.05 P >0.05 P >0.05 P >0.05 





Table S7 Sequence of primers used for quantitative RT-PCR 
Gene Primer sequence (5 -´3 )´ Product size (bp) 
DNMT1 F: TACCTGGACGACCCTGACCTC 103 
  R: CGTTGGCATCAAAGATGGACA   
DNMT3a F: TATTGATGAGCGCACAAGAGAGC 111 
  R: GGGTGTTCCAGGGTAACATTGAG   
DNMT3b F: GGCAAGTTCTCCGAGGTCTCTG 113 
  R: TGGTACATGGCTTTTCGATAGGA   
GAPDH F: GGAGAAGGCTGGGGCTCAT 230 
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The fullerene C60 is one of the most promising manufactured carbon-based 
nanoparticles, and with the wide applications it could possibly release into the 
environment. However, C60 is likely to associate with other substances in 
environment that are toxic. The interaction with C60 can impact on the environmental 
fate, transport and bioavailability of the toxicants in organism, which is largely 
unknown. Benzo[a]pyrene (B[a]P) is one of the most common polycyclic aromatic 
hydrocarbons (PAHs) among the environmental persistent organic pollutions. When 
B[a]P interacts with C60, the association may affect the biological effects of NPs per 
se or that of B[a]P. Thus, in this study two cell lines were employed in such an 
investigation to explore the biological impacts of the co-exposure of C60 and B[a]P. 
Post-exposure cells were then interrogated using a Fourier-transformation infrared 
(FTIR) microscope. By employing subsequent computational analysis including 
principal component analysis (PCA) and linear discriminant analysis (LDA), data 
reduction is achieved to allow for visualisation of cellular differentiation and the 
identification of wavenumber-related biomarkers corresponding to cellular 
biochemical alterations. The results indicated that low-dose C60 could increase the 





With the rise of nanotechnology, there has been a rapid increase in the use of 
nanoparticles in commercial applications. However, there is little known of the fate 
and behaviour of engineered nanoparticles in the environment, and concerns have 
emerged on the potential impact to health for human.
1, 2
 Furthermore, quantitative 
analytical methods are required to determine environmental concentrations and enable 
both effect and exposure assessments. Many methods still need optimization and 
development, especially for new types of nanoparticles.
3-6
 To date, these 
disadvantages contribute to the inclusive to the current data about the safety risk of the 
nanoparticles. 
Fullerene C60, the first manufactured nanoparticle, possesses unique physical and 
chemical properties, which makes it a candidate substance for many 
nanotechnological applications in the industrial and medical fields.
7-10
 However, its 
extremely small size, unique conformation, large surface area, and propensity for 
surface modification raise possibility that C60 could pose a hazard to humans and 
other living organisms, which has been assessed and determined by numerous 
scientific groups
11
. It seems that the cytotoxicity of C60 differs on the type of cells 
used and how C60 test suspensions are prepared
12, 13
. 
Despite the debate on the acute toxicity induced by nanoparticles, emerging concerns 
about release of nanopartilces into environment that it may not only potentially affect 
biological systems, but also could interact with other substance (e.g., pollution 
compounds) as co-contamination. Consequently, the nanopartilces could affect the 
fate, transportation and bioavailability of the pollution compounds by co-
contamination. In aquatic environment, contamination compounds can accumulate in 
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aqueous nanoparticles and this accumulation appears to affect the physicochemical 
property of both nanoparticles and the co-contamination.
14
 Investigations showed that 
nanoparticles seemed to behaviour highly reactive to interaction with the other 
compounds. Furthermore, researchers found that nano-silica could facilitate the uptake 
of the metals by the cells, and induced higher damage in cells than that induced by 
metal or nano-silica alone.
15
 This type of delivery mechanism was so called ‘Trojan 
horse’ effects. In another case, it was found that nano-TiO2 enhanced the 
bioaccumulation and toxicity of copper in Daphnia magna.
16
 Similar situations 
occurred mainly in metal nanoparticles with heavy metal. However, studies 
investigating the co-contamination on carbon-based nanoparticles seemed to be less 
conclusive. Recent studies showed that carbon nanomaterials could highly interact 
with the chemical compounds in the environment.
17-19
 Single-walled carbon nanotubes 
were found to act as a contaminants carrier and enhance the accumulation of 
phenanthrene in fish digestive track.
20
  However, another study suggested that co-
exposure with carboxyl-functionalized single-walled carbon nanotubes could 




Among the persistent organic pollutions, polycyclic aromatic hydrocarbons (PAHs) 
are a large class of widespread organic compounds with two or more fused aromatic 
rings and they have a relatively low solubility in water, but are highly lipophilic.
22
 
Benzo[a]pyrene (B[a]P) is one of the most important PAHs, and it has been identified 
as being highly carcinogenic. Although B[a]P itself does not exhibit carcinogenic 
activity, it is a potent ligand for the aryl hydrocarbon receptor (AhR), which may 
mediate teratogenic and carcinogenic effects of certain environmental pollutants.
23
 In 
cells, B[a]P  can bind to AhR and activate it to induce further response, or it is 
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effectively metabolised  by several xenobiotic metabolizing enzymes in cells  to 
B[a]P-7,8-diol-9,10-epoxide (BPDE), which is its main ultimate carcinogenic forms, 
and can forms adducts with DNA.
24-26
  
It is highly possible that the carbon-based nanomaterials would actively interact with 
PAHs and form co-contamination in the environment. In order to understand how this 
kind of co-exposure will impact on the toxicity, C60 with B[a]P was employed to co-
expose on cells. The toxic effects in cells were then assessed using a biospetroscipic 
method; post-exposure cell samples were interrogated by a Fourier-transformation 
infrared (FTIR) microscope. Such biospectroscopy technique provides us a rapid, bio-
agent free and non-destructive method for biological analysis.
27
 Therefore, IR 
spectroscopy has been widely applied in biological researches, such as disease 
diagnosis
28
, stem cell research
29
 and toxic assessment
30
. The mid-IR region (4000-400 
cm
-1
) is specific for biological application and it provides us abundant chemical bond 
information in the ‘biochemical-fingerprint’ region (1800-900 cm-1), which can 
generate identifiable peaks at specific absorption frequencies, such as Amide I (~1650 
cm
-1
), Amide II (~1550 cm
-1
), Amide III (~1260 cm
-1





), lipids (~1750 cm
-1
), asymmetric phosphate stretching 
vibrations (νasPO2; ~1225 cm
-1
), symmetric phosphate stretching vibrations (νsPO2; 
~1225 cm
-1




 Overall, coupled with 
computational multivariate analysis FTIR spectroscopy can be used as sensitive tool 
for toxic test. 
In this study, two cell lines, including a gill cell line and a mammalian cell line (MCF-
7) were used to conduct the co-exposure of C60 with B[a]P, and the response in cells 
following exposure were later determined using FTIR spectroscopy. According our 
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previous investigations, three relative low doses were employed in the co-exposure for 




 M and 10
-8
 
M; C60 at 0.1 mg/L, 0.01 mg/L and 0.001 mg/L).
32, 33
This study aimed to gain an 
insight into the toxicity of the two agents and the influence of co-exposure on the 
bioavailability. 
Materials and Methods 
Chemicals and carbon nanoparticles 
All test agents were purchased from Sigma. Benzo[a]pyrene was HPLC-grade (>96%) 
and existing as powder, while dimethyl sulfoxide (DMSO) used as solvent was GC-
grade (≥99.5%). Bovine serum albumin (BSA) was also obtained from Sigma was ≥98% 
pure. 
Fullerene C60 used in the study was also from Sigma. As stated, C60 had a 
purity >99.5% and particle size of 1 nm, and was analysed by Raman spectroscopy 
(Renishaw PLC, Gloucestershire, UK) with a 785 nm laser, and determined to be of 
high purity. Additionally, images of C60 were taken using a scanning electron 
microscope (SEM) [JSM 5600 (JEOL)] [see Electronic Supporting Information (ESI) 
Figure S1].  





 M and 10
-5
 M. C60 were dispersed in 1% BSA solution 
following a 15-min ultrasonication in ice-water bath and stock solutions were made at 
concentrations of 100 mg/L, 10 mg/L and 1 mg/L. Agglomerate could be observed in 
the solution due to its lipophilic property. To ensure a homogeneous mixture of 
chemical agents, solvent and exposure medium, and as well to avoid any solvent 
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specific effects, stock solutions and exposure medium were mixed prior to application 
to the cells. In this case, as CNPs and B[a]P were dispersed in 1% BSA solution and 
DMSO respectively, each experimental medium finally contain 0.1% (vol/vol) 1% 
BSA solution and DMSO as a background control. Therefore an experimental medium 
containing 0.1% (vol/vol) 1% BSA solution and DMSO without test agents were used 
as a vehicle control. All these experimental medium were prepared 72 h prior to cell 
exposure and stored in fridge, which allowed the absorption equilibrium of B[a]P onto 
C60. 
Cell culture 
Human breast cancer MCF-7 cells were cultured in Dulbecco’s modified essential 
medium (DMEM) supplemented with 10% heat-inactivated foetal bovine serum, 
penicillin (100 U/mL), and streptomycin (100 µg/mL). MCF-7 Cells were maintained 
in the incubator of a humidified atmosphere with 5% CO2 in air at 37℃. The gill cells 
for primary cultures were derived from gills of rainbow trout (Oncorhynchus mykiss)
 
34. The cells were cultured with Leibovitz’s L-15 culture media supplemented with 10% 
heat-inactivated foetal bovine serum, penicillin (100 U/mL), and streptomycin (100 
µg/mL) as well. These gill cells were maintained without CO2 incubation in free gas 
exchange with air at an optimal temperature (~ 18℃). All these two cell lines were 
routinely cultured in 75 cm
2
 cell culture flasks. MCF-7 cells were split twice a week, 
while gill cells were split once a week. 
CNPs exposure 
For MCF-7 cells, the same medium was used for incubation before and during 
exposure (namely exposure medium), while L15 medium was used only for gill cell 
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growing prior to exposure, but a different medium, L15/ex was then introduced as the 
experimental medium during exposure. L-15/ex medium was firstly introduced in the 
exposure experiment on RTgill-w1 cell line, which was determined also capable for 
the gill cells employed in this study. L15/ex medium contains only salts, galactose and 
pyruvate to provide an isotonic environment and a source of energy and as such is 
fully defined
35, 36
. Bioavailability of test chemicals in this in vitro system is not 
influenced by a serum component. Binding of hydrophobic test chemicals to 
constituents of serum was suggested to contribute to the systematic deviation of 
mammalian cell viability versus fish acute toxicity depending on the chemicals’ 
octanol−water partition coefficient (Kow) and is also a likely cause of underestimation 
of fish acute toxicity in previous investigations using fish cell lines
36
. 
For exposure, cells were directly grown on Low-E slides (Kevely Technologies, OH, 
USA) in the 45 mm culture dishes. Prior to cell seed, Low-E slides were immersed in 
ethanol for 30 mins. Following rinsed in sterile water, Low-E slides were then stored 
in empty culture dishes and dried in incubator. Confluent cells were disaggregated 
with trypsin (0.05%)/EDTA (0.02%) solution, and were immediately resuspended in 
complete medium. Cells were then seeded to the culture dishes and allowed to attach 
on the slides and to form a cell layer on the Low-E slides. After 72 h, the original 
medium was removed and experimental medium containing test agents or not was 
added. After 24-h incubation, the cells were grown on the Low-E slides were rinsed in 
PBS and then fixed in 4% formalin in PBS for 30 min. Once fixed, the slides were 
rinsed in PBS and followed by a quick wash (~ 3 seconds) in distilled water. 






All cell samples on Low-E slides were interrogated using a Bruker TENSOR 70 FTIR 
spectrometer (Bruker Optics Ltd., Germany) equipped with a HYPERION 1000 
microscope containing a liquid nitrogen cooled detector. Instrument parameters were 
set at 32 scans, 8 cm
-1
 resolution. For each slide, about 20 IR spectra were acquired at 
different points across the sample. Prior to starting a new slide or after each ten 
spectra, a background was taken. 
Spectral data acquired from FTIR spectroscopy, were processed by using IRootLab 
toolbox (http://irootlab.googlecode.com) running on MATLAB r2010a (The 
MathWorks, Inc., US).  IR spectra were pre-processed by as follows: cut to 1800-900 
cm
-1
 (the biochemical fingerprint range), rubberband baselined, and normalisation to 
Amide I peak. Computational analysis using multivariate techniques including 
principal component analysis (PCA) and linear discriminant analysis (LDA) can 
efficiently analyse the large spectral dataset. Following pre-processing, PCA was 
applied to the spectral dataset. PCA is an unsupervised technique employed to reduce 
the dimensions of the data. Undoubtedly PCA is capable of identifying some 
important biochemical information in the spectral data. However, it has less 
discrimination power due to the fact that it is an unsupervised procedure. In order to 
interpret the complex biochemical information obtained through vibrational 
spectroscopic techniques it requires further data analysis by using supervised 
procedures such as LDA, PLS, HCA etc. Thus, the output data derived from PCA was 
then input into LDA analysis
37
. The first ten PC factors of PCA were used for LDA 





Multivariate analysis results were visualized either as scores plots and/or cluster 
vectors plot. In scores plots, nearness between two groups means similarity, while the 
distance indicates dissimilarity
38, 39
.  Cluster vectors plot from PCA-LDA was develop 
to help reveal the biochemical alterations associated with each group in the dataset. To 
simplify the identification of the main biochemical alteration of each group, cluster 
vector peak plots were used to indicate the first 7 highest peaks in the cluster vector 
plots. 
Result and discussion 
Following exposure to the test agents, cells were harvested and interrogated by FTIR. 
The interrogation under FTIR microscope gave rise to a large spectral dataset 
containing 12 classed groups, which were labelled according the treatments as: 
Control, C60 0.1 mg/L, C60 0.01 mg/L, C60 0.001 mg/L, B[a]P at 10
-8
 M, B[a]P at 
10
-7
 M, B[a]P at 10
-6
 M, Mix1 (C60 0.001 mg/L & B[a]P at 10
-6
 M), Mix2 (C60 0.01 
mg/L & B[a]P at 10
-6
 M), Mix3 (C60 0.1 mg/L & B[a]P at 10
-6
 M), Mix4 (C60 0.1 
mg/L & B[a]P at 10
-7
 M), and Mix5 (C60 0.1 mg/L & B[a]P at 10
-8
 M). 
As specific wavenumbers in IR spectra can be used as marker of biochemical 
compounds in cells, the intensity absorbance at such a wavenumber in the IR spectra 
following simply processed (including baseline corrected and normalized) could be 
used for assessment of alterations in cells. The intensity absorbance at 1400 cm
-1
 was 
used as a protein marker as it corresponds to C=O symmetric stretching of amino 
acids and 1740 cm
-1
 is associated with C=O stretching vibrations of lipids. Thus, the 
protein-to-lipid ratio using the intensity absorbance at these two vibration modes were 
calculated to assess cell proliferation after exposure
38
. Similarly, other absorbance 
ratio were employed including: intensity absorbance ratio of 1650 cm
-1





as ratio of  protein/nucleic acid (1650 cm
-1
 corresponding to Amide I in protein; 1084 
cm
-1
 corresponding to symmetric phosphate stretching for DNA/RNA)
40
, and intensity 




) used as RNA/DNA ratio
40, 41
. 
The tendency elevated protein-to-lipid ratio indicated that all test agents tend to result 
active cell proliferation
42
. However, the statistical results listed that most of the 
treatment in gill cells significantly activated cell proliferation compared with the 
control, while in MCF-7cells only exposure of Mix4 caused significant proliferation 
(Figure1a and statistical results in supporting information Table S1). In contrast to the 
protein-to-lipid ratio, the protein-to-nucleic acid ratio displayed a downregulation by 
the most exposures in gill cells except for the Mix3 (Figure1b and statistical results in 
supporting information Table S2). Whereas, the pattern of protein-to-nucleic acid ratio 
in MCF-7 was complicated; only treatment of 60 0.1 mg/L, Mix4 and Mix5 
significantly reduced protein-to-nucleic acid level, while it was significantly elevated 
by Mix1 (Figure1b and statistical results in supporting information Table S2). 
Moreover, the ratio of RNA/DNA (Figure1c and statistical results in supporting 
information Table S3) manifested by IR spectra suggested that in gill cells treatment 
with C60 at 0.01 mg/L and 0.1 mg/L could significantly reduce RNA/DNA level, 
which potentially indicated an inhibition in gene expression, while B[a]P of 10
-8
 M, 
Mix1, Mix4 and Mix5 showed capability of stimulation in gene expression. However, 
the change trend of RNA/DNA level in MCF-7 cells following exposure was different 
from that in gill cells, especially for the treatment of C60. It was found that 
RNA/DNA level in MCF-7 cells was significantly increased only by treatment with 
B[a]P at 10
-7
 M and 10
-6
 M, as well as Mix4. 
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As the mid-IR spectra from the multi-constituent biological samples are rich of 
biochemical information and greatly complex, using simple intensity absorbance ratio 
(peak-to-peak ratio) is inadequate for interpretation of the complex biological 
alteration
43
. Thus, multivariate data-analysis techniques (computational analysis) were 
employed to help with the bio-information extraction in spectral dataset from the 
interrogated samples
44, 45
. Combination of different groups consisted a few datasets 
with emphasis on different purpose to explore the cellular toxicity resulted from single 
treatment or binary treatment. When the spectral dataset was processed by 
computational analysis, alterations induced by both single agent and binary mixture 
were determined. Based on the PCA-LDA, dimensional (1-, 2-, or 3-D) scores plots 
were performed for visualisation using the first three LD factors, where most 
segregations among groups were observed. The first two factors were particularly 
displayed in 1-D scores plot with their corresponding loadings plot, which identifies 
the wavenumbers responsible for segregation of scores of spectral clusters following 
exposure. Additionally, cluster vector plot was applied in the dataset of binary mixture 
exposure so that the global alterations in cells induced by each treatment could be 
identified compared with the control group. 
When the spectral dataset containing whole groups was inputted into PCA-LDA 
method, 3-D scores plots were performed for visualisation. However, it was difficult 
to recognise the segregation in 3-D or 2-D scores plot as too many groups involving in 
the dataset (supporting information). Thus, displaying the first two LD scores in 1-D 
plots gave rise to a clear global view of segregations among groups (Figure 2). For 
both LD1 and LD2 space, the corresponding loadings plots were displayed with the 
first seven primary wavenumbers marked. In LD1 space, the wavenumbers derived 





(Lipid), 1664 (Amide I), 1070 (DNA/RNA, vsPO2
-
), 985 (Protein phosphorylation), 
1417 (amino acid, v[COO
-
]), and 1556 (Amide II), while those from MCF-7 cells 
were similar with gill cells: 1101 (DNA/RNA, vsPO2
-
), 1508 (Amide II), 1026 
(Glycogen), 1566 (Amide II), 983 (Protein phosphorylation), 1406 (amino acid, 
v[COO
-
]), and 1712 (Lipid); namely, these wavenumbers corresponding to specific 
biochemical structures could be used as multi biomarkers in the assessment, in which 
importance of biomarkers weigh the pronounced extent of wavenumbers in loadings 
plot. However, in LD2 space the loadings plots for each cell line laid emphasis to 
different biomarkers; pronounced wavenumbers in loadings plot from gill cells were 
mainly located in the DNA/RNA region (~1250-1000 cm
-1
), while counterparts in 
MCF-7 cells mostly appeared to be in lipid and protein (Amide I) region (~1750-1500 
cm
-1
). For gill cells, significant alterations were observed between the exposed groups 
and the control in both LD1 and LD2 space, except for that with treatment of Mix3 
(statistical results in supporting information Table S4). From this global view, it was 
found that binary treatment with both high dose of B[a]P and C60 was likely to result 
a highly reduced effects in gill cells, while exposure of  a high dose mixed with a low 
dose could greatly enhanced the toxicity in gill cells. As MCF-7 exposed to the test 
agents, a similar response mode was presented in 1-D scores plots of both LD space. 
The dataset of the control group and those from single treatment with either C60 or 
B[a]P was performed to explore the toxicity of single agent. When cells were exposed 
to C60, both gill cells and MCF-7 cells were likely to show a linear dose-response in 
the LD1 space (Figure 3). It also showed that gill cells were significantly affected by 
C60 at each dose in both LD spaces, while MCF-7 cells only with treatment of 0.1 
mg/L in LD1 space and treatment of 0.01 mg/L in LD2 space appeared to be 
significantly altered (statistical results in supporting information Table S4). In LD1 
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loadings plot derived from gill cells, the most pronounced wavenumbers were related 
to amide I, glycogen, DNA/RNA, and lipid regions (Figure 3a and supporting 
information Table S6). It is similar for MCF-7 cells that segregations in LD1 were 
mostly resulted from alterations in amide I, lipid, amide II and DNA/RNA region 
(Figure 3c and supporting information Table S8). These spectral profiles indicated that 
C60 was capable to induce alterations in outer cellular structures (lipid and protein), 
but also in the internal materials of DNA/RNA, namely genotoxicity
46, 47
. It is 




However, B[a]P treatment was likely to result a non-linear dose-response in both cell 
lines, and in both LD space the significant segregations were observed in the treated 
groups compared with the control group, except that the group of gill cells exposed to 
B[a]P at 10
-8
 M (Figure 3b & 3d  and supporting information Table S4). B[a]P is 
specifically targeting to induce alterations in the DNA/RNA, as loadings plots in both 
LD1 and LD2 showed obviously pronounced peaks in the wavenumbers 
corresponding to the biochemical structure of DNA/RNA in cells. This indicated that 
B[a]P was a genotoxic compound inducing DNA damage
25, 49
, which  is consist with 
previous studies in our group
32
. Moreover, a low-dose effects was observed in cells 
following B[a]P exposure. 
In order to look insight into the mechanism underlying the action of the binary 
exposure in cells, specific groups were put together as an associated dataset for further 
analysis. In these dataset, cluster vector plot was employed to indicate the pronounced 
wavenumbers corresponding for biochemical alterations in each treated cell group 





and their mixture were processed by computational analysis, the 2-D and 3-D scores 
plots derived from PCA-LDA were performed for visualisation (Figure 4). For gill 
cells, both the 2-D scores plot and cluster vector plot showed that the treatment of 
B[a]P 10
-6
 M lead to the most pronounced alterations in cells, which mostly appeared 
to be in the DNA/RNA region, while C60 exerted a lower extent of toxicity in cells 
(Figure 4a). However, the 1-D scores plots (supporting information) in the first two 
LD space indicated that co-exposure of these two treatment could dramatically reduce 
their toxic action in cells, but it still showed a slight genotoxicity, which was indicated 
by the cluster vector. The similar situation occurred in the dataset of MCF-7 cells 
(Figure 4b). Cluster vector plot showed that all treatment caused wide alterations in 
cells including lipid, protein and DNA/RNA, and it was found that both C60 0.1 mg/L 
and B[a]P 10
-6
 M induced highly remarkable alteration in cells, while the treatment of 
Mix3 displayed a relatively limited toxic action. Additionally, the cluster vector peak 
C60 tended to induced higher alteration in the protein rather than in the DNA/RNA, 
while B[a]P affected cell with emphasis on the DN/RNA region. However, the cluster 
vector peak plot suggested that the toxic action of the co-exposure was likely to be 
limited in the lipid and protein region of MCF-7 cells. 
In addition, extra dataset were also performed to explore the differences of the 
alterations in cells when the binary treatment varied. When gill cells were treated with 
both C60 and B[a]P, the alterations in cells were observed to be elevated with the dose 
of C60 decreased (B[a]P kept at 10
-6
 M) (Figure 5). As it was showed in cluster vector 
plot, the Mix3 (C60 0.001 mg/L and B[a]P 10
-6
 M) caused the most distinct alteration 
in cells, and the cluster vector showed that its toxic action seems to be a combination 
of that from C60 and B[a]P, while it was even highly enhanced. However, when it 
kept the dose of C60 at 0.1 mg/L and decrease the dose of the B[a]P, the toxic effects 
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would increase but quite limited by contrast to that from C60 (Figure 6). Toxic 
mechanism revealed by cluster vector suggested that co-exposure of high dose C60 
with low dose B[a]P could induce alterations in protein and DNA/RNA region at a 
similar extent.  Additionally, the toxic action of the co-exposure appeared to be 
similar in the MCF-7 cells. The only thing to make it a bit different is that higher 
alterations in DNA/RNA region were observed as MCF-7 cell are mammalian cells 
and more sensitive to the genotoxicity of B[a]P. Therefore, it evidenced that high 
concentration of C60 could limit the toxicity of B[a]P. 
Conclusion 
In general, the biological effects resulted from the binary exposure of contamination 
compounds exposure are quite complicated and it is difficult to predicted
50
. 
Particularly, when the nanoparticles encounter the chemical compounds in the 
environment, this issue become more intractable
51
, as it requires taking more factors 
into account
52
. Moreover, the binary effect of C60 co-exposure with other chemical 
compounds is a controversial issue. It was reported that association of Hg
2+
 with C60 




. Similar investigation also 
determined that co-exposure with C60 fullerene may strengthen the health effects of 
organic industrial chemicals
54
. Another study in ZF-L cells that also focused on the 
co-exposure of C60 and B[a]P (only using one higher dose of C60 at 1.0 mg/L in co-
exposure) suggested that C60 could elicited toxicity by increasing the intake of 
B[a]P
55
. While a few other studies draw a different conclusion. Another research 
group observed that the association between nC60 and 17α-ethinylestradiol (EE2) 
reduced EE2 bioavailability in zebrafish
56, 57
.  Additionally, Yang et al. reported lower 





. In this study, the spectral data indicated that low dose of C60 could 
elevate the toxicity of B[a]P, while high concentration of C60 could limit the toxicity 
of B[a]P. The biospectroscopic method also interpreted the toxic action mode of the 
test agents at such a low dose, both the single treatment and the binary ones. However, 
the mechanism underlying the different actions from co-exposure with diverse 
combinations of the two agents still requires further investigation. 
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Figure 1. Intensity absorbance ratio derived from IR spectra of the cells a) Ratio of 





Figure 2. One-D Scores plot in LD1 derived from PCA-LDA of spectral dataset 








Figure 3. One-D Scores plot in LD1 derived from PCA-LDA of spectral dataset for 






Figure 4. Scores plot and cluster vector derived from PCA-LDA of spectral dataset 




Figure 5. Scores plot and cluster vector derived from PCA-LDA of spectral dataset 




Figure 6. Scores plot and cluster vector derived from PCA-LDA of spectral dataset 





Figure S1. Scanning electron microscopy (SEM) images of fullerene C60 with Raman 





Figure S2. Three-dimension PCA-LDA scores plots (95% Confidence ellipsoids 
projected on walls) derived from post-exposure cells interrogated by FTIR a) Gill 





Figure S3. One-D Scores plot in LD2 derived from PCA-LDA of spectral dataset 







Figure S4. One-D Scores plot in LD2 derived from PCA-LDA of spectral dataset for 




Figure S5. One-D Scores plot derived from PCA-LDA of spectral dataset (Dataset 




Figure S6. One-D Scores plot derived from PCA-LDA of spectral dataset (Dataset 




Figure S7. One-D Scores plot derived from PCA-LDA of spectral dataset (Dataset 
C60mix), with corresponding loading plot. BaP, B[a]P   
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 Table S1 Ratio of Protein to Lipid derived from FTIR spectra of cells 
One-way ANOVA with Dunnett's 
Multiple Comparison Test 
Gill cells MCF-7 cells 
Control vs C60 0.001 mg/L P >0.05 P >0.05 
Control vs C60 0.01 mg/L P <0.05 P >0.05 
Control vs C60 0.1 mg/L P <0.001 P >0.05 
Control vs B[a]P 10
-8
 M P <0.001 P >0.05 
Control vs B[a]P 10
-7
 M P <0.001 P >0.05 
Control vs B[a]P 10
-6
 M P <0.0001 P >0.05 
Control vs Mix1 P >0.05 P >0.05 
Control vs Mix2 P <0.05 P >0.05 
Control vs Mix3 P >0.05 P >0.05 
Control vs Mix4 P >0.05 P <0.001 





 Table S2 Ratio of Protein to Nucleic acid derived from FTIR spectra of cells 
One-way ANOVA with Dunnett's 
Multiple Comparison Test 
Gill cells MCF-7 cells 
Control vs C60 0.001 mg/L P >0.05 P >0.05 
Control vs C60 0.01 mg/L P <0.0001 P >0.05 
Control vs C60 0.1 mg/L P <0.0001 P <0.0001 
Control vs B[a]P 10
-8
 M P <0.0001 P >0.05 
Control vs B[a]P 10
-7
 M P <0.0001 P >.05 
Control vs B[a]P 10
-6
 M P <0.0001 P >0.05 
Control vs Mix1 P <0.0001 P <0.05 
Control vs Mix2 P <0.0001 P >0.05 
Control vs Mix3 P <0.0001 P >0.05 
Control vs Mix4 P <0.0001 P <0.05 





 Table S3 Ratio of RNA to DNA derived from FTIR spectra of cells 
One-way ANOVA with Dunnett's 
Multiple Comparison Test 
Gill cells MCF-7 cells 
Control vs C60 0.001 mg/L P >0.05 P >0.05 
Control vs C60 0.01 mg/L P <0.0001 P >0.05 
Control vs C60 0.1 mg/L P <0.0001 P >0.05 
Control vs B[a]P 10
-8
 M P <0.05 P >0.05 
Control vs B[a]P 10
-7
 M P >0.05 P <0.05 
Control vs B[a]P 10
-6
 M P >0.05 P <0.0001 
Control vs Mix1 P <0.001 P >0.05 
Control vs Mix2 P >0.05 P >0.05 
Control vs Mix3 P >0.05 P >0.05 
Control vs Mix4 P <0.0001 P <0.05 





 Table S4 Scores plots derived from PCA-LDA of FTIR spectra of cells 
One-way ANOVA with Dunnett's 
Multiple Comparison Test 
Gill cells MCF-7 cells 
LD1 LD2 LD1 LD2 
Dataset  
C60 
Control vs C60 0.001 mg/L P <0.05 P <0.0001 P >0.05 P >0.05 
Control vs C60 0.01 mg/L P <0.0001 P <0.0001 P >0.05 P <0.0001 
Control vs C60 0.1 mg/L P <0.0001 P <0.0001 P <0.0001 P >0.05 
Dataset 
BaP 
Control vs B[a]P 10
-8
 M P <0.0001 P >0.05 P <0.0001 P <0.0001 
Control vs B[a]P 10
-7
 M P <0.0001 P <0.001 P <0.0001 P <0.0001 
Control vs B[a]P 10
-6
 M P <0.0001 P <0.001 P <0.0001 P <0.0001 
Dataset  
total 
Control vs C60 0.001 mg/L P <0.0001 P <0.05 P >0.05 P >0.05 
Control vs C60 0.01 mg/L P <0.001 P <0.0001 P <0.001 P <0.0001 
Control vs C60 0.1 mg/L P <0.001 P <0.0001 P <0.0001 P <0.0001 
Control vs B[a]P 10
-8
 M P <0.0001 P <0.0001 P >0.05 P <0.0001 
Control vs B[a]P 10
-7
 M P <0.001 P <0.001 P <0.05 P <0.0001 
Control vs B[a]P 10
-6
 M P <0.0001 P <0.001 P <0.0001 P >0.05 
Control vs Mix1 P <0.0001 P <0.001 P <0.0001 P <0.0001 
Control vs Mix2 P <0.001 P <0.0001 P >0.05 P >0.05 
Control vs Mix3 P >0.05 P >0.05 P >0.05 P <0.0001 
Control vs Mix4 P <0.0001 P <0.0001 P <0.0001 P <0.0001 





 Table S5 Scores plots derived from PCA-LDA of FTIR spectra of cells 
One-way ANOVA with Dunnett's 
Multiple Comparison Test 
Gill cells MCF-7 cells 
LD1 LD2 LD1 LD2 
Dataset  
BaPmix 
Control vs B[a]P 10
-6
 M P <0.0001 P <0.0001 P <0.0001 P >0.05 
Control vs Mix1 P <0.0001 P <0.001 P <0.0001 P <0.05 
Control vs Mix2 P <0.0001 P <0.0001 P >0.05 P <0.0001 
Control vs Mix3 P >0.05 P >0.05 P <0.0001 P <0.0001 
Dataset  
C60mix 
Control vs C60 0.1 mg/L P <0.0001 P <0.0001 P <0.0001 P <0.0001 
Control vs Mix3 P >0.05 P >0.05 P <0.0001 P <0.0001 
Control vs Mix4 P <0.001 P <0.0001 P <0.0001 P <0.0001 
Control vs Mix5 P <0.0001 P <0.0001 P <0.0001 P <0.0001 
Dataset  
mix 
Control vs C60 0.1 mg/L P <0.0001 P <0.0001 P <0.0001 P >0.05 
Control vs B[a]P 10
-6
 M P <0.0001 P <0.0001 P <0.0001 P <0.0001 
Control vs Mix3 P >0.05 P <0.05 P <0.0001 P <0.0001 





Table S6  Primary wavenumbers in loadings plots derived from PCA-LDA of FTIR 
spectral dataset (Gill cells) 












1656 Amide I 1658 Amide I 
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  1003 Glycogen 
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 Table S7 Primary wavenumbers in loadings plots derived from PCA-LDA of FTIR 
spectral dataset (Gill cells) 
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Table S8  Primary wavenumbers in loadings plots derived from PCA-LDA of FTIR 
spectral dataset (MCF-7 cells) 
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  1593 Amide I 
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phosphorylation 
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 Table S9 Primary wavenumbers in loadings plots derived from PCA-LDA of FTIR 
spectral dataset (MCF-7 cells) 
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1024 Glycogen 1153 Carbohydrates 
1585 Amide I 1192 Collagen 
1219 vasPO2
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 Table S10 Primary wavenumbers in cluster vector plots for PCA-LDA derived from 
IR spectra 
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 Table S11 Primary wavenumbers Cluster vector plots for PCA-LDA derived from IR 
spectra 
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Table S12 Primary wavenumbers Cluster vector plots for PCA-LDA of IR spectra 
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Chapter 6 - Discussion 
1. Biospectroscopy 
Infrared (IR) and Raman spectroscopies have capability of providing biochemical 
information about the structure, functional groups and even the environment of the 
molecules in the biological samples. Over the past few decades, techniques based on 
Infrared (IR) and Raman spectroscopies (namely, biospectroscopy) have been 
extensively used to understand fundamental biology and responses of living systems 
under diverse physiological and pathological conditions (Diem et al. 1999; Matthäus 
et al. 2007; Walsh et al. 2007; Wood et al. 2004). Biospectroscopy is not only capable 
to differentiate cells or tissues based on the spectral properties, but also capable to 
serve as a potential diagnostic tool for discriminating various diseases or disease 
progression, as well as detecting biochemical alteration in toxicity assessment. 
Additionally, biopspectroscopy also provides us a rapid label-free testing method with 
advantages of non-destructive and time saving, by contrast to the conventional 
biological assays, which commonly requires high-cost bioreagents and technically 
labour-intense sample preparation. 
The spectra from biological systems contain complex and diverse information of bio-
molecules such as proteins, lipids, nucleic acids, carbohydrates etc., which could 
sometimes even interpret the minor differences between samples with the help of 
computational data-analysis. The computational analysis mainly consists of two parts: 
the spectral pre-processing and multivariate data-analysis; the latter including various 
methods (e.g., PCA, LDA, PLS and PCA-LDA) can efficiently process the huge 
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dataset derived from the spectra and help with information extraction and biomarker 
identification. 
2. Determining dose-response alterations induced by CNPs 
The dose and time are considered as the two key factors in toxicology (Rozman and 
Doull 2000). However, the toxicological dose response could be complicated and 
often displayed as a non-linear relationship, especially in the low and high dose. In 
general, high dose exposure is likely to induce acute toxicity, while the chronic low 
dose exposure over a life time could potentially increase the incidence of degenerative 
diseases, which is more predictive of the main public health. In nanotoxicology, it is 
important to evaluate the toxicity of CNPs at a relevant and realistic environmental 
level, which can make the conclusions from in vitro and in vivo experiments more 
meaningful for public risk assessment; this suggests that it is more urgent to test 
nanotoxicity on real-world doses rather than high dose.  
In the published investigation on the toxicity of CNPs, most of the doses employed 
were quite high (about ≥1 mg/L), which is unlikely to predict the human pathology 
from environmental exposure. In our studies, we have validated the application of 
biospectroscopy in nanotoxicity assessment and significant responses from cells or 
fish have been detected in parts per billion (ppb) level (Low to 0.001 mg/L) (Chapter 
2 and 3). 
When MCF-7 cells both in S-phase and G0/G1-phase were treated with CNPs (C60, 
long and short MWCNTs), significant alterations (P ≤0.05) in cells interrogated by 
ATR-FTIR were observed even at the treatment concentration at 0.0025 mg/L, and 
most of the dose response appeared to be non-linear (Chapter 2). Especially, low-dose 
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effects were detected, which is remarkably common in studies of endocrine-disrupting 
chemicals (EDCs)(Vandenberg et al. 2012). This indicated that biospectroscopy has 
capability to detect such a response. Similarly, the four types CNPs (C60, long and 
short MWCNTs, SWCNTs) could induce significant dose-dependent alterations in 
A549 cell population (Chapter 4), which were interrogated by both ATR-FTIR and 
surface-enhanced Raman spectroscopy. Moreover, the dose-related effects in vivo 
were more complex. The alterations in tissues, including gill, brain, liver and gonad, 
of zebrafish induced by the four types CNPs with exposure duration of 21 days were 
determined by ATR-FTIR, with complement of Raman (Chapter 2). Although no 
evidence showed the transportation of CNPs into brain and gonad, significant 
biochemical alterations were observed, which may involve in physiologically-based 
toxic-kinetics and required further investigations. 
In general, biopsectroscopy showed powerful ability of detecting the biochemical 
alterations induced by CNPs both in vitro and in vivo at a ppb level, which is real-
world or closer to the realistic scenario. 
 3. Insight into the mechanism underlying the nanotoxicity of CNPs 
Multivariate data-analysis approaches, such as PCA, PCA-LDA, possess ability to 
reduce data dimension and is capable to extract biomarkers corresponding for the 
biochemical alterations in samples. Loadings plot or cluster vector plot derived from 
PCA or PCA-LDA can be used in purpose to identify the biomarkers. 
In this thesis, studies on MCF-7 cells showed that the spectra profiled the lipid and 
protein as the main target of CNPs toxicity, as cluster vector plot displayed that the 
most pronounced wavenumbers were related to lipid (~1750 cm
-1





) and amino acid (~1400 cm
-1
). This suggested CNPs may exert toxicity mainly at 
the outer site of cells. However, changes in the wavenumbers corresponding to 
DNA/RNA region were also observed, while cells in S-phase appeared to be more 
sensitive to genomic injure rather than those in G0/G1-phase. Additional evidence of 
CySS-to-protein ratio indicated that CNPs could elevate the reactive oxygen species 
(ROS) in cell, which is considered as the predominant mechanism for nanotoxicity, 
and could possibly exert toxicity onto the cellular internal material, including the 
DNA/RNA (namely, genotoxicity) (Fu et al. 2014) (Chapter 2). 
Loadings plots of Spectral dataset from in vitro experiment on A549 cells (Chapter 4) 
profiled that segregations between the exposed groups and the control one were 
mostly resulted from lipid and protein region (~1750-1400 cm
-1
), while DNA/RNA 
region was slightly affected; it means nanotoxicity of CNPs were mainly activated at 
the sites of lipid and protein, which was consist with the results in Chapter 3. 
Additional experiments also determined that CNPs were possibly of capability to 
elevate global genomic methylation level in A549 cells, which implied the risk of 
cancer for CNPs exposure. In this experiment SERS also proved to be an ultra-
sensitivity technique for biological analysis. 
For risk assessment, in vitro models are insufficient to alone predict potential hazard 
for human. Thus zebrafish was employed as an animal model for investigation of 
nanotoxicity with a chronic exposure (Chapter 3).The gill, as the initial site for CNPs 
exposure directly contact with CNPs and presented an obvious response to the CNPs 
treatment, while biochemical alterations were mainly located in protein and lipid. By 
contrast, alterations in the main metabolic organ of liver were not only limited to lipid 
and protein, but also involving in the genomic level. Brain and the gonad were the 
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most concerned sites, since brain acts as a control centre for the whole body, and any 
biochemical alteration in brain could potentially lead to neuro-dysfunction diseases, 
while gonad plays a key role in fertility. However, the spectral dataset highlighted that 
both these two organs were significantly affected by the CNPs exposure, though there 
were blood-brain barrier (BBB) and blood-gonad barrier (BGB) existing to protect the 
two organs respectively. Moreover there appeared to be obvious alterations of 
DNA/RNA in brain and gonad, which gave raise to high risk of genotoxicity in these 
two sites. 
Among the four tested CNPs, long MWCNTs was likely to result in the most 
pronounced alterations A549 cells, but not in MCF-7, where C60 induced the highest 
extent of alterations. This is possible because of the different cell lines employed in 
the experiments. However, all biological models displayed a similar toxic action mode 
of CNPs. 
4. Predicting effects of CNPs interacting with PAHs in cells 
When CNPs were released to environment, it will possibly encounter other 
contamination compounds. The interaction between CNPs and other compounds may 
affect the biological impact of the CNP itself or the other pre-existing compounds, 
which is still largely unknown. The dose response relationship is commonly based on 
the single agent exposure, while cellular response to the co-exposure is difficult to 
predict. And there is always a debate existing on whether co-exposure of CNPs with 
other chemical compound will increase the bioavailability of the chemical compounds, 
or it can reduce the toxicity (Canesi et al.). 
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Two cell lines, gill cells and MCF-7 cells were employed to investigate the effects pf 
co-exposure (Chapter 5). Both cell lines showed a dose-response alterations resulted 
from the exposure of single agents. Infrared spectra highlighted that the B[a]P was of 
high-level genotoxicity, while C60 seems to be more toxic to lipid and protein rather 
than DNA/RNA. In this study, it was found that low dose of C60 could elevate the 
toxicity of B[a]P, while high concentration of C60 could limit the toxicity of B[a]P. In 
addition, it also interpreted binary test agents at such a low dose could enhance both 
toxic action mode of the two agents. This suggested the behaviour of such a coexisting 
mixture is more complex in the realistic environment and it is more unpredictable. 
5. General conclusion and future recommendation 
In this thesis, biospectroscopy, including both IR and Raman spectroscopy, coupled 
with computational analysis showed capability to detect biological alteration in 
subcellular level. Additionally, it was determined to be an excellent tool for 
naonotoxicity assessment especially at low dose. Moreover, infrared spectroscopy 
(ATR-FTIR and FTIR microscopy) can provides us global information of the 
biological samples, as well as Raman spectroscopy. Although SERS is likely to 
partially collect information from the cells, it turned to be highly sensitive. All 
methods showed capability of detecting dose–dependent toxicity of CNPs and 
successfully identified the biomarkers corresponding to the biochemical alterations. 
Based on the recent results from this thesis, it would be important to introduce the real 
environmental condition to the Nanotoxicity assessment both in vitro and in vivo. It is 
also important to relate nanotoxicity with diseases, as our studies show that CNPs in 
vitro could cause hypermethylation and in vivo it exerted toxicity to brain and gonad 
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a  b  s  t  r  a  c  t
Chemical  contaminants,  such  as  benzo[a]pyrene  (B[a]P),  may  modulate  transcriptional  responses  in cells
via  the activation  of  aryl  hydrocarbon  receptor  (AhR)  or through  responses  to DNA  damage  following
adduct  formation.  Attenuated  total  reflection  Fourier-transform  infrared  (ATR-FTIR)  spectroscopy  can  be
employed  in  a non-destructive  fashion  to  interrogate  the  biochemical  signature  of  cells  via generation  of
infrared  (IR) spectra.  By  applying  to generated  spectral  datasets  subsequent  computational  approaches
such  as  principal  component  analysis  plus  linear  discriminant  analysis  (PCA–LDA),  derived  data  reduction
is  achieved  to  facilitate  the  visualization  of wavenumber-related  alterations  in  target  cells.  Discriminating
spectral  variables  might  be associated  with  lipid  or glycogen  content,  conformational  protein  changes
and  phosphorylation,  and  structural  alterations  in DNA/RNA.  Using  this  approach,  we  investigated  the
dose-related  effects  of B[a]P  in  MCF-7  cells  concentrated  in  S-  or  G0/G1-phase.  Our  findings  identified  that
in  PCA–LDA  scores  plots  a clear  segregation  of  IR  spectra  was  evident,  with  the  major  spectral  alterations
associated  with  DNA/RNA,  secondary  protein  structure  and  lipid.  Dose-related  effects  were  observed
and  even  with  exposures  as  low  as  10−9 M B[a]P,  significant  (P  ≤  0.001)  separation  of  B[a]P-treated  vs.
vehicle  control  cells  was  noted.  ATR-FTIR  spectroscopy  with  computational  analysis  is  a  novel  approach
to  identify  the  effects  of  environmental  contaminants  in  target  cells.
© 2012 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Benzo[a]pyrene (B[a]P) is an environmental pro-mutagenic and
pro-carcinogenic contaminant derived mainly from tobacco smoke,
automobile exhaust, industrial wastes and food products (Rubin,
2001; Boström et al., 2002). Although B[a]P itself does not exhibit
carcinogenic activity, it is a potent ligand for the aryl hydrocarbon
receptor (AhR), which may  mediate teratogenic and carcinogenic
Abbreviations: AhR, aryl hydrocarbon receptor; asPO2− , asymmetric phos-
phate;  ATR-FTIR, attenuated total reflection Fourier-transform infrared; B[a]P,
benzo[a]pyrene;  BPDE, B[a]P-7,8-diol-9,10-epoxide; IR, infrared; LD, linear discrim-
inant; LDA, linear discriminant analysis; PC, principal component; PCA, principal
component analysis; sPO2− , symmetric phosphate.
∗ Corresponding author at: The School of Public Health, Guangxi Medical Univer-
sity,  Nanning, Guangxi 530021, PR China. Tel.: +86 0773 5895812;
fax:  +86 0773 5895812.
∗∗ Corresponding author at: Centre for Biophotonics, Lancaster Environment Cen-
tre, Lancaster University, Bailrigg, Lancaster LA1 4YQ, United Kingdom.
Tel.: +44 1524 510206.
E-mail  addresses: xqqiu9999@sina.com (X. Qiu), f.martin@lancaster.ac.uk
(F.L.  Martin).
effects of certain environmental pollutants (Birnbaum, 1994; Bock,
1994). B[a]P can bind to and activate AhR (Tsuchiya et al., 2003). The
activated receptor is a key component of the B[a]P-induced target
genes’ expression response. Several target genes encode xenobiotic
metabolizing enzymes involved in the bioactivation of B[a]P to its
ultimate carcinogenic forms, mainly B[a]P-7,8-diol-9,10-epoxide
(BPDE),  which forms adducts with DNA (Shimizu et al., 2000;
Shimada et al., 2003; Shimada, 2006).
Induced responses are associated with modification of genes
and proteins involved in the regulation of a plethora of mecha-
nisms including transcription, cell cycle, apoptosis, transport, signal
transduction and metabolism (Yoshino et al., 2007; Shen et al.,
2008). However, it is difficult to predict biological responses to
low-dose exposures based on adverse effects induced by high
concentrations (Martin, 2007). Attenuated total reflection Fourier-
transform infrared (ATR-FTIR) spectroscopy is a tool that has been
employed to examine biochemical effects of chemical contami-
nants in target cells and to fingerprint specific exposure patterns
(Llabjani et al., 2010, 2011). Utilizing infrared (IR) spectroscopy,
alterations in spectral variables (i.e., wavenumbers) can reflect DNA
adduct formation (Arakawa et al., 2001) or protein structure alter-
ations (Kelly et al., 2009; Llabjani et al., 2009, 2010, 2011). ATR-FTIR
0300-483X/$ – see front matter ©  2012 Elsevier Ireland Ltd. All rights reserved.
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spectroscopy to address biological questions is based on the con-
cept that biomolecules absorb in the mid-IR region ( = 2.5–25 m)
through the vibration of chemical bonds. These detected vibrations
give rise to a detailed biomolecular fingerprint of the cells or tis-
sue under investigation in the form of an IR spectrum relating to
chemical structures (Petrich, 2001; Kelly et al., 2011).
IR  spectroscopy experiments generate complex biochemi-
cal datasets containing hundreds or thousands of spectra, and
exploratory analysis is best achieved by multivariate approaches
such as principal component analysis (PCA) and/or linear discrim-
inant analysis (LDA) (Martin et al., 2007). This allows for data
reduction to facilitate the identification of wavenumber-related
spectral alterations associated with glycogen content, lipid content,
conformational protein changes and phosphorylation characteris-
tics, and structural alterations in DNA/RNA (Martin et al., 2010).
In  the current study, we employed ATR-FTIR spectroscopy
with subsequent multivariate analysis (PCA–LDA) to investigate
alterations in MCF-7 cells induced by various doses of B[a]P.
Dose-related cell cycle-associated effects, especially high-dose vs.
low-dose B[a]P compared to the corresponding vehicle control,
were investigated to determine the magnitude of induced alter-
ations. In addition, a growth-curve experiment was  established
to determine whether low-dose vs. high-dose B[a]P exposures
differentially alter time-related cell number increases in cul-
ture. Traditionally, short-term assessments of genotoxicity have
tested high-dose treatments, but how these reflect low-dose
contaminant-induced effects consistent with background levels
of human exposure (Hattemer-Frey and Travis, 1991) remains
obscure. Methods capable of delineating and shedding light into
relevant mechanisms of action of real-world exposures in target
cells are urgently required.
2. Materials and methods
2.1.  Chemicals
B[a]P and dimethylsulfoxide (DMSO) were obtained from Sigma Chemical Co.
(Poole, Dorset, UK). Cell culture consumables were obtained from Invitrogen Life
Technologies (Paisley, UK), unless otherwise stated.
2.2.  Cell culture and treatment
Human  breast cancer MCF-7 cells were cultured in Dulbecco’s modified essen-
tial  medium (DMEM) supplemented with 10% heat-inactivated foetal bovine serum,
penicillin (100 U/mL), and streptomycin (100 g/mL) in a humidified atmosphere
with  5% CO2 in air at 37 ◦C. Cells were disaggregated with trypsin (0.05%)/EDTA
(0.02%)  solution (inactivated with complete medium) before incorporation of cell
aliquots for routine culture in T75 flasks. Towards experiments, MCF-7 cells were
disaggregated, re-suspended in complete medium and then seeded in T25 flasks,
whereupon they were concentrated in either S-phase (grown for 24-h) or G0/G1-
phase (grown for 96-h) (Jiao et al., 2007) prior to treatment with or without test
agent (25 L stock solution/5 mL  culture medium) for a further 24 h. Following treat-
ment, cells were disaggregated into cell suspensions and immediately fixed with 70%
ethanol (EtOH).
2.3.  ATR-FTIR spectroscopy
Cellular material in 70% EtOH was applied to 1 cm ×1 cm Low-E-reflective glass
microscope slides (Kevley Technologies, Chesterland, OH, USA) and allowed to air-
dry prior to storage in marked 30-mm Petri dishes kept in a desiccated environment
until  analysis. IR spectra were obtained using a Bruker Vector 22 FTIR spectrome-
ter  with Helios ATR attachment containing a ≈250 m × 250 m aperture diamond
crystal  (Bruker Optics Ltd., Coventry, UK). The ATR crystal was  cleaned with sodium
dodecyl sulfate (SDS; Sigma Chemical Co.); a new background was  taken prior to
analysis of a new sample. Each experiment was  independently repeated on three
separate occasions over three months with duplicate flasks per experimental (i.e.,
treatment) condition. From each treatment flask (generating one slide), 10 IR spec-
tra (32 co-additions, ≈3.85 cm−1 wavenumber spacing, 2.2 kHz mirror speed) were
acquired; thus, 60 IR spectra in total were collected per experimental condition.
2.4. Spectral processing and multivariate data analysis
Raw IR spectra obtained from interrogated samples were pre-processed
prior  to computational analysis. Initially, using OPUS software, IR spectra were
individually cut to the biochemical-cell fingerprint region (1800–900 cm−1). Sub-
sequently, spectra were baseline-corrected and normalized to Amide I (1650 cm−1).
Following on, multivariate analysis (i.e., PCA–LDA) was applied to the spectral
dataset  using MATLAB R2009a (The Maths Works, Natick, MA,  USA) and a graphical
user  interface toolkit for spectroscopy (http://bioph.lancs.ac.uk/iroot).  PCA allows
for the reduction of the number of variables in the spectral dataset, whose small
number of PCA factors [i.e., principal components (PCs)] can capture >95% of the
variance present in the original dataset (Llabjani et al., 2010). In this study, the
first  10 or 20 PCs were used (Fearn, 2002). LDA is a data separation technique to
maximize between-category variance over within-category variance of the output
variables. PCA can be applied before LDA (thus “PCA–LDA”) to reduce computational
complexity,  increase the recognition accuracy in different categories, and avoid LDA
overfitting (Llabjani et al., 2009, 2010). Results were visualized through scores plots
and cluster vector plots (Martin et al., 2007).
2.5. Statistical significance tests
To  determine whether treatment groups were significantly different from
the  corresponding vehicle control, repeated-measures one-way analysis of vari-
ance (ANOVA) with Dunnett’s post hoc tests were used to examine whether the
contaminant-exposed categories observed along linear discriminant (LD)1 were
significantly distinct; there was no need to transform data to meet the underly-
ing  assumptions of homogeneity of variance between categories and normality of
residuals. A small P-value (generally below the most commonly used  ˛ = 0.05) is con-
sidered to be statistically significant. In our case, if a significant difference between
categories  was obtained, it also suggests that one can proceed to the analysis of the
corresponding cluster vectors to identify distinguishing regions of the IR spectrum
that separate the treated cells from the corresponding vehicle control.
2.6.  Determination of cell number
MCF-7  cells were seeded (≈1.0 × 105) in T25 flasks and were grown for 24 h.
This  point was taken as time zero (T0) and duplicate cell counts in triplicate flasks
were  acquired. These T0 cell counts (n = 6) were averaged and normalized to 100%
for  the purposes of this experiment. Cells were then exposed to B[a]P at concen-
trations  of 10−9 M or 10−6 M compared to vehicle control (i.e., DMSO) in 5 mL  of
complete  medium in triplicate flasks. Three independent experiments were con-
ducted on separate occasions. Cells were washed, trypsinized, re-suspended and
cell number determined at indicated time points employing a haemocytometer.
Per  flask, two  independent cell counts (i.e., one by each of two individuals) were
acquired.  The acquired values for each experimental condition were then averaged
and these contributed to the mean ± SD of the three separate experiments. Results
were  expressed as relative cell number [%; i.e., ratio of the cell number at indicated
time point relative to that determined at T0 (normalized to 100%) × 100].
3. Results
3.1. Dose–response effects of B[a]P
Throughout the biochemical-cell fingerprint region in the
derived IR spectra, no clear differences between the different
treatment categories are readily observed (data not shown) (Bi
et al., 2007). Given the overlap of data and subtlety of the spec-
tral variations between different treatment categories, exploratory
multivariate analysis (i.e., PCA–LDA) was carried out. Using this
powerful discriminatory approach, each spectrum is converted into
a single point in scores plots in which the best segregation, along
with discriminating wavenumbers, can be identified. Two indepen-
dent sets of experiments were conducted in which MCF-7 cells were
cultured in the presence or absence of different concentrations of
B[a]P. In Experimental set 1, alterations in MCF-7 cells concentrated
in S-phase or G0/G1-phase of the cell cycle and treated for 24 h with
the vehicle (i.e., DMSO), 10−9 M,  10−8 M,  10−7 M,  10−6 M or 10−5 M
B[a]P were investigated (Fig. 1).
Over the concentration range of B[a]P exposure, spectral
points in scores plots representing cells treated with higher con-
centrations (10−6 M or 10−5 M)  are more segregated from the
corresponding vehicle control compared to those treated with
lower levels, suggesting that dose-related effects were observed
(Fig. 1). ANOVA tests indicate that all treatment categories are signif-
icantly (P ≤ 0.001) different from the corresponding vehicle control
(Table 1). Along LD1 of the cell-cycle associated scores plots, there
is a clear positioning of spectral points from left to right related to
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Table  1
P-values (≤) compared to corresponding vehicle control following analysis employing ANOVA with Dunnett’s post hoc tests along LD1 in Fig. 1.
Statistical comparison B[a]P concentration in MCF-7 culture
10−9 M 10−8 M 10−7 M 10−6 M 10−5 M
vs. vehicle control (Fig. 1A) 0.001 0.001 0.001 0.001 0.001
vs.  vehicle control (Fig. 1B) 0.001 0.001 0.001 0.001 0.001
increasing B[a]P exposure. Interestingly, in these scores plots repre-
senting a comparison of six different treatment categories, clearer
category segregation is noted with B[a]P-treated cells concentrated
in G0/G1-phase (Fig. 1B) compared to those in S-phase (Fig. 1A).
This is primarily because spectral points associated with low-dose
treatment categories are more spread out in S-phase concentrated
cells (Fig. 1A), possibly reflecting a more varied cell population (Jiao
et al., 2007).
3.2.  Effects of high-dose vs. low-dose B[a]P
In Experimental set 2, MCF-7 cells concentrated in S-phase or
G0/G1-phase were treated for 24 h; corresponding vehicle con-
trol (DMSO) was compared to low-dose (10−9 M)  or high-dose
(10−6 M)  B[a]P (Figs. 2 and 3). A comparison of Fig. 2 (represent-
ing MCF-7 cells concentrated in S-phase) and 3 (in G0/G1-phase)
clearly shows that low- and high-dose B[a]P-induced different
dose-related responses. Following 24-h exposure of cells concen-
trated in S-phase to 10−9 M B[a]P, a marked shift away from the
corresponding vehicle control along LD2 but not LD1 is observed;
along LD1 (which will capture the majority of variance), there
is a clear segregation with no overlap of the vehicle control and
10−6 M B[a]P category (Fig. 2A). This suggests that low-dose B[a]P
induces subtle underlying alterations in these exposed cells com-
pared to the profound effects of high-dose treatment. In contrast,
there is a clear dose-related shift of spectral points along LD1 for
MCF-7 cells concentrated in G0/G1-phase (Fig. 3A). PCA–LDA scores
plots exhibit an obvious discrimination following exposure of cells
concentrated in G0/G1-phase, but the marked segregation of cat-
egories amongst S-phase-concentrated cells points to an elevated
Fig. 1. PCA–LDA scores plots performed on the dataset containing IR spectra derived
following indicated B[a]P treatments in MCF-7 cells. (A) MCF-7 cell line concentrated
in  S-phase; and, (B) MCF-7 cell line concentrated in G0/G1-phase. The different cat-
egories were: DMSO (red), 10−9 M (blue), 10−8 M (green), 10−7 M (magenta), 10−6 M
(yellow),  and 10−5 M (black). (For interpretation of the references to colour in this
figure  legend, the reader is referred to the web  version of the article.)
susceptibility to B[a]P-induced alterations in this latter cell popula-
tion. The effects of low-dose vs. high-dose treatment are compared
by measuring the distance in LD1 space from the mean of the
corresponding vehicle control (Figs. 2B and 3B). Distance in LDA
space enables one to determine which treatment induces the most
alterations in cellular structures compared to the corresponding
control, and cluster vector plots identify the precise biomolecular
entities most altered with different treatments (Martin et al., 2010).
One-D scores plots of derived IR spectra explored by PCA–LDA con-
firmed the dose-related increases in B[a]P-induced alterations in
MCF-7 cells concentrated in G0/G1-phase (Fig. 3B), in line with
the initial observation in Fig. 1B. Consistent with Fig. 1A, there
is overlap of spectral points representing vehicle control vs. low-
dose treatment categories with a marked segregation compared
to the high-dose exposure group (Fig. 2B). No overlap is appar-
ent in the 10−6 M B[a]P vs. vehicle control comparison in which
the following wavenumbers (ranked from higher to lower pri-
ority) were responsible for segregation: 1215 cm−1 [asymmetric
phosphate (asPO2−)], 1701 cm−1 (lipid), 1609 cm−1 (Amide I),
1304 cm−1 (Amide III) and 1381 cm−1 (COO symmetric stretching
Fig. 2. Effects of 24-h treatment of MCF-7 cells concentrated in S-phase with high
dose (10−6 M)  or low dose (10−9 M)  B[a]P. PCA–LDA scores plots and resultant clus-
ter  vectors were derived from triplicate experiments each performed in duplicate
(n = 60 IR spectra per category derived from 10 measurements per slide). (A) 2-D
PCA–LDA scores plot; (B) 1-D PCA–LDA scores plot; and, (C) cluster vectors plot. The
different categories were classified as: vehicle control (red), 10−9 M B[a]P (blue) and
10−6 M B[a]P (yellow). (For interpretation of the references to colour in this figure
legend,  the reader is referred to the web version of the article.)
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Fig. 3. Effects of 24-h treatment of MCF-7 cells concentrated in G0/G1-phase with
high dose (10−6 M)  or low dose (10−9 M)  of B[a]P. PCA–LDA scores plots and resul-
tant  cluster vectors were derived from triplicate experiment (n = 60 IR spectra per
category derived from 10 measurements per slide). (A) 2-D PCA–LDA scores plot;
(B) 1-D PCA–LDA scores plot; and, (C) cluster vectors plot. The different categories
were  classified as: DMSO (red), 10−9 M B[a]P (blue) and 10−6 M (yellow) B[a]P. (For
interpretation  of the references to colour in this figure legend, the reader is referred
to  the web  version of the article.)
vibrations of fatty acids and amino acid). Exposure to 10−9 M B[a]P
resulted in spectral alterations (vs. vehicle control) associated with
1539 cm−1 (Amide II), 1701 cm−1 (lipid), 1586 cm−1 (Amide I),
1628 cm−1 (Amide I) and 1304 cm−1 (Amide III), ranked with a
decreasing level of priority (Fig. 2C).
The greatest segregation of spectral points from vehicle
control cells concentrated in G0/G1-phase is observed in the
10−6 M B[a]P category, followed by that of the 10−9 M treatment.
Treatment with 10−6 M B[a]P induced the most pronounced
spectral alterations, with distinguishing wavenumbers (ranked
from higher to lower priority) observed at 1616 cm−1 (Amide I),
1385 cm−1 (COO symmetric stretching vibrations of fatty acids
and amino acid), 1096 cm−1 (sPO2−), 1674 cm−1 (Amide I) and
1034 cm−1 (glycogen). The main spectral alterations (ranked with
a decreasing level of priority) induced by 10−9 M B[a]P treatment
included 1616 cm−1 (Amide I), 1096 cm−1 [symmetric phosphate
(sPO2−)], 1385 cm−1 (COO symmetric stretching vibrations of
fatty acids and amino acid), 1674 cm−1 (Amide I) and 1555 cm−1
(Amide II) (Fig. 3C).
3.3.  Cell number with time in culture with exposure to B[a]P
The  effects of B[a]P on the increases in cell numbers of MCF-7
cells in culture are shown in Fig. 4. Following a 12-h treatment,
there are no marked differences between different treatment cat-
egories (vehicle control vs. 10−9 M B[a]P vs. 10−6 M B[a]P). After
a further 12 h, high-dose B[a]P (i.e., 10−6 M)  gave rise to an ele-
vated cell number, compared to the other two treatment categories.
Fig. 4. Effects of B[a]P treatment of MCF-7 cells in culture on time-related increases
in  cell number. Cells were treated with B[a]P (10−9 M or 10−6 M)  or DMSO as cor-
responding  vehicle control. Cell numbers were determined at the indicated time
points. Results are expressed as relative cell number [%; i.e., ratio of the cell number
at  indicated time point relative to that determined at T0 (normalized to 100%) × 100].
Each experiment was conducted on three separate occasions in triplicate with two
independent cell counts (i.e., one by each of two individuals) acquired per flask.
The  acquired values for each experimental condition were then averaged and these
contributed to the mean ± SD of the three separate experiments.
However, following 48-h treatment, high-dose B[a]P resulted in
marked decreases in cell numbers; in contrast, low-dose B[a]P (i.e.,
10−9 M)  exposure resulted in a similar if not slightly higher level of
cell numbers compared to the corresponding vehicle control.
4.  Discussion
ATR-FTIR spectroscopy with multivariate analysis was applied
to characterize B[a]P-induced alterations of MCF-7 cells con-
centrated in different phases of the cell cycle. The multivariate
approach of PCA–LDA was employed to extract subtle differences
in the complex dataset of derived IR spectra (Trevisan et al., 2010).
Between-category (i.e., different treatment categories) segregation
was best demonstrated in scores plots. This approach appears
capable of identifying dose-related effects of B[a]P over a large con-
centration range, down to levels lower than that required to induce
cytotoxicity (Hockley et al., 2006; Hamouchene et al., 2011). Tra-
ditionally, high-dose concentrations (primarily ≥M) have been
investigated in short-term genotoxicity assays; how the observed
effects under these experimental conditions extrapolate to real-
world low-dose environmental exposures over some decades is
uncertain (Weisz et al., 2012).
Nearness in multivariate distance implies similarity, whilst seg-
regation of category clusters in the PCA–LDA scores plots signifies
dissimilar groups of cellular structures (Martin et al., 2007, 2010).
Both 1-D and 2-D scores plots demonstrated that the 10−6 M
category exhibited a greater degree of segregation from the cor-
responding vehicle control than the 10−9 M group, irrespective of
whether exposed cells were concentrated in S-phase or in G0/G1-
phase. Extracted distinguishing features (or variables) induced by
10−6 M B[a]P treatment compared to the corresponding control
in S-phase-concentrated cells were associated with alterations in
DNA/RNA (e.g., asPO2−), lipid, secondary structures of proteins
(Amide I and Amide III) and, COO symmetric stretching vibra-
tions of fatty acids and amino acid (Figs. 2C and 3C). In contrast,
low-dose (10−9 M)  B[a]P resulted in marked alterations associated
with secondary structures of proteins (Amide I, Amide II and Amide
III) and lipid (Figs. 2C and 3C).
These dissimilar alteration profiles induced by different concen-
trations of B[a]P exposure even within cells concentrated in the
same phase of the cell cycle point to different mechanisms of action;
however, most definitive is the observations that high-dose B[a]P
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is most effective in producing DNA/RNA alterations. In addition,
B[a]P-induced spectral alterations following low-dose or high-dose
exposure in cell populations concentrated in G0/G1-phase were
associated with secondary structures of proteins, DNA/RNA and,
COO symmetric stretching vibrations of fatty acids and amino
acids. This combination of alterations in DNA/RNA and proteins is
suggestive of a genotoxic insult; alterations in protein may  also be
a consequence of AhR-stimulated influences on gene expression
(Hockley et al., 2007; Hooven and Baird, 2008; Takemura et al.,
2010).
MCF-7 cell lines differ in their response to B[a]P exposure in a
time- and concentration-specific manner. B[a]P appears capable of
inducing MCF-7 cell proliferation in comparison to corresponding
control (Fig. 4); high-dose exposure induces short-term prolif-
eration but long-term inhibition of cell growth (Kalantzi et al.,
2004) and cytotoxicity (Myllynen et al., 2007), whereas exposure to
low-dose exposure appears to generate no short-term effect. B[a]P-
induced proliferation in the oestrogen-responsive human cell line
human MCF-7 cell could be mediated by the oestrogenic proper-
ties of B[a]P (Tsai et al., 2004). It is intriguing that humans are
rarely exposed to acute high-dose levels of environmental contam-
inants akin to those tested in short-term genotoxicity assays, but
do have chronic lifetime exposures to low-dose levels. The aeti-
ology of many age-related diseases may  involve subtle alterations
accumulated over a number of decades; this study demonstrates
that low-dose exposures are capable of inducing alterations in
exposed cell populations. Critically, these alterations occur in sur-
viving cells. Biospectroscopy techniques could be an adjunct to
other emerging technologies such as epigenetic profiling in order
to better understand mechanisms of contaminant-induced effects
(Tian et al., 2012).
The  application of IR spectroscopy with computational analy-
sis offers the possibility to investigate the mechanistic effects of
low-dose levels of environmental contaminants. The potential to
produce an integrated response profile to environmental effects
(Malins et al., 1997) that may  exhibit a nonlinear dose-response
or linear dose–response (Llabjani et al., 2011) relationship is novel
and exciting. Employing multivariate analysis techniques such as
PCA–LDA could allow for an objective classification approach for
alterations induced by test agents in target cells.
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Nanotechnology has introduced a wide variety of man-made materials designed to 
nanoscale, especially nanoparticles, into our environment. Because of their unique 
physico-chemical properties, nanoparticles may pose a potential risk to human health 
and the environment. Most recent investigations assessing the risk of nanotoxicology 
have mainly focused on high-dose effects. However, classic toxicokinetic or 
toxicodynamic considerations applied for chemical risk assessment may not apply to 
nanoparticle exposures. There is also a significant lack of understanding of their 
mechanism(s) of action. Biospectroscopy techniques have been employed as a novel 
approach to identify low-dose effects induced by test agents in target cell populations 
[1]. In this study, MCF-7 cells concentrated  in S-phase or G0/G1-phase were treated 
for 24 h with short multi-walled carbon nanotubes at the following concentration 
range: 0.0025 mg/L, 0.005 mg/L, 0.01 mg/L, 0.025 mg/L, 0.05 mg/L and 0.1 mg/L. 
Cells were then examined using attenuated total reflection-Fourier-transform infrared 
(ATR-FTIR) spectroscopy coupled with multivariate analysis; this approach allows 
the derived data [i.e., infrared (IR) spectra] to be visualized as spectral points within 
respective categories, e.g., treatments. Even at the lowest concentrations employed, 
significant (P 0.05) separation of IR spectra representing treatment categories versus 
vehicle control was observed. Dose-related effects were also noted. To identify the 
discriminating biomolecular entities segregating various spectral categories, cluster 
vector plots were employed. These showed that the major alterations induced by short 









)]. These results suggest that 
short multi-walled carbon nanotubes may cross the cell membrane in order to generate 
a genotoxic mechanism of action. 
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